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Abstract 
A rise in food safety and production standards (e.g. the ban on antibiotics) has 
led to a search for alternative natural products to achieve a high yielding, safe method of 
meat production. Mannan oligosaccharides (MOS) are one such class of product that 
can potentially provide this. Abundant in the cell wall of Saccharomyces cerevisiae as 
well as other yeast species, MOS have the capacity to inhibit type 1 fimbriae containing 
pathogenic bacteria from binding to host tissue and thus prevent infection.  
Alterations in the growing conditions of several yeast strains, including 
Saccharomyces, Kluyveromyces, Candida, Schizosaccharomyces, Pichia, and 
Rhodotorula were examined to determine if by varying simple fermentation constituents 
it was possible to change yeast cell wall composition and increase its MOS content. The 
cell wall monosaccharide content (e.g. glucose and mannose) of a number of samples 
was significantly altered depending on the sole carbon source in the growth medium. 
However, the effect of carbon source on the cell wall monosaccharide content was strain 
specific. 
A quantitative assay to assess the efficacy of MOS type products to bind bacteria 
in vitro was developed. Initially, agglutination of bacteria to MOS was observed on a 
microscope slide for a number of type 1 fimbriae containing strains of Salmonella and 
Escherichia coli. The method was transferred to a 96 well plate format and optimised. 
The binding activity assay was shown to be repeatable and reproducible for Salmonella 
and E. coli strains. 
Yeast cell wall samples generated in this study were screened using the 
developed assay. S. cerevisiae 695, K. lactis 752, and Schiz. pombe 70572 cell wall 
samples had significantly higher binding activity than the control MOS used to develop 
the assay. The relationship between the yeast cell wall saccharide content and binding 
activity varied between strains indicating that the structure and not necessarily the 
quantity of the saccharides were more important in binding type 1 fimbriae containing 
bacteria. Analysis of the N-glycan profile of the samples with high binding activity 
revealed the presence of both common and unique mannan oligosaccharides. These 
unique mannan oligosaccharides may be responsible for the increased binding activity 
of these samples.   
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1.  Introduction 
 
1.1   Agricultural biotechnology 
Just as society has evolved over time, our food system has also evolved over centuries 
into a global system of immense size and complexity. Contemporary food science and 
technology contributed greatly to the success of this modern food system by integrating 
many disciplines to solve difficult problems, such as resolving nutritional deficiencies, 
disease, and enhancing food safety. During the 2009 World Summit on Food Security, it 
was recognized that by 2050 food production must increase by about 70 % to feed the 
anticipated 9 billion global population, 34 % higher than the population of 2009 (FAO, 
2009a). This projected population increase is expected to involve an additional annual 
consumption of nearly 1 billion metric tons of cereals for food and feed and 200 million 
metric tons of meat. As a consequence, science based improvements in agricultural 
production, food science and technology, and food distribution systems are critically 
important in decreasing this gap. Further advancements are needed to resolve the 
challenges of sustainably feeding the growing future population (Floros et al., 2010). 
Livestock production is a dynamic and integral part of the food system today, 
contributing 40 % of the global value of agricultural output, 15 % of total food energy, 
and 25 % of dietary protein and supporting the livelihoods and food security of almost a 
billion people (Floros et al., 2010, FAO, 2009c). The current livestock sector has shifted 
from pasture-based ruminant species (cattle, sheep, goats) to feed dependent 
monogastric species (swine, poultry) and is marked by intensification and increasing 
globalization (Floros et al., 2010). The rapidly increasing demand for meat and dairy 
products has led, during the past 50 years, to an approximate 1.5 fold increase in the 
global numbers of cattle, sheep, and goats, 2.5 fold increase in pigs, and 4.5 fold 
increase in chickens (Godfray et al., 2010). The rates of conversion of grains to meat, 
milk, and eggs from food animals have improved significantly globally (Floros et al., 
2010). In addition to these productivity gains, bird health, and product quality and 
safety have improved through applications of breeding, feeding, disease control, 
housing, and processing technologies (Floros et al., 2010, FAO, 2009c). Poultry meat 
can be produced in a very efficient way which makes it one of the lowest cost animal 
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proteins with a low environmental footprint. In addition, poultry does not carry any 
religious restrictions and is consumed almost all over the world.  
 
1.1.1  Poultry industry 
The poultry sector continues to grow and industrialize in many parts of the world, 
poultry meat will soon supplant pork as the world’s most eaten meat (AVEC, 2014). An 
increasing population, greater purchasing power and urbanization have been strong 
drivers of growth (FAO, 2014). Poultry constitutes many different domesticated species 
of bird that are subdivided into different types mainly broilers, breeders, and layers, 
depending on their purpose. The domestic chicken, Gallus gallus domesticus, dominates 
the poultry market accounting for over 85 % of all poultry meat produced worldwide 
with a global population exceeding 21 billion birds per year (FAO, 2015, 
www.thepoultrysite.com, 2013, Muir et al., 2008) and comprise an economically 
valuable global protein industry (Oakley et al., 2014). Turkeys are second to chickens in 
the poultry market. Advances in breeding have given rise to birds that meet specialized 
purposes and are increasingly productive, but need expert management (FAO, 2014, 
Wolc, 2014). Broilers form the largest group of poultry farmed commercially. These 
birds have been genetically selected for rapid growth, efficient feed conversion and 
greater production of meat. The aim of a breeder is to maximise reproductive 
performance in terms of egg numbers and hatchability, in a bird whose genetic 
background is strongly slanted towards meat production. Layers are birds that are 
selected for increased egg production with egg quality being of primary importance. 
The main goals of commercial poultry producers worldwide are in achieving the genetic 
potential for growth, maintaining health, and food safety at the lowest input costs 
(Pattison et al., 2008). 
The poultry industry has grown remarkably in the last 50 years and the production of 
poultry meat is expanding to meet higher demand for low cost, healthy, and convenient 
products. In 2012, world poultry output looked likely to approach 91 million tonnes and 
93 million tonnes by 2013. In the following years to 2020, projections point to growth 
of around two percent a year for both Europe and the world (www.thepoultrysite.com, 
2012a). Growth in meat consumption will be driven by consumer preferences together 
with disposable income and population growth. Since the early 1960s, broiler growth 
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rates have doubled and feed conversion ratios have halved (Floros et al., 2010). Modern 
broilers weigh about 2.5 kg at 39 days, with a feed conversion ratio of 1.6 kg of feed per 
kilogram of bodyweight gain. Modern commercial layers typically produce about 330 
eggs per year with a feed conversion ratio of 2 kg of feed per kilogram of eggs 
produced. Poultry meat and eggs have food nutritional values with high amounts of 
protein and low fat content. As a consequence the price for consumers is reasonable 
which is important for meeting the challenge of feeding the growing world population 
(AVEC, 2014). 
Since the 1990s, the production of poultry meat in low and middle income countries has 
increased, with chicken meat accounting for 80 percent, and duck and goose meat 
production also increasing. China and Brazil, in particular, have emerged as major 
poultry meat producers (Figure 1.1). Meanwhile North American and European 
producers have lost their global market shares. Over the last 30 years, egg production 
has also increased enormously in East and Southeast Asia. In 2007, about 45 % of the 
eggs consumed worldwide were produced in China (www.thepoultrysite.com, 2012a). 
Figure 1.1. World poultry meat and chicken meat production by region (million 
tonnes). 
Source: (www.thepoultrysite.com, 2012b) 
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1.1.2  Pork Industry 
Pork is the most commonly consumed meat in the world (Baer et al., 2013) and is the 
most popular meat in East and South East Asia. In 2014, swine production in China was 
projected to reach 723 million head, that’s more than twice the U.S. population and half 
the Chinese population (Brasch, 2014). In China, consumption of pork is close to 
saturation levels which will benefit alternative sources of proteins, such as poultry. The 
larger consumers of poultry meat per capita (Malaysia, Israel and Saudi Arabia), are 
located in countries where pork is not eaten due to religious restrictions (AVEC, 2014). 
In the United States, per capita consumption of pork has remained steady over the past 
20 years at about 27 kg/year and in the European Union (EU) people eat more pork than 
any other meat (Baer et al., 2013). With 150 million pigs and a yearly production of 
about 22 million tonnes carcass weight the EU is the world's second biggest producer of 
pigmeat after China and also the biggest exporter of pigmeat and pigmeat products. The 
EU's main producer countries are Germany, Spain and France. Together, they represent 
half of the EU's total slaughter. The EU has a self sufficiency of about 111 % and 
exports about 13 % of its total production. Most of the EU's pigmeat exports go to East 
Asia, in particular China (Commission, 2015).  
According to the US department of agriculture (USDA) in January 2012, the United 
States exported over 501 million pounds of pork (Baer et al., 2013). The United States 
accounts for 10 % of global pork production, making it the world’s third largest pork 
producer, behind China (46 %) and the EU (24 %) (Lowe and Gereffi, 2008). As the 
world’s third largest pork producer, and second largest consumer, importer and exporter 
of pork and pork products, the United States had a 2007 inventory of some 67 million 
hogs. More than 80 % of this inventory was on large farms containing at least 2,000 
animals. Between 1985 and 2007 the live weight of pigs in the US has increased by 14 
kg and the herd feed conversion has decreased by 0.57 units, respectively (Campbell, 
2008).  
In a 2008 report by www.safefood.eu more pork meat per capita was consumed on the 
island of Ireland than any other meats including poultry, beef and mutton/lamb. 
However, greater than 50 % of pork meat consumed is in a processed form. Eighty-five 
percent of people on the island consume pork and pork products with consumers in 
Northern Ireland consuming slightly more than those in the Republic of Ireland. In 2007 
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in the Republic of Ireland, pigmeat production was valued at €290 (£198) million at 
farm gate representing five percent of the grass agricultural output and making it the 
third most important sector in agriculture output after beef and milk. 
 
1.2   Challenges facing the poultry and swine industries 
The many challenges facing the animal production industry include rapid human 
population expansion, increasing demand for limited resources, and animal and human 
health concerns. The United Nations (UN) has estimated the current world population at 
7.2 billion which is projected to increase by almost one billion people within the next 
twelve years, reaching 8.1 billion in 2025 and 9.6 billion in 2050 (UN, 2014), where 70 
% of the population are expected to be urban with an increased income (FAO, 2009a). 
A challenge to the animal production industry is to be able to meet this increase in 
demand. The Food and Agriculture Organisation (FAO) in the United States suggests an 
increase in global food production of 70 % will be necessary to meet these population 
and income projections (FAO, 2009b).  
With the increase in demand for animal protein and the decrease in the quantity of 
world cereal crops being used for feed, a further challenge to the industry is to have a 
highly nutritive diet with little wasted energy and improved feed conversion 
efficiencies. The use of cereals for non-food purposes grew at treble the rate of their use 
for food purposes between 2000 and 2007 (McLeod et al., 2009). This shift of feed to 
the fuel production industry left lower quality feed for the animal feed industry. This in 
turn has led to nutritional problems and challenges in feed conversion efficiencies that 
need to be addressed. 
Disease and animal welfare are a major concern in all sectors involved with animal 
production. Loss of animal production and reproduction or even a deterioration of 
health, i.e. “going back”, due to illness both clinical and subclinical, are of major 
economic importance to the global animal production industry. A decrease in feed 
efficiencies reduces the margins for financial return on the animal. In addition, the cost 
of sick animals through medication, vet bills, housing, feed loss, recovery period 
downtime, loss of product/revenue, and cost of lost time when an animal is ill, is 
undesirable. The larger the herd/flock the greater the economic impact as disease can 
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spread throughout a flock or herd relatively quickly. A 2007 analysis conducted by the 
University of Georgia, United States, calculated that the gross value of production 
(GVP) of the United States poultry industry in 2005 was US$28.2 billion, and disease 
losses were 8.2 % of this. The study also showed that for each US$1,000 loss due to 
mortalities, another US$2,000 is lost elsewhere owing to depressed productivity 
resulting from disease (FAO, 2013). Pathogenic bacteria can remain undetected at both 
subclinical levels and high numbers within the digestive tract. In poultry, this type of 
subclinical infection can result in reduced weight gains of the birds and leads to 
significant economic losses to the farmers. Reduced supply can drive up the cost of 
meat for the consumer and the increased load of pathogenic bacteria can lead to 
increased incidences of zoonotic infection (Santos, 2006). Recently, supermarkets are 
willing to pay more for healthier/disease free products. This reflects the marketplace’s 
attitude to healthier food and food products and a general concern for food safety with 
an understanding of the risks of contaminated foods (Baer et al., 2013). Food related 
disease outbreaks have generated much media attention in recent years increasing 
consumer awareness. 
Zoonotic disease transmission is a continuing challenge to the industry. Microbiological 
hazards carried primarily by healthy animals have been identified as causing the 
majority of foodborne risks to human health. These microbes include: Salmonella 
enteritidis, Campylobacter jejuni, Escherichia coli, Shigella, Cryptosporidium, 
Clostridium perfringens, Yersinia enterocolitica, and Listeria monocytogenes, with 
salmonellosis and campylobacteriosis being the most frequently transmitted zoonotic 
agents from poultry meat and eggs to humans (Turantas et al., 2015). Avian influenza is 
a further zoonotic virus that poses a threat to the industry. In regions where the virus has 
been reported, large decreases in poultry meat consumption were seen in affected 
countries (ERSA, 2007). Porcine circovirus 2 (PCV2) is recognized as an endemic 
infection of swine, worldwide. In less than 2 decades, this virus has become one of the 
most economically important infectious agents in modern swine production. PCV2 has 
been effectively controlled with conventional vaccines to date (Ellis, 2014). The impact 
that disease has on the industry is one of its major limiting factors for optimal 
performance and has resulted in an increase in biosecurity awareness, implementation, 
and management within the sector. Consumers have also become increasingly 
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concerned about foodborne illness and infections and the control and possible 
elimination of this threat is a goal of the poultry industry (Santos, 2006).  
Antibiotics have traditionally been used in both poultry and pork feed at sub therapeutic 
levels to combat sub clinical disease and improve growth (McWilliams, 2013, Zhu et 
al., 2013, Smith et al., 2002). An increase in food safety concerns resulting from 
extensive antibiotic use has seen the poultry industry challenged further as safer meat 
free from antibiotics and disease is a necessity within the EU. Consumer demand for 
antibiotic free meat has also increased within the United States and other developed 
countries due to concerns with antibiotic resistance, making it necessary for poultry 
producers to find suitable alternatives to antibiotics as growth promoters (Sofos, 2008). 
In the United States, legislation has been introduced that seeks to restrict the use of 
certain antimicrobial drugs for subtherapeutic or nontherapeutic purposes in food 
producing animals, such as the cephalosporin class of antimicrobial drugs. In the 112th 
Congress, the leading bills were the Preservation of Antibiotics for Medical Treatment 
Act of 2011 (PAMTA, H.R. 965, S. 1211). Most U.S. livestock and poultry producers 
are opposed to such restrictions because of concerns about animal welfare and food 
safety, as well as concerns about possible increases in production costs, among other 
reasons (Johnson, 2011). 
 
1.2.1  Zoonoses associated with animal production 
Zoonoses are diseases or infections, which are transmissible from animals, both wild 
and domestic, to humans. Zoonotic disease can be caused by bacteria, viruses, fungi and 
parasites and can be transmitted to humans in different ways. These diseases can be 
acquired directly from animals but are most often acquired through ingestion of 
contaminated foods (Newell et al., 2010, Norrung and Buncic, 2008). Zoonotic diseases 
cause losses in goods produced (live animals, milk, meat, eggs, wool) and disability or 
loss of human life (Narrod et al., 2012). Foodborne pathogens are a major contributor to 
human illnesses, hospitalizations, and deaths each year. Consumption of food 
contaminated with zoonotic agents or their toxins is a serious threat for public health. In 
developed countries, it is estimated that up to one third of the population is affected by 
microbial foodborne diseases each year (Van Immerseel et al., 2009). The Centre for 
Disease Control and Prevention (CDC) estimates that approximately 47.8 million 
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illnesses and 3,000 deaths are caused by foodborne pathogens each year (Baer et al., 
2013). Using data from outbreak-associated illnesses for 1998–2008, annual US 
foodborne illnesses, hospitalizations, and deaths were attributable to each of 17 food 
commodities: 3 for aquatic animals (fish, crustaceans, and mollusks), 6 for land animals 
(dairy, eggs, beef, game, pork, and poultry), and 8 for plants (grains/beans; oils-sugars 
[refined plant foods]; fruits-nuts; fungi; and leafy, root, sprout, and vine-stalk 
vegetables). Forty six percent of illnesses were linked to food produce and more deaths 
were attributed to poultry than to any other food commodity (Painter et al., 2013).  
Data on foodborne diseases in low income countries are scarce. There is no precise and 
consistent global information about the full extent of the occurrence of food poisoning 
and the costs related to unsafe food. Symptoms are often mild and cases are not 
reported, but their importance is thought to be substantial. Children and people in stress 
situations, such as those facing malnutrition, war or natural disasters, are especially at 
risk of foodborne bacterial diseases. The main symptom is diarrhoea, and infection can 
be fatal (when compared with 0.01 % mortality in infected people in high-income 
countries). As the causal agent is a bacterium, these diseases can be treated by 
antibiotics, but access to treatment is difficult in many low-income countries. Another 
problem is the development of resistance to antibiotics among zoonotic bacteria. The 
pattern of foodborne disease outbreaks has changed during the last two decades. In the 
past, most outbreaks were acute and localized, and resulted from a high level of 
contamination. Now, more outbreaks affect several countries at once, resulting from low 
level contamination of widely distributed commercial food products. Risks of the 
contamination of poultry products by residues and bacteria exist everywhere, owing to 
the globalization of poultry production and trade (FAO, 2013). The economic burden of 
zoonosis is significant. According to the Institute of Medicine, zoonotic pathogens 
caused more than 65 % of emerging infectious disease events in the past six decades. 
The direct cost of zoonotic diseases over the decade up to 2012 has been estimated to be 
more than $20 billion with over $200 billion in direct losses to affected economies as a 
whole (Narrod et al., 2012).  
Viruses such as Newcastle disease virus and Influenza A virus are the most commonly 
spread viruses from poultry to humans and are typically resultant from direct contact 
with birds but may also be spread by the ingestion of contaminated foodstuffs (Pattison 
et al., 2008). Fungal zoonoses associated with poultry include histoplasmosis and they 
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are mainly spread through contact with infected faeces (Pattison et al., 2008, Saif and 
Fadly, 2008). Cryptosporidiosis is a parasite that infects poultry and is also 
transmissible to humans. The protozoa are shed in faeces and can contaminate water and 
other sources, where it can be transmitted to humans causing watery non bloody 
diarrhoea in immuno-competent individuals; while it can cause chronic persistent 
gastroenteritis in the immuno-compromised. In 2007, 609 cases of cryptosporidiosis 
were notified in Ireland, a crude incidence rate of 14.4 per 100,000 population, this was 
the largest annual number of cases notified since human cryptosporidiosis became 
notifiable in Ireland in 2004 (Pattison et al., 2008, Saif and Fadly, 2008, Garvey and 
McKeown, 2007).  
Bacterial zoonotic agents of poultry origin are the ones that are of most concern to the 
poultry industry, humans and economists. It is well recognized that pathogens, such as 
Campylobacter and Salmonella spp. can be transmitted along the food chain and can be 
the source of human illness (Gaggia et al., 2010). While E. coli is another important 
zoonotic pathogen it is not as prevalent. Campylobacter and non typhoidal Salmonella 
are the key causes of foodborne illness of bacterial origin, both in the US and in the EU 
(Van Immerseel et al., 2009). Salmonella are major zoonotic pathogens causing over 1 
billion cases of infection worldwide each year. Contaminated poultry meat and eggs are 
important vehicles of infection and there are approximately 100, 000 cases of 
Salmonella infection in the UK every year (Humphrey, 2006). Flock health, the 
structure of the poultry food chain (short or chilled), the quality of control procedures 
during production and supply processes and on the final product – all contribute to the 
marketing of safe poultry meat and eggs (FAO, 2013). 
Although pork is less associated with foodborne illness than other meat sources, it 
remains significant due to its large consumption in a variety of products. As pork is so 
widely consumed and is an important U.S. export, ensuring a safe pork supply is 
crucial. Furthermore, heightened consumer awareness of food safety makes the 
reduction of foodborne pathogens from pork important for producers and processors 
(Baer et al., 2013). While pigs can be infected with many different serovars, clinical 
disease is caused mainly by Salmonella choleraesuis, Salmonella typhisuis, and 
Salmonella typhimurium (Poljak, 2009). Because Salmonella resides in the intestinal 
tract of swine, shedding of the bacteria by asymptomatic carriers on the farm is 
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inevitable and is the major route for Salmonella infection in other animals (Baer et al., 
2013).  
A recent report compiled by the European Food Safety Authority (EFSA) and the 
European Centre for Disease Prevention and Control (ECDC) presented the results of 
the zoonoses monitoring activities carried out in 2013 in 32 European countries found 
that campylobacteriosis was the most commonly reported zoonosis (Table 1.1). A 
decreasing trend in confirmed salmonellosis cases in humans was observed. The 
number of confirmed verocytotoxigenic Escherichia coli (VTEC) infections in humans 
increased. The sources of VTEC infections was reported to come from food and animal 
sources (ECDC, 2015). Although various foods can serve as sources of foodborne 
illness, meat and meat products are important sources of human infections with 
Salmonella spp., Campylobacter jejuni/coli, Yersinia enterocolitica, VTEC and, to 
some extent, L. monocytogenes (Norrung and Buncic, 2008). Most foodborne outbreaks 
were caused by Salmonella, followed by viruses, bacterial toxins and Campylobacter, 
whereas in 28.9 % of all outbreaks the causative agent was unknown. Important food 
vehicles in foodborne outbreaks were eggs and egg products, followed by mixed food, 
and fish and fish products (ECDC, 2015). 
Table 1.1 Reported hospitalisation and case-fatality rates due to zoonoses in 
confirmed human cases in the EU, 2013. 
 
Source: (ECDC, 2015) 
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1.2.2  Salmonella 
Salmonella are Gram-negative, facultatively anaerobic, non spore forming, type 1 
fimbriated, rod shaped organisms of the family Enterobacteriaceae and are readily found 
in the gastrointestinal (GI) tract of humans and animals. The Salmonella spp. is divided 
into more than 2,500 serovars. Salmonlellosis is an infection caused by Salmonella and 
is one of the most common causes of food borne diarrheal disease worldwide (Wegener 
et al., 2003). The main reservoir of zoonotic Salmonella is food animals, and the main 
sources of infections in industrialized countries are animal derived products (Wegener 
et al., 2003). Egg and egg products are the largest source of salmonellosis in humans 
followed by poultry and pork meat at 11 %, 2.7 % and 1.5 % respectively, of all cases 
reported (Van Immerseel et al., 2009, Norrung and Buncic, 2008).  
Human salmonellosis is usually characterised by prolonged fever, diarrhoea, abdominal 
pain, nausea, stomach pain, spleen enlargement, rash, and severe headache (Niskanen et 
al., 2015). The majority of human cases are caused by only a few non typhoidal 
serovars. Approximately 60 % of human cases reported to the CDC in 1995 were 
caused by four serovars, including Salmonella enteritidis (24.7%), Salmonella 
typhimurium (23.5%), Salmonella newport (6.2%) and Salmonella heidelberg (Rabsch 
et al., 2001). The incidence of food borne human infections caused by Salmonella 
enteritidis and by multi-drug-resistant strains of Salmonella typhimurium increased 
substantially during the second half of the 20th century in both the US and Europe 
(Rabsch et al., 2001). In 2013, a total of 82,694 confirmed salmonellosis cases were 
reported by 27 EU member states, resulting in an EU notification rate of 20.4 cases per 
100,000 of the population. The two most commonly reported Salmonella serotypes in 
2013 were Salmonella enteritidis and Salmonella typhimurium, representing 39.5 % and 
20.2 %, respectively. Salmonella was most frequently detected in poultry meat, and less 
often in pig or bovine meat. Salmonella findings were also reported in other animal 
species, including ducks, geese, sheep and goats (ECDC, 2015). From fowl, Salmonella 
infantis was the most commonly reported isolated serovar in 2013; in broiler meat the 
most common serotypes were Salmonella infantis and Salmonella enteritidis, while 
from feed for fowl, Salmonella senftenberg was most commonly reported, followed by 
Salmonella typhimurium. In turkey meat the three most common reported serotypes 
were Salmonella derby, Salmonella typhimurium and Salmonella stanley. Salmonella 
typhimurium was the most frequently reported serotypes in pigs and pigmeat. In cattle, 
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Salmonella typhimurium was the most commonly reported, followed by Salmonella 
dublin. Also in bovine meat, Salmonella typhimurium were the most frequently reported 
serotypes, followed by Salmonella enteritidis (ECDC, 2015).  
A number of these serovars can replicate readily within the host organism however they 
are non host specific in poultry, normally causing asymptomatic intestinal infections 
which are therefore difficult to diagnose and treat. Acute outbreaks exhibiting clinical 
disease along with high levels of mortality may occur in chicks younger than two weeks 
old. Infection, usually by the faecal oral route, of newly hatched chicks results in rapid 
and massive multiplication within the alimentary tract due to the absence of competing 
microflora. Thusresulting in extensive faecal shedding for a number of weeks and cross 
contamination within the house or hatchery (Pattison et al., 2008). An important means 
of preventing human salmonellosis is by preventing infection of poultry (Porter, 1998). 
This strategy can also be applied to the pork industry. 
Clinical infection causes diarrhoea in birds along with depression, reduced feed intake, 
weight loss and possible visual impairment. Subclinical infection may cause an 
inflammatory response in the intestine with tissue damage and possibly result in 
systemic infection. Humans, rodents, wild birds, insects, water and feed can all 
introduce infection into a poultry unit and Salmonella spp. can spread from unit to unit 
through vehicles and equipment such as egg trays and trolleys. The infection cycle can 
also occur via eggs at the time of hatch by the faecal contamination of egg surfaces 
when passing through the cloaca. Avian systemic salmonellosis causes considerable 
worldwide economic loss both through chicken mortality and through loss of 
productivity (Parsons et al., 2015). The most common disease causing Salmonella 
serotypes in poultry are Salmonella gallinarum and Salmonella pullorum. Under the 
new naming system the Salmonella enterica serotypes gallinarum is divided into biovar 
gallinarum and pullorum; these are non motile, host specific salmonellae which are 
identified to cause fowl typhoid and pullorum disease in poultry respectively, but are 
not important causes of infection in humans (Cheraghchi et al., 2014, Pattison et al., 
2008). These diseases are characterized by anorexia, diarrhoea, dehydration, anaemia 
and up to 50 % mortality of flocks. Symptoms also include decreased laying and 
hatchability and high chick mortality (Van Immerseel et al., 2013). Among diseases of 
poultry, salmonellosis is of great concern and has been responsible for serious economic 
Section 1  Introduction 
13 
 
losses of poultry through mortality and loss of production (Parsons et al., 2015, Akiba et 
al., 2011, Kabir, 2010). 
 
1.2.3  Escherichia coli 
Escherichia coli are Gram-negative bacteria that are a normal constituent of the 
intestinal tract microbiota of humans and warm blooded animals (Andersson et al., 
2012). The niche of commensal E. coli is the mucous layer of the mammalian colon 
(Kaper et al., 2004). They are facultatively anaerobic, flagellated, type 1 fimbriated, and 
rod shaped bacteria (Pattison et al., 2008). Certain strains are also important disease 
causing pathogens of both humans and poultry. Pathogenic E. coli strains possess 
specific adherence factors or lectins that allow them to colonize sites that E. coli does 
not normally inhabit, such as the small intestine and the urethra (Kaper et al., 2004). An 
individual bacterium may co-express more than one lectin e.g. certain strains of E. coli 
are both mannose and galabiose specific (Sharon, 2006). Some strains of E. coli, e.g., 
O157:H7, are acid tolerant, which permits them to pass through the stomach without 
being killed (Saif and Fadly, 2008). Many different serotypes of E. coli exist and three 
types of antigens, the O (lippopolysaccharide, LPS), K (capsular), and H (flagellar) 
antigens are used to identify them. A serogroup is identified by the O antigen only, a 
serotype by both the O and H (Kaper et al., 2004). 
Pathogenic E. coli strains use a multi step scheme of pathogenesis that is similar to that 
used by other mucosal pathogens, which consists of colonization of a mucosal site, 
evasion of host defences, multiplication and host damage (Kaper et al., 2004). In 
Europe, antimicrobial resistance in Gram-negative bacteria is on the rise, particularly in 
E. coli, which constitutes a majority of invasive Gram negative isolates in European 
countries. The emergence and diffusion of multi drug resistant strains of E. coli is 
complicating the treatment of several serious infections. Enterobacteriaceae, particularly 
E. coli, are the most frequent cause of hospital and community acquired infections 
(Allocati et al., 2013). Pathogenic E. coli are characterised based on virulence 
properties, mechanisms of pathogenicity, clinical symptoms and serology (Mora et al., 
2009). Three general clinical syndromes can result from infection with one of the 
pathogenic strains of E. coli pathotypes: enteric/diarrhoeal disease, urinary tract 
infections (UTIs) and sepsis/meningitis. Among the enteric pathogens there are six well 
Section 1  Introduction 
14 
 
described categories: enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli 
(EHEC) or Shigga toxin producing E. coli (STEC) or verocytotoxiginic producing E. 
coli (VTEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), 
enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC). UTIs are the most 
common extraintestinal E. coli infections and are caused by uropathogenic E. coli 
(UPEC). An increasingly common cause of extraintestinal infections is the pathotype 
responsible for meningitis and sepsis, meningitis associated E. coli (MNEC) (Kaper et 
al., 2004). An additional animal pathotype, known as avian pathogenic E. coli (APEC), 
causes extraintestinal infections, primarily respiratory infections, pericarditis, and 
septicaemia of poultry (Mora et al., 2009, Kaper et al., 2004).  
Some pathogenic strains of ETEC cause diarrheal disease with severe symptoms and 
dehydration, leading to annual mortality of hundreds of thousands of children below the 
age of five in developing countries (Andersson et al., 2012). E. coli O157:H7 is 
probably the most common source of VTEC infection (Niskanen et al., 2015), is widely 
known regarding foodborne illness in humans and is transmitted by infected meat and 
unwashed fruit and vegetables. A report published by the European centre for disease 
control estimated that the incidences of VTEC in the EU/EAA increased significantly 
during 2008-2012. The highest number of cases was reported in 2011 due to a large 
outbreak of VTEC O104:H4 occurring in Germany. Eighty six percent of the confirmed 
VTEC cases reported in 2010-11 were of domestic origin. The five most common 
VTEC ‘O’ serogroups (55 % of known data) in 2010-12 were: O157:H7 (26 %), O104 
(24 %), O26 (10 %), O103 (3.7 %) and O91 (3.0 %) (Niskanen et al., 2015). During 
2010-12, a total of 18,955 confirmed cases of VTEC infections were reported by 26 EU 
member states and 2 European Economic Area (EAA) countries. The number of 
confirmed cases of VTEC has increased significantly in the EU since 2008 (Niskanen et 
al., 2015). In 2013, 6,043 confirmed cases of VTEC infections were reported in the EU. 
The EU notification rate was 1.59 cases per 100,000 of the population, which was 5.9 % 
higher than in 2012. The most commonly reported VTEC serogroup in 2013 was, as in 
previous years, O157 (48.9 % of cases with known serogroup). VTEC serogroup O157 
was primarily detected in ruminants (cattle, sheep and goats) and meat thereof (ECDC, 
2015). 
Among extraintestinal pathogenic E. coli (ExPEC) strains, the O1 serogroup is one of 
the most commonly detected in APEC, UPEC, MNEC and septicemic E. coli strains. 
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APEC strains are responsible for avian colibacillosis in domesticated and wild birds, an 
illness which starts as a respiratory tract infection and evolves into a systemic infection 
of internal organs (Mora et al., 2009). Avian colibacillosis is considered one of the 
principal causes of morbidity and mortality, associated with heavy economic losses to 
the poultry industry by its association with various disease conditions, either as primary 
pathogen or as a secondary pathogen (Kabir, 2010). Most of the pathogenic E. coli 
belongs to a small range of serogroups that includes O1:K1, O2:K1 and O78:K80. The 
O1 carbohydrate capsule has been identified as an important virulence determinant that 
inhibits phagocytosis (Pattison et al., 2008). 
 
1.2.4  Campylobacterosis 
Campylobacter spp. are rod shaped, Gram negative, capsulated, flagellated, 
microaerophilic organisms and are readily found in the environment and the avian 
gastrointestinal tract (Evans and Powell, 2008). Symptoms of campylobacterosis in 
humans include bloody diarrhoea, abdominal pain, fever, headache and nausea. 
Undercooked meat (poultry, cattle, pigs, and sheep), untreated drinking water and 
unpasteurised milk have all been recognised as major sources of human infection 
(Ingresa-Capaccioni et al., 2015, WHO, 2011). Campylobacter jejuni and 
Campylobacter coli are the most common species causing foodborne illness. 
Campylobacter spp. infection in broilers usually takes place after three weeks post hatch 
and infection spreads rapidly throughout the flock. This high rate of colonisation leads 
to a high degree of carcass contamination at processing plants through spillage of 
intestinal contents, thus increasing the incidence of campylobacterosis (Sahin et al., 
2002). The main site of campylobacter infection in chickens is in the lower intestine 
particularly the caecum and the cloaca (Beery et al., 1988). Infected birds show few or 
no signs of clinical illness making the infection hard to treat and therefore difficult to 
control (Evans and Powell, 2008). 
 
1.3   Pathogen control strategies for reducing zoonoses 
In an effort to control zoonotic disease the main strategy is not only to reduce the risk of 
infection and the bacterial load at the farm level but also to control the spread of disease 
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causing bacteria from this point throughout the production chain. The use of 
management processes such as the ‘hazard analysis critical control point’ (HACCP) 
approach identifies critical points in the control and prevention of the spread of disease 
(Unnevehr and Jensen, 1996). Increased biosecurity standards at the farm level can help 
eliminate the intake of bacterial pathogens. This is achieved by controlling the amount 
of pathogen carriers coming into contact with the flock/herd, i.e. wild animals, infected 
members of the flock/herd, as well as maintaining clean sterile bedding, fresh water, and 
the identification and removal of contaminated feeds. This is difficult as subclinical 
amounts of bacteria are challenging to detect. Treatment of feed by thermal processing 
or pelleting can help reduce infection at this level. 
The addition of feed additives such as antibiotics, vaccines, organic acids, in-feed 
enzymes, and/or pre- and probiotics, to the feed is a highly effective way of reducing 
the bacterial load and decreasing the spread of disease (Sofos and Geornaras, 2010, 
Norrung and Buncic, 2008). The correct application of these controlling procedures can 
reduce the burden of zoonoses to the farmer, the consumer and the economy. The most 
economical and efficient method of preventing contamination is at the farm level 
through feed supplementation; antibiotic use in feed historically being the most 
prevalent and successful. 
 
1.3.1  Biosecurity 
This is defined as the prevention or reduction of the spread of microbial disease prior to 
detection. A collection of rules and procedures exist that minimize exposure (security) 
of a susceptible population to an infectious (biological) agent (Cox, 2005). Exclusion of 
enteropathogens at the early stages of stock production among elite flocks prevents 
widespread dissemination. There are numerous codes of practices, standards and 
guidelines published in many poultry producing nations that underline the importance of 
biosecurity. At all levels of flock management, ingress of any carrier, including wild 
birds, mice and rats, insects, as well as humans, should be minimized, as all are 
potential sources of enteric pathogens (Arsenault et al., 2007). Housing must be 
designed to prevent entry of any carrier, and pest-control measures such as traps and 
baits should be used. While human access is necessary, sanitation and hygiene measures 
such as footbaths should be employed. At the elite flock levels, measures such as 
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change-in–change-out (farm or shed based apparel) or even shower-in–shower-out 
(disinfection shower prior to and post-entry to farm) may be used. These precautions are 
also used for grandparent and parent stock, and some countries, such as Sweden, extend 
such practices to broiler production (Sternberg Lewerin et al., 2005). Movement of 
animals also includes the stock; in meat production, stock is usually populated and 
depopulated on an all-in–all-out basis (Forshell and Wierup, 2006). This approach 
minimizes the likelihood of cross-contamination between flocks as multi-age stocking 
increases the risk of colonization in one flock being passed to others (Cox and Pavic, 
2010). 
 
1.3.2  Antibiotics 
Throughout much of the twentieth century, antibiotics have been a primary defence 
against bacterial disease. The utilisation of antimicrobial drugs has played an important 
role in animal husbandry; they have been used in prophylaxis, treatment and growth 
promotion (Jassim and Limoges, 2014, Page and Gautier, 2012, Dias de Oliveira et al., 
2005). Antibiotics, acting as growth promoters, have been included in animal feed at 
sub-therapeutic levels for approximately 60 years to compensate for the unsanitary 
conditions in which they are raised (Page and Gautier, 2012, Gaggia et al., 2010, Dibner 
and Richards, 2005). This results in the exposure of a large number of animals, 
irrespective of their health, to frequently sub-therapeutic concentrations of 
antimicrobials (Dias de Oliveira et al., 2005). Antibiotics traditionally used in the 
animal feed industry include aminoglycoside, penicillin, cephalosporin, inophores, 
lincosamide, macrolide, streptogramin, sulphonamide, tetracycline, bambermycins, 
novobiocin, spectinomycin, avoparcin, spiramycin, tylosin, virginiamycin, bacitracin, 
quinoxaline, flavophosphlipol, avilamycin, salinomycin, and monensin. Multi resistant 
strains are on the rise worldwide principally due to the spread of genes located on 
mobile genetic elements, including plasmids, integrons and transposons. Furthermore, 
the combination of these genes with chromosomally encoded resistance genes 
frequently results in bacteria that are resistant to all main classes of available 
antimicrobials (Allocati et al., 2013). The removal of these compounds from animal 
diets was prophesized to lead to a substantial increase in the use of therapeutic 
antibiotics (Gaggia et al., 2010). Evidence of the use of therapeutic antibiotics in the 
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Netherlands was reflected by the number of livestock animals produced remaining 
stable after the European ban on AGPs. Therefore it can be concluded that the 
antimicrobial growth promoters were fully replaced by increased therapeutic 
antimicrobials. However, the Dutch government have introduced and executed plans to 
reduce the use of therapeutic antibiotics in animal production (Mevius and Heederik, 
2014).  
Worldwide concern about the development of antimicrobial resistance and the 
transference of antibiotic resistance genes from animal to human microbiota led to 
banning the use of antibiotics as growth promoters in the EU since January 2006 
(Gaggia et al., 2010). Antibiotics given to animals and closely related compounds used 
in human therapy have been exerting selective pressure on their target bacteria for 
decades and have generated a reservoir of antimicrobial resistant bacteria (Dias de 
Oliveira et al., 2005). Agricultural antibiotic use increases the frequency of antibiotic 
resistant zoonotic pathogens such as Salmonella (FAO, 2013, Dias de Oliveira et al., 
2005, Smith et al., 2002). Resistant bacteria from animals can infect humans by direct 
contact as well as via food products of animal origin. Multidrug resistance is defined as 
resistance to three or more antimicrobial classes to which bacteria do not show intrinsic 
resistance (Allocati et al., 2013, Johnson and Nolan, 2009). The development of 
antimicrobial resistance among pathogenic bacteria has emerged as a major public 
health concern, which has led to an intensification of discussion about the prudent use 
of antimicrobial agents, especially in veterinary medicine, nutrition and agriculture 
(Dias de Oliveira et al., 2005).  
The ban on the use of in feed antibiotics in animal feeds in some countries is an effort to 
arrest the development of antimicrobial resistant strains of pathogens. Resistant bacteria 
are still detected in meat of livestock animals; however the numbers are decreasing 
(Marshall and Levy, 2011). In other countries, the number of in feed antibiotics 
available for use in poultry diets has been restricted. In the US, retail giant Walmart is 
urging its meat, dairy, seafood and egg suppliers to cut back on the use of antibiotics in 
their livestock, making it the first multiple grocer to make such a stance. In March of 
2015, the fast food chain McDonald’s said that in 2 years its US restaurants would stop 
buying chicken reared on antibiotics (Arnold, 2015). The withdrawal of this preventive 
measure has serious implications for the productivity of birds, encouraging considerable 
research effort into finding potential alternatives for antibiotics (FAO, 2013). A need 
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exists to search for viable alternatives that could enhance the natural defence 
mechanisms of animals and reduce the massive use of antibiotics (Gaggia et al., 2010).  
 
1.4   Alternatives to antibiotic growth promoters (AGP’s) 
There are a number of in feed alternatives to the use of AGPs. Improvements in our 
knowledge of the digestive physiology of the gut as well as the microbiology and 
microbial ecology of the digestive system has led to the development of alternative 
strategies and products which are based on a number of well-established principles. 
These include: diet acidification to maintain gastric pH, increasing gastric proteolysis 
and nutrient digestibility, promotion of beneficial bacteria at the expense of pathogenic 
organisms and decreasing intestinal pathogenic bacterial growth. The addition of 
specific enzymes, such as proteases, amylases and lipases can augment and complement 
endogenous enzymes, improving nutrient digestion and absorption and hence growth 
rate for a range of diets. Direct fed microbials, including pro and prebiotics, are added to 
the diet to influence the microfloral colonisation of the gastro intestinal (GI) tract 
resulting in competitive exclusion of pathogenic bacteria through competition for 
nutrients, provision of nutrients for the commensal microflora, changes in pH, and the 
production of short chain fatty acids (SCFA). 
These non-nutritive substances are usually added in amounts of less than 0.05 % to 
maintain health status, uniformity and production efficiency in intensive animal 
production systems. These additives have now become vital components of practical 
diets (FAO, 2013). A combination of probiotics and prebiotics called synbiotics could 
also be a possible alternative to AGPs. The main effects of these additives are the 
improved resistance to pathogenic bacteria colonization and enhanced host mucosal 
immunity; thus resulting in a reduced pathogen load, an improved health status of the 
animal and a reduced risk of foodborne zoonotic pathogens in foods (Gaggia et al., 
2010).  
Ideally, alternatives to AGPs should have the same beneficial effect as AGPs. Whatever 
the mechanism of action of AGPs, the main characteristic of a good alternative from a 
practical point of view is that it must improve performance at least as well as AGPs 
(Huyghebaert et al., 2011).  
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1.4.1  In feed enzymes 
The animal feed industry has been confronted with increased costs of raw materials over 
the last decade, mainly because of increased demands for cereals and oil seeds by 
emerging markets and the rise in use of these products for energy production (de Vries 
et al., 2012, FAO, 2011). Utilization of by products from the bio fuel and food 
industries as feed ingredients is important to reduce feed costs and enhance the 
sustainable use of feed resources for animal production. Many of these products contain 
high levels of plant cell wall material, mainly composed of non-starch polysaccharides 
(NSP), which cannot be digested by mammalian enzymes, but can be partly degraded 
by the microbial community residing in the intestinal tract of animals (de Vries et al., 
2012). 
NSP can interfere with digestive processes and associate with other nutrients, thereby 
reducing digestibility and absorption of these nutrients (de Vries et al., 2012). The 
presence of high levels of NSP in cereal-based diets results in a poor feed conversion 
rate, slow weight gain, and sticky droppings by young animals, especially chicks (Bhat, 
2000). In poultry there is a greater risk of an outbreak of necrotic enteritis with the use 
of barley or rye rather than maize. Immerseel et al. (2004) suggested that this was 
related to the viscous water soluble NSP in barley and rye slowing digestion and thus 
leaving undigested nutrients for microbial propagation. Hydrolases are the main class of 
enzymes used in monogastric feed. Hydrolases are used to eliminate anti nutritional 
factors present in grains or vegetables, degrade certain cereal components in order to 
improve the nutritional value of feed, or to supplement the animals’ own digestive 
enzymes (e.g. proteases, amylases and glucanases), whenever these enzymes are 
inadequate, e.g. during post-weaning period, as is often the case with broilers and 
piglets (FAO, 2013, Bhat, 2000). 
In pigs, NSP degradation by microbial enzymes mainly occurs in the large intestine, 
although some degradation has been reported to occur in the stomach and may reach 
considerable levels at the terminal ileum. In poultry, NSP degradation mainly occurs in 
the crop or gizzard (de Vries et al., 2012). Enzymes widely used in the poultry industry 
are the carbohydrases e.g. cellulases, glucanases, pectinases and xylanases, that cleave 
the viscous fibre components in cereals and phytases that target the phytic acid 
complexes in plant ingredients (FAO, 2013). The mechanisms by which feed enzymes 
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influence the intestinal microbiota have been known for some time, e.g. through 
enhancing nutrient delivery to the host and by provision of fermentable oligosaccharides 
(Bedford and Cowieson, 2012). The improvement in the nutritional value of broiler 
diets by enzyme supplementation facilitates the growth of beneficial gut microflora 
which in turn produce metabolites such as SCFA’s that can be used as an energy source 
by the host. These SCFA’s are also thought to control Salmonella and Campylobacter 
populations by reducing the pH of the environment and rendering the growth conditions 
less favourable (Bedford and Cowieson, 2012).  
Proteases have been used in both pig and poultry nutrition to improve protein 
digestibility of feed ingredients. Most current commercial proteases for animal feed are 
alkaline proteases of bacterial origin. Feed cost is reduced with the inclusion of 
proteases through a reduction of crude protein and first limiting amino acids supplied by 
dietary ingredients. Peek et al. (2009) found that a protease from Bacillus licheniformis 
increased the body weight gain of broilers challenged with three Eimeria species, and 
suggested that the mechanism was a reduction in the attachment of parasites to the 
mucus layer. This was supported by an increase in the thickness of the adherent mucus 
layer of the intestine due to protease. Marti et al. (2010)   proposed that proteases may 
dissolve the biofilm matrix and inhibit biofilm formation. Proteases are being used in 
combination with other feed enzymes such as the carbohydrases. 
More recently, technically successful enzyme preparations for use in maize-soybean 
diets have become available. Future advances in feed enzyme technology will involve 
the development of enzymes that can be used to target the anti-nutritive factors in non-
traditional feedstuffs and improve their feeding value (FAO, 2013). 
 
1.4.2  Vaccines 
Vaccination is a widely used preventive measure against many infectious diseases in 
mammals and poultry (Dahiya et al., 2006). Traditional vaccines are generally classified 
into live attenuated and inactivated/killed (bacterins) bacteria (Cheng et al., 2014). The 
immune response of poultry reduces the duration and severity of Salmonella infections 
and helps to prevent reinfection. This response provides the basis for efforts to protect 
birds against infection by vaccination and for the serological detection of infected flocks 
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(Gast, 2007). Currently vaccines are used as the primary method for coccidiosis 
prevention in breeding flocks and to some extent in laying hens and broiler chickens. 
Vaccines have proved to be a valid addition to coccidiosis control in commercial 
broilers and it is estimated that approximately 12 % of commercial broilers produced in 
Europe rely on vaccines alone for coccidiosis control (Taylor-Pickard and Spring, 
2008). 
Immunisation with live or inactivated Salmonella vaccine is regarded as an important 
prophylactic measure to protect chickens against Salmonella infections, thereby 
protecting human consumers from foodborne disease (Van Immerseel et al., 2009, Gast, 
2007, Dahiya et al., 2006). However, the delay in the development of a protective 
response after vaccination in young broilers with immature immune systems coupled 
with the early age of slaughter means there is insufficient time to clear the system of 
Salmonella after vaccination. Although vaccination of broilers is not commercially 
feasible, vaccination of broiler breeders has been successful in transferring maternal 
immunity. However, these antibodies did not show a reduction in colonisation of 
Salmonella in day-old chicks that were challenged with a low dose of Salmonella (Van 
Immerseel et al., 2009, Gast, 2007). In the case of layers, vaccination has been shown to 
be very effective in reducing the contamination in the intestine and in eggs (Van 
Immerseel et al., 2009) leading to an increase in egg production and a reduction in 
foodborne illnesses.  
Neither type of vaccine, bacterin or live, have been able to provide consistent inhibition 
of Salmonella infection, especially against high challenge doses of Salmonella. 
Multivalent bacterins, containing a mixture of serotypes, can provide a wider range of 
protection. Bacterins are more commonly employed as alternatives to live vaccines as 
they raise fewer consumer concerns (Cox and Pavic, 2010). Bacterins cannot revert 
back to a virulent form nor can they carry antibiotic resistance genes. Bacterins, 
however, do have numerous disadvantages such as the lack of relevant protective 
antigens due to in vitro growth conditions and killing processes, antigenic competition 
between non protective and protective components, a lack of safety due to potentially 
harmful components such as liposaccharides, and a lack of broad spectrum protection 
(Cheng et al., 2014, Gast, 2007). 
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As a broad generalization, the vaccination of pullets or hens with either killed or live 
preparations has often reduced but not entirely prevented faecal shedding, organ 
invasion, and egg contamination following experimental Salmonella challenge. 
Vaccination does not create an impenetrable barrier against Salmonella infection. It is 
important to note that environmental stresses on poultry can have a negative effect on 
the vaccine performance (Gast, 2007). A combination vaccine, using attenuated then 
killed Salmonella serovars, stimulated both cell-mediated and humoral immune 
systems, resulting in higher titres than individual vaccination (Cox and Pavic, 2010).  
 
1.4.3  Probiotics 
The first proposed definition of a probiotic was suggested by Fuller in 1989 as ‘viable 
microorganisms used as feed additives which lead to beneficial effects for the host by 
improving its microbial balance’ (Fuller, 1989). The current definition as used by the 
FAO/WHO defines probiotics as ‘live microorganisms which when administered in 
adequate amounts confer a health benefit on the host’(Smith, 2014, FAO/WHO, 2001). 
More precisely, probiotics are live microorganisms of non pathogenic origin and are 
non toxic in nature, which when administered through the digestive route, are 
favourable to the host’s health . It is believed by most investigators that there is an 
unsteady balance of beneficial and non-beneficial bacteria in the tract of normal, 
healthy, non stressed poultry. When a balance exists, the bird performs to its maximum 
efficiency, but if stress is imposed, the beneficial flora has a tendency to decrease in 
numbers and an overgrowth of the non-beneficial bacteria occurs. This occurrence may 
lead to disease, both acute i.e. diarrhoea, or subclinical and reduce production 
parameters of growth, feed efficiency (Kabir, 2009). 
Two basic mechanisms by which probiotics act to maintain a beneficial microbial 
population include “competitive exclusion” and immune modulation (Yang et al., 
2009). Growth promotion of beneficial bacteria is competitive and antagonistic to 
pathogenic bacteria thus preventing the establishment of bacterial infection and 
reducing the bacterial load of potentially pathogenic bacteria and, by extension the 
incidence of zoonosis (Van Immerseel et al., 2009). The competitive exclusion concept 
developed by Nurmi and Rantala (1973) was a critical stage in the development of 
probiotics where they found that newly hatched chicks could be protected against 
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Salmonella enteritidis colonisation by dosing a suspension of gut contents derived from 
healthy adult chickens. A variety of microbial species have now been established and 
used as probiotics including Bacillus spp., Bifidobacterium ssp., Enterococcus spp., E. 
coli spp., Lactobacillus spp., Lactococcus spp., and Streptococcus spp. Common human 
probiotics include Lactobacillus spp. and Bifidobacterium spp. whereas Bacillus spp,  
Enterococcus spp. and Saccharomyces spp. are common probiotics in livestock 
(Chaucheyras-Durand and Durand, 2010). In order for a probiotic to be selected it must 
meet a number of criteria including: the bacteria must demonstrate non pathogenic 
behaviour, exhibit resistance to technological processes, withstand the hosts’ gastric 
acids and bile, persist and adhere within the intestinal tract thereby producing inhibitory 
compounds, modulate immune response, and alter microbial activities. Probiotics must 
not carry transferable resistance genes; this reduces the problem associated with 
transferable antibiotic resistance genes between probiotics and microflora (Mathipa and 
Thantsha, 2015, Smith, 2014, Kabir, 2009, Simmering and Blaut, 2001).  
Probiotics containing antibiotic resistance are not generally a safety concern. Specific 
antibiotic resistance determinants carried on mobile genetic elements, such as 
tetracycline resistance genes, are often detected in the typical probiotic genera, and 
constitute a reservoir of resistance for potential food or gut pathogens, thus representing 
a serious safety issue (Gueimonde et al., 2013). Multi drug resistant bacteria (MDR), 
resistant to at least one antibiotic drug of three or more antibiotic classes, including 
extended-spectrum-β-lactamase (ESBL) producing Enterobacteriaceae, methicillin 
resistant S. aureus (MRSA) and vancomycin-resistant Enterococci (VRE), may be 
transferred from probiotic bacteria to pathogenic bacteria (Petternel et al., 2014). 
Antibiotic resistance found among the genus Lactobacillus include the vancomycin 
resistant phenotype, chloramphenicol resistance genes, erythromycin resistance genes, 
aminoglycoside resistance genes, and β-lactam resistance genes. Many of these genetic 
markers have been found in potentially mobile elements, such as transposons and 
plasmids, which could spread the antibiotic resistance genes through conjugation. Some 
of these genes have been found to be transferred in vitro between strains of 
Lactobacillus and also from lactobacilli to different Gram-positive bacteria, including 
food pathogens, such as Streptococcus (Gueimonde et al., 2013, Tannock et al., 1994). 
Bifidobacteria are intrinsically resistant to mupirocin and are not susceptible to 
aminoglycosides. A few streptomycin resistant strains have also been characterised 
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(Sato and Iino, 2010). Tetracycline resistance in Bifdobacterium are commonly found in 
this genus and under adequate conditions the gene (tet) could be transferred. 
Tetracycline resistance has also been characterised in mobile elements in Bacillus 
(Gueimonde et al., 2013). 
 
1.4.4  Prebiotics 
A prebiotic is a non digestible food ingredient that beneficially affects the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria 
in the colon, and thus improves host health (Gibson and Roberfroid, 1995). This 
definition was later updated in 2004 and prebiotics are defined thereafter as ‘selectively 
fermented ingredients that allow specific changes, both in the composition and/or 
activity in the gastrointestinal microbiota that confers benefits upon host well-being and 
health (Li et al., 2015, Swanson et al., 2002). Additionally, prebiotics can induce 
microbial competition and reduce the populations of harmful intestinal microbiota (Li et 
al., 2015). It is estimated that the lower intestinal tract of monogastric animals and man 
harbours as many as 500 to 1,000 different bacterial species (Guarner and Malagelada, 
2003). Over 90 % of the known phylogenetic categories in the caecum and colon belong 
either to the phylum Firmicutes (including Clostridium, Enterococcus, Lactobacillus 
and Ruminococcus genera) or to the phylum Bacteroidetes (including Bacteroides and 
Prevotella genera) (Ducatelle et al., 2015). Ingested carbohydrates such as lactose and 
sucrose can hardly reach the colon because they are rapidly digested and adsorbed in the 
small intestine, and thus they cannot act as prebiotics. However, glycosidic linkages of 
galactooligosaccharides (GOS) and fructooligosaccharides (FOS) derived from lactose 
or sucrose make them more resistant to digestion, which might facilitate them arriving 
at the colon in their intact forms (Li et al., 2015). Availability of carbohydrates that 
escape metabolism and adsorption in the small intestine have a major influence on the 
microflora that become established in the colon (Kaplan and Hutkins, 2000). Dietary 
carbohydrates can be classified by their degree of polymerization (DP) into 
monosaccharides, oligosaccharides (DP ~ 2, 10), and polysaccharides (DP ≥ 10) (Sako 
et al., 1999). 
Among food ingredients, non digestible carbohydrates (oligo and polysaccharides), 
some peptides and proteins, and certain lipids (both ethers and esters) are candidate 
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prebiotics. Because of their chemical structure, these compounds are not absorbed in the 
upper part of the gastrointestinal tract or hydrolyzed by digestive enzymes. Such 
ingredients could be called “colonic foods”, i.e., foods entering the colon and serving as 
substrates for the endogenous colonic bacteria, thus indirectly providing the host with 
energy, metabolic substrates and essential micronutrients (Gibson and Roberfroid, 
1995). Although food ingredients that escape digestion in the upper gastrointestinal tract 
have the potential to act as a prebiotic, only certain carbohydrates have been shown to 
provide convincing evidence in favour of this. A range of dietary oligosaccharides, such 
as lactosucrose, GOS, FOS, transgalactosaccharide, and isomaltooligosaccharides, have 
been shown to exert prebiotic properties (Li et al., 2015, Shashidhara and Devegowda, 
2003). Prebiotics alter the microbial populations of the gut, and consequently, improve 
the health of the host (Swanson et al., 2002). Mannooligosaccharides (MOS) may soon 
be added to this list as they were shown by Cuskin et al, (2015) to be fermentable by 
certain endogenous Bacteroidetes spp. in humans. Corrigan et al. (2015) , found an 
increase in Bacteroidetes species in broilers fed a MOS supplemented diet. 
 
1.4.4.1  Inulin 
Inulin and oligofructose are natural food ingredients commonly found in varying 
percentages in dietary foods, they are present in a wide variety of plants as natural 
storage carbohydrate (≥ 36,000 plant species) (Samanta et al., 2013, Niness, 1999). 
Inulin and oligofructose are either synthesized from sucrose or extracted from chicory 
roots; the root of the Cichorium intybus plant contains ~ 15–20 % inulin and 5–10 % 
oligofructose (Niness, 1999). Inulin (Figure 1.2) is a polydisperse β-(2-1) fructan, the 
fructose units in this mixture of linear fructose polymers and oligomers are each linked 
by β-(2-1) bonds. The first monomer of the chain is either a β-D-glucopyranosyl or β-
D-fructopyranosyl residue. A glucose molecule typically resides at the end of each 
fructose chain and is linked by an α-(1-2) bond, as in sucrose (Samanta et al., 2013, 
Roberfroid, 1999, Niness, 1999). 
Oligofructose is a subgroup of inulin, consisting of polymers with a degree of 
polymerization of less than 10. The polyfructan inulin is considered to act as a prebiotic, 
since it can modulate the composition and metabolic activity of the intestinal 
microbiota, which might potentially enhance the health of the host organism (Passlack 
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et al., 2015). The best known nutritional effects of inulin and oligofructose are their 
actions to stimulate Bifidobacteria growth in the intestine (Watson et al., 2013). 
Nourishing beneficial bacteria, such as Bifidobacteria, with inulin or oligofructose 
allows them to “outcompete” potential detrimental organisms and thereby potentially 
contribute to the health of the host. Health benefits ascribed to Bifidobacteria include 
inhibiting the growth of harmful bacteria, stimulating of components of the immune 
system, aiding the absorption of certain ions and the synthesis of B vitamins (Niness, 
1999). 
Several studies have demonstrated that inulin can modulate the intestinal microbiota in 
pigs. In particular, Bifidobacteria and Lactobacilli were increased in different segments 
of the intestinal tract, when inulin was added in at a concentration of 1.6 % and 4 % to 
the diets. Moreover, a decrease of Clostridium perfringens in the porcine digesta of the 
colon and rectum or Clostridium spp. and members of Enterobacteriaceae in the 
porcine digesta and mucus in different segments of the intestine was reported after the 
dietary inclusion of inulin (Passlack et al., 2015). Passlack et al. (2015) found that the 
addition of inulin to a gestation and lactation diet can not only modulate the intestinal 
microbiota of sows, but also of their offspring. Researchers also demonstrated efficacy 
of inulin type fructans in combination with competitive exclusion flora in chickens 
where a reduction in colonisation by the pathogenic bacteria (Salmonella and 
Campylobacter)  in chickens was observed (Verdonk et al., 2007).  
 
Figure 1.2. Structure of inulin. 
The number of repeating units, n, is in the range 0–60 in chicory. Source: (Muzzarelli et al., 2012) 
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1.4.4.2  Fructooligosaccharides (FOS) 
FOS is a common name for fructose oligomers, and these are usually understood as 
inulin type oligosaccharides or inulin derivatives (Apolinario et al., 2014, Dominguez et 
al., 2013). The production of FOS is generally through the degradation of inulin or by 
sucrose transfructosylation to fructooligosaccharide (Paulino and Zuniga-Hansen, 
2010). This results in the production of homologous oligosaccharides represented by the 
formula GFn, which are mainly composed of 1-kestose (GF2), nystose (GF3), and 1F -
β-fructofuranosyl nystose (GF4), in which two, three, and four fructosyl units are bound 
at the β-2,1 position of glucose, respectively, as shown in Figure 1.3. As FOS cannot be 
digested by the enzymes of the small intestine, due to the β-linkages, they are fermented 
in the large intestine to selectively stimulate the growth of probiotic like bacteria that 
are part of the commensal gut microbiota i.e. FOS are thought to act as a growth 
substrate for Bifidobacterium spp. and Lactobacillus spp (Ricke, 2015, Oakley et al., 
2014, Dominguez et al., 2013, Biggs et al., 2007, Kaplan and Hutkins, 2000). Lactic 
acid and SCFAs such as formic, acetic, propionic and butyric acids are desirable 
products of such fermentation reactions, as they can contribute to the improvement of 
colonic and systemic health (Li et al., 2015, Dominguez et al., 2013).  
 
Figure 1.3. Structures of FOS.  
Including 1-kestose (n2, left), nystose (n3, centre), and fructofuranosyl nystose (n4, right). Source:   
 (Ohta et al., 1998) 
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FOS also acts like a growth promoter to commensal bacteria which inhibit the 
adherence and invasion of pathogens in the colonic epithelia by competing for the same 
glycoconjugates present on the surface of epithelial cells (Dominguez et al., 2013). The 
most important property of FOS is their ability to stimulate bifidobacterial growth 
specifically while suppressing the growth of some other species in the colon, such as 
Clostridium perfringens (Bornet et al., 2002). The ability to control or reduce the 
growth of Clostridium perfringens by FOS, is important to the poultry industry because 
this bacterium is a primary cause of necrotic enteritis that has been estimated to cost the 
worldwide poultry industry $2 billion each year (Biggs et al., 2007). FOS has been 
shown to inhibit Escherichia coli and Salmonella in the large intestine of broilers 
(Ricke, 2015, Donalson et al., 2008, Xu et al., 2003, Fukata et al., 1999). It has also 
been reported to increase growth and improve feed conversion ratio as a consequence of 
inclusion in broiler diets (Xu et al., 2003). Another interesting feature of FOS is its 
positive effect on mineral absorption (Dominguez et al., 2013). 
Found in trace amounts as natural components in fruits, vegetables, and honey, FOS 
forms a series of fructose oligomers and polymers derived from sucrose. They occur in 
many higher plants as reserve carbohydrates. Asparagus, sugar beet, garlic, chicory, 
onion, Jerusalem artichoke, wheat, honey, banana, barley, tomato, and rye are well 
known sources of FOS (Dominguez et al., 2013). Microbial sources of enzymes with 
transfructosylation activity for the production of FOS from sucrose include Aspergillus 
spp. (Park and Almeida, 1991), Aureobasidium spp., and Fusarium spp. (Dominguez et 
al., 2013, Sangeetha et al., 2005, Yun, 1996). Marketed commercially as Raftilose and 
Nutraflora, FOS has been self-affirmed by the manufacturers as GRAS (generally 
recognized as safe) and have been added to infant formulas, yogurt, and other food 
products and food supplements (Kaplan and Hutkins, 2000). 
 
1.4.4.3  Galactooligosaccharides (GOS) 
GOS are non digestible carbohydrates, which are resistant to gastrointestinal digestive 
enzymes, but are fermented by specific colonic bacteria (Sako et al., 1999). This 
oligosaccharide is a synthetic compound produced from lactose by enzymatic 
transgalactosylation and consists of lactose and several galactose molecules. It passes 
through to the hindgut undigested due to its β-(1, 6) and β-(1, 4) linkages that avoid 
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digestion by β-galactosidase (Figure 1.4) (Biggs et al., 2007, Sako et al., 1999). It is 
stable at high temperature and low pH, and has a long shelf life (Sako et al., 1999).  
In the livestock industry, GOS is a relatively unstudied compound. However, it has been 
examined for its bifidogenic effect in humans (Ito et al., 1993). Diets enriched with 
GOS increase populations of Bifidobacterium spp. and Lactobacillus spp. and their 
fermentation products in the colon. The fermentation products are mainly SCFAs, 
which improve the energy supply to the colonic epithelium, and facilitate calcium and 
magnesium absorption. Moreover, glycoconjugates containing GOS have been 
implicated in interactions between epithelial and bacterial cells, implying that these 
compounds also have the capacity to inhibit the binding of pathogens to cell surfaces by 
acting as competitive receptors (Tzortzis et al., 2005). GOS formulations have the 
potential to reduce the adherence of enteropathogens such as EPEC and Salmonella 
typhimurium in vitro and in vivo (Searle et al., 2009). GOS addition has shown strong 
inhibition of EPEC and Salmonella attachment to HT29 cells in vitro. Shoaf et al. 
(2006) demonstrated that purified GOS exhibited adherence inhibition of EPEC on both 
Caco-2 and Hep-2 cells by 65 % and 70 %, respectively. The effect of GOS on the 
microbial population of the major bacterial genera in the proximal and distal colonic 
contents of pigs included significant increases in Bifidobacter spp. and Lactobacilli 
spp., while no change was observed for Clostridium histoyticum or Bacteroidetes spp. 
(Tzortzis et al., 2005). 
 
Figure 1.4. Structure of galactooligosaccharide. 
Source: (Souza et al., 2015) 
 
1.4.4.4  Mannan oligosaccharides (MOS) 
Mannan oligosaccharides (MOS) are sugars composed of polymers of mannose (Figure 
1.5) that have been shown to affect gut health by pathogen adsorption, immune 
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modulation and improving intestinal morphology. A widely known property of MOS is 
their ability for the agglutination of Gram-negative pathogenic bacteria containing type 
1 fimbriae. These pathogens can be absorbed to the MOS instead of attaching to 
intestinal epithelial cells and move through the intestine without colonisation (Luquetti 
et al., 2012, Hooge and Connolly, 2011, Oliveira et al., 2009, Yang et al., 2009, Ferket 
et al., 2002, Spring et al., 2000). 
Many enteric pathogens must attach to the mucosal surface of the gut wall to establish 
themselves in the GI tract (Spring et al., 2000). As attachment is often mediated through 
binding of bacterial type 1 fimbriae to receptors containing D-mannose (Eshdat et al., 
1978), it may be possible to block the lectins with mannose or similar sugars and inhibit 
bacterial attachment (Spring et al., 2000). Some bacteria recognize binding sites on 
prebiotics instead of on the intestinal mucosa, and the colonisation by pathogenic 
bacteria in the intestine is thus reduced (Ganguly, 2013). Type 1 fimbriae are common 
on numerous species of E. coli and Salmonella (Swanson et al., 2002). Specifically 
MOS prevent the pathogen from adhering to enterocytes, making it difficult to establish 
an infection, thus reducing colonization of the intestinal epithelium (Lourenco et al., 
2015, Ganguly, 2013). 
As relatively high concentrations of mannose are required to control colonization of 
pathogenic bacteria, the cost of using pure mannose in commercial production is 
prohibitive. However, mannose-based carbohydrates occur naturally in many products, 
such as yeast cell walls or different gums, which are available at reasonable prices. One 
MOS product contains yeast cell wall fragments derived from Saccharomyces 
cerevisiae. The cell wall fragments are obtained by centrifugation from a lysed yeast 
culture. The pellet containing the yeast cell wall fragments is then washed and spray 
dried (Spring et al., 2000). MOS derived from yeast cell wall are more complex than the 
name suggests; they are components of the outer layer of yeast cell walls and their 
components include: proteins, glucans and phosphate radicals as well as mannose (Yang 
et al., 2009). 
Three major modes of action by which broiler performance is improved by MOS are 
proposed: control of pathogenic or potential pathogenic bacteria which possess type 1 
fimbriae (mannose sensitive lectin), immune modulation based on the antigenicity 
characteristics of its mannan and glucan components, and modulation of intestinal 
Section 1  Introduction 
32 
 
morphology and expression of mucin and brush border enzymes (Yang et al., 2009). 
New evidence by Cuskin et al. (2015) suggests that MOS may be fermentable by 
Bacteroidetes spp. in humans. Yang et al. (2009) showed that MOS inhibited the 
development of Lactobacilli spp. and coliforms; in particular the colonization of 
mucosa associated coliforms in broilers was inhibited by MOS as early as 7 days of age 
(Yang et al., 2009, Cuskin et al., 2015). Research by Corrigan et al. (2015) , found that 
MOS supplementation consistently and reproductively altered the cecal microbiota and 
increased the levels of Bacteroidetes in the broiler cecum. 
The MOS derived from the outer cell wall of yeast, and its evaluation in diets for 
breeders is of particular interest because it not only shifts gastrointestinal microflora 
balance toward beneficial organisms but also has immunomodulatory properties. The 
yeast cell wall has powerful antigenic stimulating properties, and it is well established 
that this property is a characteristic of the mannan chain (Shashidhara and Devegowda, 
2003). Studies by Tohid et al. (2010) and Shashidhara and Devegowda (2003) 
investigating the immunomodulatory properties of MOS found improved antibody 
response in broilers and layers, stimulation of the humoral response, and increased 
maternal immunity in the progeny of MOS treated poultry. MOS supplemented pigs 
were also found to have an improvement in total Ig levels (IgG, IgM and IgA) in the 
colostrums. In a series of experiments by Spring et al. (2000) dietary MOS has been 
shown to reduce intestinal Salmonella and coliform concentrations in broiler chicks. 
The reduction in pathogenic bacteria with the inclusion of dietary MOS has been 
demonstrated consistently (Baurhoo et al., 2009). It has been reported that the inclusion 
of MOS at 0.05 % in turkey diets from 0 to 105 days of age significantly reduce litter 
moisture and numerically lowered coliform counts versus the negative control 
(Navidshad et al., 2015, de Barros et al., 2015, Ganguly, 2013, Wasilewska et al., 2010, 
Sims et al., 2004). MOS has been studied to control necrotic enteritis in chickens by 
promoting commensal bacteria while controlling pathogen invasion (Yitbarek et al., 
2012). 
In the search for alternatives to AGPs for poultry production, MOS has demonstrated its 
potential to reduce enteric disease in poultry and subsequent contamination of poultry 
products. A relatively cheap source of MOS exists as the cell wall of Saccharomyces 
cerevisiae. 
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Figure 1.5. Chemical structure of α-(1, 3) Mannose and α-(1, 6) Mannose 
linkages.  
Source: (Davidson et al., 2000) 
 
1.4.5  Synbiotics 
A synbiotic is, in its simplest definition, a combination of probiotics and prebiotics (de 
Vrese and Schrezenmeir, 2008). This combination could improve the survival of the 
probiotic organism, because its specific substrate is available for fermentation. This 
could result in advantages to the host through the availability of the live microorganism 
and the prebiotics. Examples of synbiotics are fructooligosaccharides (FOS) and 
Bifidobacteria, and lactitol and lactobacilli (Yang et al., 2009). A combination of 
Bifidobacterium breve strain Yakult and Lactobacillus casei strain Shirota and 
galactooligosaccharides in patients with systemic inflammatory response syndrome had 
significantly greater levels of beneficial Bifidobacterium and Lactobacillus and SCFAs 
and lower incidence of infectious complications such as enteritis, pneumonia and 
bacteremia than those who received no synbiotics (Shimizu et al., 2013). The 
combination of FOS and competitive exclusion flora was more effective at reducing 
Salmonella in broilers than either of the material on their own (Yang et al., 2009). Li et 
al, (2008) reported that application of a combination of FOS and bacillus to a corn 
soybean basal diet improved the average daily gain (ADG) and feed conversion ratio 
(FCR) by 6 % and 2 %, respectively. Furthermore, diarrhoea and mortality rate were 
reduced by 58 % and 67 %, respectively, which were comparable to aureomycin 
(chlortetracycline) treatment (the relative changes were 4 % for ADG, 2 % for FCR, 69 
% for diarrhoea rate and 33 % for mortality rate) (Li et al., 2008). 
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There are some reports on the effect of synbiotics on the physiological and biochemical 
indexes of piglets including the enhancement of immune function, the improvement of 
ADG and digestibility, the reduction of diarrhoea, morbidity and mortality, the ease of 
weaning stress response, and the significant promotion of piglet performance. However, 
the reports of the beneficial effects of synbiotics on swine production are still limited. 
So far, the synergy mechanism of probiotics and prebiotics has not been thoroughly 
understood. As such the extensive application of synbiotics has a long way to go (Cheng 
et al., 2014). 
 
1.5   Yeast cell wall 
Yeast cell structure extends beyond the plasma membrane into an extracellular network 
of proteins and polysaccharides. Fungi have extracellular matrices containing 
polysaccharide protein complexes termed cell walls allowing them to build structure. 
Much of the diversity between fungi comes at the level of the extracellular matrices 
themselves, while the underlying mechanisms are conserved. Fungal cell walls are 
highly diverse so yeast study will only capture a fraction of the fungal cell wall 
repertoire (Lesage and Bussey, 2006). The cell wall of Saccharomyces cerevisiae is a 
sturdy structure providing physical protection, osmotic support (Klis et al., 2002) and is 
required for cell viability (Orlean, 1997). It defines cell shape during budding, growth, 
mating, sporulation, pseudohypha formation, presents adhesive glycoproteins to other 
yeast cells, and participates in cell to cell recognition (Orlean, 2012, Klis et al., 2006, 
Orlean, 1997). The cell wall, far from being a static structure armouring the cell, 
represents a highly dynamic carbohydrate moiety which grows and constantly 
undergoes modifications in shape, chemical composition and physical properties 
(Teparic and Mrsa, 2013). In addition, it provides a matrix for a variety of enzymes 
involved in the hydrolytic processes, nutritional uptake, end metabolite secretion and 
cellular maintenance (Aguilar-Uscanga and Francois, 2003). 
The cell wall comprises 15-30 % of the dry weight of the cell, is as wide as 110-200 
nm, with the major components being β-(1, 3) glucan, β-(1, 6) glucan, chitin and 
proteins that bear N- and O-linked glycans (mannoproteins) and a glycolipid anchor 
(GPI). These components are linked to form macromolecular complexes, which are 
assembled to form the intact cell wall as illustrated in Figure 1.6 (Klis et al., 2002, 
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Kollar et al., 1997). β-(1, 6) glucan has a central role in cross linking wall components. 
Wall composition and degree of cross-linking vary during growth and development and 
change in response to cell wall stress (Orlean, 2012). The yeast cell wall is typically 
composed of approximately 85 % polysaccharides and approximately 15 % proteins but 
the relative amount of wall components can vary depending on growth conditions, yeast 
species, growth phase, and stress conditions (Teparic and Mrsa, 2013).  
The cell wall has two layers, a mannan outer layer and glucan inner layer with different 
structures, different physicochemical properties, and different physiological roles 
(Teparic and Mrsa, 2013). The outer layer is electron dense, has a brush like surface, 
and can be removed by proteolysis; it therefore consists mostly of mannoproteins. These 
heavily glycosylated mannoproteins emanating from the cell surface are involved in 
cell-cell recognition events. This layer also limits the accessibility of the inner part of 
the wall and the plasma membrane to foreign enzymes such as cell wall degrading 
enzymes in plant tissue. The outer protein layer accounts for about one third of the wall 
dry weight and may at anytime consist of at least 20 different glycoproteins, the 
composition of this protein layer may vary depending on growth conditions (Klis et al., 
2006, Klis et al., 2002). The inner layer, more electron transparent, is microfibrillar and 
is β-glucanase digestible, indicating that its major components are glucans (Orlean, 
2012). The mechanical strength of the wall is mainly due to the inner layer, which 
consists of β-(1, 3) glucan and chitin, and represents about 50-60 % of the wall dry 
weight (Klis et al., 2002). 
Glucan provides osmotic stability and serves as an anchoring moiety for wall proteins 
(Teparic and Mrsa, 2013). The protein population that is anchored to the stress bearing 
polysaccharides of the cell wall, and forms the interface with the outside world, is 
highly diverse. This diversity is believed to play an important role in adaptation of the 
cell to environmental conditions, in growth mode and in survival (Klis et al., 2006). Cell 
wall proteins allow the cells to flocculate, recognize mating partners, form a biofilm and 
grow pseudohyphally. They also help the cells to retain iron and facilitate sterol uptake 
and are required for growth under anaerobic conditions (Klis et al., 2006). 
The majority of cell wall proteins are glycophosphatidylinositol (GPI)-modified and are 
thus indirectly linked to the β-(1, 3) glucan network (CWP-GPI) (Klis et al., 2006). In 
addition to the GPI-CWPs, a smaller group of proteins are directly linked to the β-(1, 3) 
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glucan network through an unidentified linkage that is sensitive to mild alkali, as β-(1, 
3) glucan is alkali insoluble. These proteins are called ASL (alkali-sensitive linkage)-
CWPs and includes the family of Pir-CWPs (Pir, proteins with internal repeats). The 
Pir-CWPs seem to be uniformly distributed throughout the inner skeletal layer, which is 
consistent with their being directly connected to β-(1, 3) glucan macromolecules. It 
seems conceivable that Pir-CWPs may interconnect two or even more β-(1, 3) glucan 
molecules. This would considerably strengthen the wall. It may be advantageous to the 
cell to use Pir-CWPs during a period of isotropic growth (Klis et al., 2006). The cell 
wall also contains proteins that are either retained in a noncovalent fashion, such as 
Bg12p, or via disulphide bridges to other proteins (Klis et al., 2006). 
 
Figure 1.6. Yeast cell wall architecture.  
Transmission electron micrograph of yeast cell wall on the left and the cartoon on the right illustrates the 
structure. Source:  (Brown et al., 2014) 
 
1.5.1  β-glucan 
β-glucans generally described as polymers of glucose, form the major structural 
polymer in the yeast cell wall and encompass the entire yeast cell with a microfibrillar 
net (Lipke and Ovalle, 1998, Kollar et al., 1997). β-glucans compose 30-60 % of the dry 
weight of the wall and can be separated into three fractions. The first fraction which 
makes up approximately 35 % of the dry weight of the wall, is an acid- and alkali-
insoluble β-(1, 3) glucan with a degree of polymerization of approximately 1500 and β-
(1, 3) linked glucan side chains initiated at branching β-(1, 6) linked glucoses that 
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represent approximately 3 % of the whole polymer. The non reducing ends of β-(1, 3) 
glucan chains in this fraction can be linked to the reducing end of chitin through β-(1, 4) 
linkages, rendering the β-glucan insoluble; up to 50 % of chitin chains could be linked 
in this way. One chitin-β-glucan linkage per 8000 hexoses would have a major impact 
on the solubility of β-glucan (Orlean, 2012). A second β-glucan fraction, representing 
approximately 20 % of the dry weight of the wall, is similar in size and composition to 
the alkali-insoluble β-(1, 3) glucan, but soluble in alkali because it is not cross linked to 
chitin (Orlean, 2012). A third fraction, making up approximately 5 % of the dry weight 
of the wall, can be released from alkali-insoluble glucan by extraction with acid or 
digestion with endo-β-(1, 3) glucanase. This fraction is a β-(1, 6) glucan with a degree 
of polymerization of 140, in which 14 % of the β-(1, 6) linked residues bear a side 
branching β-(1, 3) glucan (Orlean, 2012). Three types of β-glucan linkages are shown in 
Figure 1.7  
 
Figure 1.7. β glucan linkages. 
Source:  (Megazyme, 2015) 
 
1.5.2  Chitin 
Chitin, as pictured in Figure 1.8 is a polymer of β-(1, 4) linked N-acetylglucosamine 
(GlcNAc) and contributes only 1-2 % of the dry weight of the wall of unstressed wild 
type cells. The structure of α-chitin is similar to α-cellulose, with hydrogen bonded anti 
parallel chains of GlcNAc units (Lipke and Ovalle, 1998). Chitin is normally deposited 
in a ring in the neck between a mother cell and its emerging bud, in the primary division 
septum, and in the lateral walls of newly separated daughter cells. In addition to free 
chitin, some is bound to β-(1, 3) glucan and present mainly in the neck between mother 
and daughter cell, whereas a lesser amount found in lateral walls, is bound to β-(1, 6) 
glucan. Chitin is glycosidically linked to non reducing branches of the β-(1, 3) glucan 
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and β-(1, 6) glucan (Kollar et al., 1997). Chitin levels increase in response to mating 
pheromones and delocalized chitin in lateral walls can increase to as much as 20 % of 
the wall in Saccharomyces cerevisiae mutants mounting the cell wall stress response 
(Orlean, 2012). 
 
Figure 1.8. Chemical structure of chitin. 
Source: (Rhee and Berg, 1995) 
 
1.5.3  Mannoproteins 
Mannoproteins are cell wall polysaccharides that form yeast mannan oligosaccharides 
(MOS), the electron dense, fibrillary outer layer of the cell wall. The polysaccharide 
structure on Saccharomyces cerevisiae mannoproteins can vary considerably among 
yeast species (Lesage and Bussey, 2006). Mannoproteins represent 25-50 % of the yeast 
cell wall and determine the cell surface properties (Lipke and Ovalle, 1998). Yeast cell 
wall proteins can bear the asparagine (N-) linked glycans, serine/threonine (O-) linked 
mannan oligosaccharides and often a glycosylphosphatidylinositol anchor as well. Cell 
wall and secreted mannoproteins are extensively mannosylated in the Golgi. The N-
linked glycans can be extended with an outer chain of 50 or more α-(1, 6) linked 
mannose residues, extending from the N-glycan core, that is extensively decorated with 
short α-(1, 2) mannan side branches terminated in α-(1, 3) mannan forming a highly 
branched structure containing as many as 200 mannose residues. Phosphodiester linked 
mannose can also be attached to α-(1, 2) linked residues as depicted in Figure 1.9. 
Mannosylphosphate outer chains result in a negative net charge (Orlean, 2012, Lesage 
and Bussey, 2006). Mannan attached to proteins, in a process of protein glycosylation, 
creates a chemically inert external shield which defines the porosity of the cell wall 
(Teparic and Mrsa, 2013). Many glycoproteins also bear mannosyl glycans, which are 
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often present in Ser/Thr-rich stretches, these O-mannose saccharides are thought only to 
exist in yeast such as Saccharomyces cerevisiae, where they occur as linear chains of 
one to six mannose units on a wider variety of proteins (Haltiwanger and Lowe, 2004). 
Polymannose structures found on secreted or cell wall mannoproteins may contribute to 
95 % of the molecular mass of these glycoproteins. Intracellular glycoproteins are short 
Man9-Man13GlcNAc2 (Dean, 1999). 
Cell wall proteins are thought to form three groups of proteins: the first contains those 
with potential to participate in wall construction as hydrolyases or glycosidases. The 
second contains non enzymatic agglutinins, flocculins, or β-(1, 3) glucan cross 
connectors. Most of these proteins are glycosylated. Proteins covalently attached to the 
cell wall are referred to as CWP and fall into GPI proteins, mild alkali releasable 
proteins, and disulphide linked proteins. The third group consist of single pass plasma 
membrane proteins with short C-terminal cytoplasmic domains and long Ser/Thr rich 
extracellular regions, which also have N-terminal cysteine rich domains. These are the 
mechanosensors that detect cell wall stress and activate the cell wall integrity signalling 
pathway (CWI) (Orlean, 2012). The CWI pathway is responsible for glucan synthesis at 
the site of wall remodelling, gene expression related to cell wall biogenesis, 
organization of the actin cytoskeleton, and secretory vesicle targeting to the growth site 
(Levin, 2005). Some mannoproteins have, or are predicted to have, enzymatic activity 
as hydrolases or cross linkers; others may have structural roles or mediate “social 
activity” by serving as mating agglutinins or flocculins (Teparic and Mrsa, 2013). 
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Figure 1.9. N-linked mannan oligosaccharide 
Source: (Nani, 2007) 
 
1.6  MOS and the control of pathogenic bacteria 
Adhesion of pathogenic organisms to host tissues is the prerequisite for the initiation of 
the majority of infectious diseases (Sharon, 2006). Adhesion is required so that the 
organisms are not swept away by the natural cleansing mechanisms of the host, like 
airflow in the respiratory tract or urine flow in the urinary tract, leading eventually to 
the penetration of bacteria into the tissues. The most common means of adhesion is 
mediated by lectins present on the surface of the infectious organism that bind to 
complementary carbohydrates on the surface of the host tissues (Sharon, 2006). These 
filamentous structures were recognized and characterized for several Gram-negative 
species by two research groups, one led by James Duguid, who referred to these 
structures as fimbriae (derived from the Latin word for fringe); and the other led by 
Charles Brinton, who preferred to call these structures pili (derived from the Latin word 
for hair or fur) (Telford et al., 2006). These bacterial lectins are typically in the form of 
elongated submicroscopic multi-subunit protein appendages, expression of which is 
dependent on growth conditions (Sharon, 2006). 
Compelling evidence for the role of fimbriae in bacterial infection derives from 
experiments in which blocking the fimbriae by suitable sugars provided protection 
against such infection. Fimbriae bind mono- and oligosaccharides reversibly and with 
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high specificity, but are devoid of catalytic activity, and in contrast to antibodies, are not 
products of an immune response. On the basis of their specificity, fimbriae are classified 
into five groups, according to the monosaccharide for which they exhibit the highest 
affinity: mannose, galactose/N-acetylgalactosamine, N-acetylglucosamine, fucose, and 
N-acetylneuraminic acid. These sugars are typical constituents of the surfaces’ of 
eukaryotic cells. Studies with fimbriated E. coli (as well as purified fimbriae) and 
uroepithelial cells suggested that adherence induces a two way flow of biological cross 
talk via the fimbrial bridge, affecting both partners. The target cell is activated, with 
resultant production of cytokines that engender acute inflammation and symptoms of 
disease. In the bacterium the interaction leads to up regulation of two signal 
transduction systems that allow responses to the changing environment (Lis and Sharon, 
1998).  
Since anti adhesive agents do not act by killing or arresting the growth of the pathogens, 
it is very likely that strains resistant to such agents will emerge at a markedly lower rate 
than of strains that are resistant to antibiotics. Saccharides are ideal for this purpose as 
they are unlikely to be toxic or immunogenic, since many of those that inhibit bacterial 
adhesion are normal constituents of cell surfaces or body fluids (Sharon, 2006).  
Yeast agglutination tests have been used to show the binding of pathogenic bacteria to 
yeast and yeast cell wall (Tiago et al., 2012, Perez-Sotelo et al., 2005, Spring et al., 
2000). Spring et al. (2000) demonstrated that the MOS fraction of yeast cell wall was 
responsible for the agglutination of type 1 fimbriae containing Salmonella and E. coli 
spp. in vitro and agglutination was inhibited in the presence of mannose. In addition, 
their study reported a reduction of Salmonella typhimurium colonisation in vivo when 
MOS was added to the basal diet of newly hatched chicks. However, as agglutination 
tests are qualitative they do not provide a means to quantify the amount of bacteria 
bound to MOS. 
 
1.7  Actigen® 
Alltech, Inc. (Nicholasville, Kentucky, USA) has pioneered industrial extraction 
procedures that are currently used to produce functional mannanoligosaccharides extract 
from the cell wall of Saccharomyces cerevisiae var. boulardii and this is marketed as 
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Actigen®. It is a prebiotic; a non digestible food ingredient which may be fermented in 
the hind gut (Cuskin et al., 2015, Nurmi and Rantala, 1973). It added to animal diets and 
results have shown that it improves feed efficiencies, weight gain, reduces mortalities, 
decreases pathogen load and improves overall gut health (Hooge, 2004a, Hooge, 
2004b). Actigen® can bind enteropathogenic bacteria such as Salmonella and E. coli 
spp. and reduce colonisation (Luquetti et al., 2012, Biggs et al., 2007).  Saccharomyces 
cerevisiae, a budding yeast, is commercially produced under controlled conditions in an 
aerobic environment. The yeast cells are autolysed and the cell wall material is 
separated from the intracellular contents. The outer cell wall consists of mannan and 
glucan fractions; the mannan portion is extracted for Actigen® production. The 
fractionated liquid product is pumped to low temperature spray driers where the liquid 
is evaporated at the lowest temperature possible in the shortest time. The final dried 
product is collected in a cooling chamber and held for the quality analysis and 
packaging.  
 
1.8  Type 1 Fimbriae 
Type 1 fimbriae are the most abundant surface structures both in pathogenic and non-
pathogenic Gram-negative bacteria (Bernardi et al., 2013). Adhesion fimbriae are 
specialized to sustain attachment of bacterial cells under the environmental conditions 
surrounding their preferred host target tissue (Andersson et al., 2012). A single bacterial 
isolate often can express more than one type of fimbriae (Althouse et al., 2003). The 
best characterised fimbriae are the type 1 fimbriae of E. coli. Several genera of bacteria 
possess type 1 fimbriae, which are specific for mannose and allow the attachment to 
mannose receptors on various host tissues. In short, bacteria utilize the sugar decoration 
of cells, to colonize the cell surface, wherever cells are in contact with the outside 
environment, as in the case of epithelial cells (Hartmann and Lindhorst, 2011, Krogfelt 
et al., 1990). Type 1 fimbriae are expressed by a large number of E. coli strains, and are 
found in more than 95 % of E. coli isolates from the intestinal and extraintestinal 
infections such as urinary ones. They are also produced by other enterobacterial species 
including: K. pneumonia, Salmonella typhimurium and Salmonella enteritidis (Sharon, 
2006). In vitro studies have shown that 80 % of Salmonella typhimurium, 67 % of 
Salmonella enteritidis, and over 65 % of E. coli possess fimbriae which attach to 
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mannose receptors (Duguid et al., 1966). The affinity of different phenotypes of E. coli 
type 1 fimbriae to mannose may differ within a factor of 15 and they can be functionally 
subdivided into either low mannose binding (M1L) or high mannose binding (M1H) 
phenotypes. These two basic phenotypes have been found to predominate in different 
niches (Sharon, 2006, Sokurenko et al., 1998). The galabiose specific P fimbriae and the 
N-acetylglucosamine specific F17 fimbriae of E. coli are also well characterised 
(Sharon, 2006). The K88 (F4) type 4 fimbrial adhesions are common in enterotoxigenic 
E. coli and are reported to bind to galactose residues (Payne et al., 1993). 
Type 1 fimbriae, shown in Figure 1.10 A, are threadlike appendages consisting of about 
1000 subunits of the FimA protein as well as a few percent of minor components. 
Structurally, the fimbriae are 1-2 µm long and 7 nm thick fibres, that are rod like, made 
up largely of repeating immunoglobulin like FimA subunits (mw 17 kDa) that are 
helically arranged in a structure referred to as a “shaft” (Madison et al., 1994). The 
shaft, anchored to an outer plasma membrane pore assembly platform termed usher 
(FimD), is joined to a short 3 nm thick distal tip fibrillum that consists of two adaptor 
proteins, FimF and FimG, and a third of a different kind, FimH (m.w. 29-31 kDa) 
(Figure 1.10 B). The latter is the only subunit that possesses a carbohydrate binding site 
and is thus responsible for the sugar binding activity of the fimbriae. FimH is also 
present in small numbers at intervals along the fimbrial filament, but only the subunit at 
the tip appears to be able to mediate mannose specific adhesive interactions, whereas 
the subunits at the other positions are inaccessible to the carbohydrate ligand (Sharon, 
2006). Recombinant bacteria expressing fimbriae consisting of FimA only or FimA, 
FimF, and FimG but not FimH do not exhibit any binding ability (Krogfelt et al., 1990). 
Nearly all mutations in the combining site of FimH abolished or decreased its binding 
not only to mannose, but also to urinary epithelial cells, indicating that the site may be 
highly conserved (Sokurenko et al., 1998). Since the FimH binding site can 
accommodate only one α-mannoside, multivalency effects which have been observed in 
the inhibition of type 1 fimbriae mediated bacterial adhesion cannot be explained on the 
basis of the structure of mannose specific lectin FimH. Nevertheless, avidity effects 
have been frequently observed with a variety of multivalent mannose containing 
glycomimetics. Such avidity can originate from statistical effects arising from a higher 
concentration of mannose in the proximity of the carbohydrate binding site, the 
existence of additional carbohydrate binding sites on the lectin FimH, or the occurrence 
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of the natural multivalent process, since fimbriae occur on the bacterial surface in 
several hundreds of copies (Bernardi et al., 2013). 
In vitro work has shown that the presence of D-mannose can inhibit type 1 fimbriae 
mediated association of E. coli to human mucosal cells (Ofek et al., 1977) and 
Salmonella to small intestinal enterocytes of the rat (Lindquist et al., 1987). Typically, 
type 1 fimbriae of E. coli have a considerably higher affinity for oligosaccharides such 
as the constituents of cell surface glycoproteins compared to mannose (Sharon, 2006). 
Type 1 fimbriae have been shown to cause an immune response through the activation 
of the target cells and production of high levels of certain cytokines, in particular TNF-
α, can be induced by the purified type 1 fimbriae, as well as by the isolated 
carbohydrate binding subunit of the fimbriae (FimH) (Lis and Sharon, 1998). 
 
  
Figure 1.10. A: Type 1 fimbriated E. coli, and B: structure of Type 1 fimbriae.   
Source:  A:Sharon (2006) and B: Busch et al. (2015) 
 
1.9   Assay development 
During assay development, or assay optimisation, an analytical process or idea is 
defined and optimised into a robust and reproducible device that delivers results as 
intended. An assay’s development requires continuous evaluation that should be clearly 
distinct from the validation phase. Optimising an assay involves choosing the optimal 
A B 
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format. With the intended use in mind, a new assay’s appropriate performance 
characteristics are then defined. The optimisation phase is a continuous cycle that 
begins with defining these initial performance characteristics and continues until the 
performance metrics are established and there is confidence in the results that are 
obtained for the assay. Once a final optimised and feasible prototype design is 
completed, it proceeds to validation (Derzko, 2005).  
 
1.9.1  Specificity/selectivity 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present (ICH, 1995, ICH, 1996). Typically 
these may include impurities, degradants and matrix among others. The term “specific” 
generally refers to a method that produces a response for a single analyte only, while the 
term “selective” refers to a method which provides responses for a number of chemical 
entities that may or may not be distinguished from each other. If the response is 
distinguished from all other responses, the method is said to be specific. Since there are 
very few methods that respond to only one analyte, the term selectivity is usually more 
appropriate. 
 
1.9.2  Precision 
Precision of an analytical procedure expresses the closeness of agreement between a 
series of measurements obtained from multiple sampling of the same homogenous 
sample under the prescribed conditions (ICH, 1995). Precision may be considered at 
two levels: 
Repeatability: 
An assay’s repeatability expresses the precision under the same operating conditions 
over a short interval of time and can also be termed intra-assay precision. The level of 
repeatability of an assay is assessed when the analysis is carried out in one laboratory by 
one operator using one piece of equipment over a relatively short time span (ICH, 
1995). 
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Reproducibility: 
Reproducibility is expressed as within laboratory variation. The extent to which 
reproducibility should be established depends on the circumstances under which the 
procedure is intended to be used. The applicant should establish the effects of random 
events on the precision of the analytical procedure. Typical variables to be studied 
include days, analysts, equipment, etc. It is not considered necessary to study these 
effects individually (ICH, 1996). 
 
1.10  Objectives of this study 
A rise in food safety and production standards (e.g. the ban on antibiotics) has led to a 
search for alternative natural products to achieve a high yielding, more efficient method 
of meat production. Mannan oligosaccharides are one such class of product that can 
potentially provide this. Mannan oligosaccharides are abundant in the cell wall of 
Saccharomyces cerevisiae as well as other yeast species. Yeast cell wall mannan 
oligosaccharides have the capacity to inhibit type 1 fimbriae containing pathogens from 
binding to host tissue and prevent biofilm development. The mannan oligosaccharide 
acts as an alternative, more attractive, binding site for the pathogens and the mannan 
oligosaccharide – pathogen complex are removed from the host system. 
A review of the literature on these yeast cell wall products has indicated that other than 
in vivo animal studies very few studies exist which demonstrate the efficacy of these 
types of products. Of the assays that do exist the majority of these tests are qualitative 
e.g. agglutination (Spring et al., 2000). 
The initial aim of this project was the production and characterisation of cell wall 
samples from a variety of yeast species in search of a new or next generation MOS 
product. Alterations in the growing conditions of several yeast strains were examined to 
determine if by altering simple fermentation constituents it was possible to alter yeast 
cell wall composition. The saccharide content of the yeast cell wall material samples 
was determined. Another objective of this study was to develop a quantitative assay to 
assess the efficacy of yeast cell wall material to bind pathogens in vitro. This assay 
could be used to screen other yeast cell wall material samples in the search for a second 
generation yeast cell wall product. Correlation of the saccharide content with the 
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pathogen binding capacity was undertaken in an effort to understand some of the factors 
involved in the binding of type 1 fimbriae containing pathogens by yeast cell wall 
material. The specific goals of this thesis were: 
• Development of a second generation yeast cell wall product by growing a 
number of GRAS listed yeasts with augmented growth medium. The altered 
growth conditions included carbon source supplementation. Saccharide 
composition of these yeast strains was determined by HPLC. 
• Development and optimisation of an assay to quantify the capacity of YCWM to 
bind pathogens in vitro. 
• Screening of samples using the developed pathogen binding assay. 
• Analysis of the complexity of the glycan profiles of selected samples was 
performed. 
  
 
Section 2 
Materials and Methods 
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2. Materials and methods 
 
2.1   Materials 
2.1.1  Chemicals, solvents, and other reagents 
2, 2’-azio-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABSA), 3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), acetonitrile, 
ammonium peroxisulphate, bovine serum albumin (BSA), calcium carbonate, D-(+)-
fructose, D-(+)-galactose, D-(+)-glucose, D-(+)-maltose, D-(+)-mannose, D-(+)-
trehalose, D-(+)-xylose, dithiothreitol (DTT), formic acid, glycerol, Gram stain kit, 
iodoacetamide (IAA), Jack Bean mannosidaes, oxalic acid, peptide N-glycosidase F 
(PNGase F), peptone (from soya), phosphate buffered saline, potassium chloride, 
potassium phosphate (dibasic), sodium chloride, sodium phosphate (monobasic), 
streptavidin peroxidase polymer, sucrose, sulfuric acid, tetramethylethylenediamine 
(TEMED), and TWEEN 20 were all supplied from Sigma-Aldrich, Arklow, Ireland. 
Galactosidase was provided by Megazyme (Bray, Ireland) 
Becton Dickinson (BD) Difco agar, nutrient broth (NB), peptone, yeast extract, and 
yeast extract-peptone-dextrose (YPD) broth were all supplied by Unitech, Dublin, 
Ireland. 
LudgerTag™ 2-AB (2-aminobenzamide) Gycan labelling kit was purchased from 
LudgerTag, Oxford, U.K. 
Phytips were ordered from PhyNexus, CA, USA. 
RapiGest SF surfactant was supplied by Waters, Dublin, Ireland. 
Amicon YM-10 regenerated cellulose 10 KD MWCO filters were purchased from 
Fisher Scientific, Dublin, Ireland. 
Rabbit polyclonal antibody to Salmonella group antigen (HRP labelled) (ab53299) and 
rabbit polyclonal antibody to Escherichia coli (Biotin labelled) (ab20640) were 
obtained from abcam® (Cambridge, UK). 
Escherichia coli 10778, Escherichia coli 17076, Escherichia coli 30083, 
Schizosaccharomyces pombe 70572, Rhodotorula mucilaginosa 70825, Rhodotorula 
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mucilaginosa 18184, Rhodotorula mucilaginosa 70404, and Candida utilis 70167 were 
supplied by DSMZ GmbH, Braunschweig, Germany. 
Salmonella enterica var. dublin 15480 was supplied by ATCC, American Type Culture 
Collection, VA, U.S.A. 
Salmonella enterica var. enteritidis 12694 was supplied by NCTC, National Collection 
of Type Cultures, Salisbury, U.K.  
Salmonella enterica var. gallinarum 2931, and Salmonella enterica var. typhimurium 
2514 were supplied by KCTC, Korean Collection for Type Cultures, Yuseong-gu, 
Daejeon 305-806, Korea. 
Saccharomyces cerevisiae 72, Saccharomyces cerevisiae 358, Saccharomyces 
cerevisiae 88, Saccharomyces pastorianus 203, Saccharomyces cerevisiae 695, Pichia 
membranifacieus 326, and Kluyveromyces lactis 752 were supplied by NCYC, National 
Collection of Yeast Cultures, Institute of Food Research, Norwich, U.K.  
Kluyveromyces marxianus 2415, Kluyveromyces marxianus 701, Saccharomyces 
cerevisiae 67, Alltech SC1, Alltech SC2, and Alltech SC 3, Alltech SC 4 were obtained 
from Alltech Inc., Nicholasville, Kentucky, U.S.A. 
Kluyveromyces lactis 141 and Saccharomyces cerevisiae 4070 were supplies by CBS, 
CBS-KNAW, Fungal Biodiversity Centre, Utrecht, The Netherlands. 
Yeast cell wall material was made available by Alltech Inc. (Nicholasville, KY 40356, 
USA). 
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2.2  Methods 
 
2.2.1 Growth and maintenance of bacteria 
A bacterial suspension was prepared from a stored glycerol stock by aseptically 
transferring 100 µL to a 20 mL fresh sterile nutrient broth (NB) and incubated at 37 °C 
for 24 hours at 150 RPM a Grant-bio orbital shaker incubator ES 20. Aliquots of the 
suspension were used to subculture fresh nutrient agar plates and incubated for 24 hours 
at 37 °C. Single colony isolates (SCI) were used to inoculate fresh agar plates and were 
incubated at the appropriate conditions. These plates were kept for short term storage at 
4 °C from which liquid starter cultures of pathogen were inoculated. For long term 
storage, frozen stocks of bacteria (liquid culture) were prepared and stored at -70 °C in 
10 % (v/v) growing culture in 70 % (v/v) glycerol. 
A liquid culture of pathogen was inoculated from a SCI and incubated under the 
appropriate conditions. Cells were harvested by centrifugation at 4 °C and washed three 
times with ice cold sterile 10 mM phosphate buffered saline (PBS), pH 7.4, to remove 
any residual growth medium. The cell pellet was resuspended in 10 mM PBS and the 
optical density at 650 nm (OD650nm) for each pathogen was determined using a 
Shimadzu 1601 PC UV-visible Spectrophotometer. The samples were adjusted to their 
required OD650nm using 10 mM sterile PBS for further analysis. 
 
2.2.2 Microscopic imaging of pathogen and cell wall material binding 
The ability of yeast cell wall material to agglutinate pathogens was evaluated according 
to the protocol used by Perez-Sotelo et al. (2005) with the following modifications: an 
overnight bacterial culture was washed to remove any growth medium and suspended in 
10 mM PBS, pH 7.4, to an OD650nm of approximately 1.0. Ten µL of this was mixed 
with 10 µL of (1 % w/v) yeast cell wall material suspension in 10 mM PBS, pH 7.4, on 
a microscope slide. A control sample contained equal volumes (10 µL) of testing 
bacteria and 10 mM PBS, pH 7.4, and was analysed in parallel with the other slides. All 
the slides were stained with Safranin O using a standard method. Slides were observed 
at 10, 40, and 100 X magnifications by light microscopy (Olympus BX53).  Adhesion 
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was subjectively evaluated by observing the amount of bacteria bound to the yeast cell 
wall material (Perez-Sotelo et al., 2005). 
 
2.2.3 Sample and standard preparation 
2.2.3.1 Preparation of yeast cell wall material standard 
Exact quantities of yeast cell wall material were weighed into 500 mL of sterile 10 mM 
PBS, pH 7.4, making a concentration of 10 µg 100 µL-1. The mixture was stirred for 1 
hour at room temperature to ensure homogenous mixing. A 40 mL aliquot of the yeast 
cell wall material suspension was collected. The suspension was sonicated twice, using 
a Branson sonifier 150, at a power setting of 15 Watts for 30 seconds, keeping the 
sample on ice between rounds of sonication. The sample was stored at 4°C prior to use 
or at -70 °C for long term storage. These samples were utilized in the yeast cell wall 
material activity assay. 
 
2.2.3.2 Preparation of yeast samples 
Yeast samples were prepared and harvested as described in Section 2.2.8. Samples were 
weighed into cold, sterile 10 mM PBS, pH 7.4, 5 % (w/v). The yeast cells were lysed by 
sonication to break open the yeast cells. The suspension was sonicated for ten rounds of 
30 seconds at a power setting of 15 Watts, keeping the suspension on ice between 
rounds. The sonicated samples were centrifuged to separate the cell wall material from 
the intercellular matrix. The pellet containing the cell wall material was freeze dried and 
stored at room temperature until needed. 
 
2.2.4 Quantification of bacteria 
2.2.4.1 Determination of colony forming units of a bacterial strain by plate count 
method 
To quantify the colony forming units (CFUs) of a bacterial strain suspension, nutrient 
agar plates were prepared according to the manufacturer’s instructions. A standard 
curve of dilutions was prepared for the pathogen suspension in sterile 10 mM PBS, pH 
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7.4. The OD650nm of the dilutions were recorded on a Shimadzu 1601 PC UV-visible 
spectrophotometer. Serial dilutions were made of the bacterial strain suspension before 
inoculation onto agar plates in order for the CFUs to be within the countable range of 
30-300 CFUs. The agar plates were inoculated, in triplicate, with 100 µL of the bacterial 
strain dilutions and spread using a sterile T-spreader. The agar plates were incubated 
overnight at 37 °C. The CFUs were counted, recorded and the CFUs were adjusted to 
CFU mL-1. A standard curve was plotted using the optical density values versus the 
CFU mL-1 values. 
 
2.2.4.2 Quantification of bacteria using an enzyme linked immunosorbent assay 
A liquid culture of pathogen was prepared under the appropriate conditions and cells 
were harvested as outlined in Section 2.2.1. A standard curve for each bacterial strain 
was created by dilution with sterile 10 mM PBS, as in Section 2.2.4.1. The OD650nm of 
the pathogen dilutions were recorded on a Shimadzu 1601 PC UV-visible 
spectrophotometer. Each dilution of the bacterial solution at OD650nm (100 µL well-1), 
were mixed together in a well of a NUNC Maxisorb 96-well micro-titre plate with an 
equal volume of sterile 10 mM PBS, bringing the final volume to 200 µL well-1. The 
plate was incubated overnight at 37 °C with constant shaking (150 RPM in a Grant-bio 
orbital shaker incubator ES 20). After the overnight incubation, the micro-titre plate was 
washed twice with 300 µL wash buffer (10 mM PBS, pH 7.4). 
For the Salmonella strains, 200 µL of blocking solution (3 % (w/v) bovine serum 
albumin (BSA) in 10 mM PBS) was added to each well and incubated at room 
temperature for 1 h, to prevent non-specific binding. After blocking, the plate was 
washed twice with 300 µL washing buffer. Each well was treated with 100 µL of 
antibody solution (0.4 µg L-1 HRP labelled rabbit polyclonal antibody to Salmonella 
group antigen in 10mM PBS containing 1 % (w/v) BSA and 0.05 % (v/v) Tween). The 
plate was incubated at room temperature for 1 hour. 
After four additional post-incubation washes, 100 µL of substrate (2, 2’-Azino-bis 3-
ethylbenzthiazoline-6-sulfonic acid (ABSA)) was added to each well. Following 
incubation at room temperature for 20 min, the reaction was stopped by the addition of 
stopping reagent (100 µL of 0.5 M oxalic acid) to each well. The optical density was 
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read at 410 nm, using a BioTek Synergy HT micro-titre plate reader (BioTek 
Instruments Inc., Winooski, Vermont, USA). The absorbance values at 410 nm for each 
point on the standard curve were recorded and plotted against the CFU mL-1 value for 
the corresponding standard point determined by the plate count method (Section 
2.2.4.1). 
For the E. coli strains, strains were plated as outlined for Salmonella. Blocking solution 
(200 µL), containing 4 % (w/v) BSA in 10 mM PBS for O157:H7 and O2:K1:H-, and 
containing 3 % (w/v) BSA in 10 mM PBS for O1:K1:H7, was added to each well and 
incubated at room temperature for 1 h, to prevent non-specific binding. After blocking, 
the plate was washed twice with 300 µL washing buffer. Each well was treated with 100 
µL of antibody solution (0.4 µg mL-1 of biotin labelled rabbit polyclonal antibody to E. 
coli for O157:H7, 4 µg mL-1 of the biotin labelled for O2:K1:H-, and 1.6 µg mL-1 of the 
biotin labelled antibody for O1:K1:H7, in 10mM PBS containing 1 % BSA (w/v) and 
0.05 % (v/v) Tween). The micro-titre plate was then incubated at room temperature for 
1 hour. 
The plate was washed four times with 300 µL 10 mM PBS, pH 7.4. Each well was 
treated with 100 µL of streptavidin peroxidise solution (1 µg mL-1 streptavidin 
peroxidise polymer in 10mM PBS containing 1 % (w/v) BSA and 0.05 % (v/v) Tween) 
and was incubated at room temperature for one hour. After four additional post-
incubation washes, 100 µL of substrate (ABSA) was added to each well. Following 
incubation at room temperature for 20 min, the reaction was stopped by the addition of 
stopping reagent (100 µL of 0.5 M oxalic acid) to each well. The optical density was 
read at 410 nm, using a BioTek Synergy HT micro-titre plate reader. The absorbance 
values at 410 nm for each point on the standard curve were recorded and plotted against 
the CFU mL-1 value for the corresponding standard point determined by the plate count 
method (Section 2.2.4.1). 
 
2.2.5 Yeast cell wall material binding activity assay for Salmonella and E. coli 
serotypes 
A yeast cell wall material standard (10 µg 100 µL-1) and a bacterial solution (100 µL 
well-1, of 0.03 OD650nm for each strain of Salmonella, and an OD650nm of 0.08 for E. coli 
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O157:H7, 0.12 for E. coli O2:K1:H-, and 0.06 for E. coli O1:K1:H7), were prepared as 
described in Sections 2.2.3.1 and 2.2.1, respectively. The yeast cell wall material and 
the pathogen were mixed together in a well of a NUNC Maxisorb 96-well micro-titre 
plate and incubated overnight at 37 °C at 150 RPM in a Grant-bio orbital shaker 
incubator ES 20. A yeast cell wall material control was prepared by mixing 100 µL of 
yeast cell wall material standard and 100 µL of 10 mM PBS, pH 7.4, in a well of the 
plate; while a pathogen control was prepared by mixing 100 µL of the bacterial solution 
and 100 µL of 10 mM PBS, pH 7.4, in a well of the plate. The plate was incubated 
overnight at 37 °C at 150 RPM in a Grant-bio orbital shaker incubator ES 20. The plate 
was washed twice with 300 µL washing buffer (10 mM PBS, pH 7.4). The quantity of 
bacteria remaining on the plate was determined as outlined in Section 2.2.4.2.  
As a known quantity of bacteria was added to the plate initially, the quantity of bacteria 
bound to yeast cell wall material is calculated by subtracting what is left on the plate 
from what was added to the plate initially. The activity of the yeast cell wall material 
was calculated as follows: 
% 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = 𝐶𝐹𝑈 𝑏𝑜𝑢𝑛𝑑 𝑡𝑜 𝑌𝐶𝑊𝑀
𝐶𝐹𝑈 𝑎𝑑𝑑𝑒𝑑 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑙𝑦  × 100 
 
2.2.6 Determination of the optimum bacterial cell number for use in the yeast cell 
wall material activity assay 
These determinations were conducted by preparing a serial dilution of the pathogen 
suspension in sterile 10 mM PBS, each pathogen was cultured as described in Section 
2.2.1. The optical density for each dilution was recorded on a Shimadzu 1601 PC UV-
Vis spectrophotometer. A yeast cell wall material standard (10 µg 100 µL-1), prepared 
as in Section 2.2.3.1, was mixed with 100 µL of each dilution of the pathogen solution 
in a well of a micro-titre plate. A control was prepared by mixing 100 µL of each 
dilution of the pathogen solution with 100 µL of 10 mM PBS, pH 7.4. The mixture was 
incubated overnight at 37 °C at 150 RPM in a Grant-bio orbital shaker incubator ES 20. 
The plate was analysed according to the ELISA protocols in Section 2.2.5. The percent 
of pathogen bound by the yeast cell wall material standard was determined for each of 
the dilutions of the pathogen solution as described in Section 2.2.5. 
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2.2.7  Growth and maintenance of yeast strains 
2.2.7.1  Yeast maintenance and storage 
Yeast strains, as shown in Table 2.1, were cultured in 1 % (w/v) yeast extract, 2 % (w/v) 
peptone, and 2 % (w/v) dextrose medium (YPD), and sterilised by autoclaving at 105 
°C for 30 minutes. SCIs of yeast isolated on YPD agar plates were used to aseptically 
inoculate 20 mL seed cultures which were cultivated overnight at 28 °C in a 
Gallenkamp (cat. 10X400XX2.C) shaking incubator chamber at 200 RPM.  
Sterile inoculation loops were used to subculture fresh agar plates from the seed culture, 
which were incubated accordingly. These agar plates of actively growing cultures were 
used to inoculate liquid starter cultures or stored at 4 °C for up to a month. For long 
term storage, frozen stocks of yeast (liquid culture) were prepared and stored at -70 °C, 
10 % (v/v) growing culture in 70 % (v/v) glycerol. 
Table 2.1. Yeast strains and their reference identification code. 
Yeast Reference 
Saccharomyces cerevisiae 72 
Saccharomyces cerevisiae 88 
Saccharomyces cerevisiae SC 4 
Saccharomyces cerevisiae 4070 
Saccharomyces cerevisiae 695 
Saccharomyces pastorianus 203 
Saccharomyces cerevisiae SC1 
Saccharomyces cerevisiae SC2 
Saccharomyces cerevisiae SC 3 
Kluyveromyces marxianus 2415 
Kluyveromyces marxianus 701 
Kluyveromyces lactis 752 
Pichia membranifaciens 326 
Rhodotorula mucilaginosa 18184 
Rhodotorula mucilaginosa 70825 
Candida utilis 70167 
Schizosaccharomyces pombe 70572 
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2.2.7.2  Yeast liquid fermentation conditions 
A starter culture was prepared in 20 mL of YPD culture medium by adding a SCI of 
actively growing yeast isolated on YPD agar prepared according to Section 2.2.7.1. The 
yeast was allowed to grow in the medium at an appropriate temperature at 200 RPM in 
a Gallenkamp incubator for 1 day until confluent growth was achieved. From this starter 
culture of yeast, 1 mL was used to inoculate 100 mL of any subsequent liquid medium. 
 
2.2.8  Carbohydrate supplementation of yeast fermentation 
A liquid starter culture of yeast was prepared in fresh sterile medium (Section 2.2.7.2) 
according to the optimal growth conditions for yeast production. On the second day, the 
starter culture was distributed into test flasks in triplicate and diluted to 1 % (v/v). Fresh 
sterile modified YPD medium (100 mL) was set up in 250 mL Erlenmeyer flasks. The 
dextrose was omitted from the medium and the medium was supplemented with 
individual carbon sources (1.0 and 2.0 %, w/v). The carbon sources used were fructose, 
galactose, glucose, maltose, mannose and sucrose. Liquid cultures were grown at the 
appropriate conditions for 1 day, following which the yeast biomass was separated from 
the culture medium by centrifugation and washing with deionised water. This was 
repeated twice to ensure complete removal of growth medium. The yeast biomass was 
freeze dried and stored in sealed containers at room temperature until needed. 
 
2.2.9  Compositional analysis of the yeast cell wall material 
2.2.9.1  Acid hydrolysis and sample preparation 
Dry biomass (0.3 ± 0.01 g) was accurately weighed in triplicate and placed in a test 
tube. Following careful mixing, the biomass was hydrolysed with 3 mL of 72 % (v/v) 
H2SO4 for 2 hours at 30 °C and mixed intermittently throughout the hydrolysis. Each 
hydrolysate was transferred to its own 100 mL serum bottle and diluted to a 4 % (v/v) 
sulphuric acid concentration by adding 84 mL deionised water. Each bottle was sealed 
using a crimper (Wheaton corporation, Millville, New Jersey) and autoclaved for 1 hour 
at 121 °C. After completion of the autoclave cycle, the samples were allowed to cool at 
room temperature before removing the seals and stoppers. Aliquots of the hydrolysate 
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(20 mL) were neutralised with calcium carbonate to a pH of between 5 and 6. The 
neutralised hydrolysate was filtered through a 0.2 µM filter (Chromafil ultra RC). A 
dual-component series of sugar calibration standards were prepared in deionised water. 
This contained D-(+) glucose and D-(+) mannose. Recovery standards of glucose, 
mannose, and an in house reference material (cell wall material) were hydrolysed in 
parallel with the yeast biomass samples. 
 
2.2.9.2  Carbohydrate compositional analysis by high performance liquid 
 chromatography 
Separation by HPLC was performed using an Agilent Infinity 1290 liquid 
chromatography system with a refractive index detector. The mobile phase consisted of 
filtered, deionised water at a constant flow rate of 0.6 mL min-1 for 30 minutes. The 
column used for separation was a Bio-rad Aminex® HPX-87p column (300 X 7.8 mm), 
thermostatted at 80 °C, whilst accompanying column guards were maintained at room 
temperature. Samples were analysed for glucose and mannose and were quantified 
against reference standards of known concentration. 
 
2.2.10  N-glycan analysis of yeast samples 
2.2.10.1 Protein extraction from yeast cell wall material 
Yeast proteins were extracted using CHAPS extraction buffer (150 mM NaCl, 20 mM 
sodium phosphate monobasic, pH 7.4, and 1 % CHAPS) and sonicated at 15 Watts for 
three rounds of 30 seconds, keeping the samples on ice between rounds of sonication. 
The sonicated material was agitated at 4 °C for 1 hour to maximise protein extraction. 
The samples were centrifuged at 16600 x g for 40 minutes at 4 °C to pellet the cellular 
debris. The supernatant containing the protein fraction was dried in a vacuum 
centrifuge. 
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2.2.10.2 In-gel block release of N-glycans with PNGase F.  
The vacuum dried protein samples (Section 2.2.10.1) were reduced by adding 4 µL of 5 
X sample buffer (0.625 mL of 0.5 M Tris, pH 6.6., 1 mL of 10 % SDS, and 3.375 mL of 
water), 15 µL of water, and 1 µL of 1.0 M DL-dithiothreitol (DTT) and incubated at 65 
°C for 15 minutes. The samples were then alkylated by adding 1 µL of 100 mM 
indoleacetic acid (IAA) and were incubated for 30 minutes in the dark at room 
temperature. The sample was set into a gel block by adding 45 µL 30 % (w/w) 
acrylamide/ 0.8 % (w/v) bis-acrylamide stock solution, Tris (pH 8.8), 10 % SDS, 10 % 
ammonium peroxodisulfate (APS), and finally N, N, N, N’-tetramethyl-ethylenediamine 
(TEMED), mixed, and left to polymerize for 15 minutes. The gel samples were washed 
with 1 mL 100 % acetonitrile (ACN) for 10 minutes. The ACN was removed and the 
samples were washed with 1 mL of 20 mM NaHCO3 for 10 minutes. This wash 
procedure was repeated once more, with a final wash with 1 mL ACN for 10 minutes. 
The gel pieces were centrifuged briefly to remove any traces of ACN. N-glycans were 
released by adding 25 µL PNGase F (2 U mL-1), mixed gently with pipette action, and 
left at room temperature for 5 minutes. An additional 25 µL of PNGase was then added 
followed by 50 µL of 20 mM NaHCO3 and was incubated over night at 37 °C. The 
released glycans were collected by washing the gel pieces with three by 200 µL of 
deionised water for 10 minutes, 200 µL of ACN for 10 minutes, 200 µL of water for 10 
minutes and finally 200 µL of ACN for 10 minutes. The liquid fraction was collected 
after each wash step. The N-glycans were dried using a vacuum centrifuge overnight. 
The glycans were converted back to reducing aldoses with 20 µL 1 % (v/v) formic acid 
and the mixture was incubated at room temperature for 40 minutes. The samples were 
then dried for further processing. 
 
2.2.10.3 2-AB glycan labelling and clean-up 
The in-gel block released dried glycan samples were labelled by adding 5 µL 2-AB 
labelling solution (LudgerTag™ 2-AB labelling kit) and thoroughly mixed for 2 hours 
at 65 °C. Excess 2-AB was removed using Phytips. The glycans were dried overnight in 
a vacuum centrifuge. The samples were suspended in 75 % (v/v) ACN for HILIC UPLC 
analysis. 
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2.2.10.4 Hydrophilic interaction chromatography (HILIC) UPLC analysis of 
 N-glycans 
The N-glycans were analysed using an Agilent 1290 Infinity Ultra Pure Liquid 
Chromatography (UPLC) system, coupled to a fluorescence detector (UPLC-FLD). 
Separation was achieved on an Acquity UPLC 1.7 µm BEH Glycan column (2.1 X 150 
mm), thermostatted at 40 °C. The samples were kept at 5 °C and the volume injection 
was 20 µL. A solvent system consisting of 50 mM ammonium formate, pH 4.4, (solvent 
A) and acetonitrile (solvent B) was used with the following gradients: 30 minute linear 
gradient with a flow rate of 0.561 mL min-1 (except for wash step): 30 % solvent A for 
1.47 minutes, increasing to 47 % solvent A over 23.34 minutes, increasing to 70 % 
solvent A over 0.69 minutes; 70 % solvent A for 0.75 minutes and then for a further 0.3 
minutes at a reduced flow rate of 0.4 mL min-1, returning to 30 % solvent A over 0.3 
minutes at a flow rate of 0.4 mL min-1, then equilibrating with 30 % solvent A for 1.95 
minutes with the flow rate returned to 0.561 mL min-1. The sample loop was washed 
and purged with 80 % acetonitrile. Glycans were identified by comparison of retention 
times of a dextran standard used to generate glucose unit (GU) values, standard units for 
carbohydrate analysis, and relative percentage peak areas were calculated. Detection 
was performed with a fluorescence detector, set at the following wavelengths: excitation 
λ330nm and emission λ420nm. The UPLC system was calibrated by running an external 
standard of 2-AB dextran ladder (2-AB labelled glucose homopolymer) alongside the 
sample runs.  
 
2.2.10.5 Confirmation of high mannose N-glycan identification 
The 2-AB labelled glycan samples were digested with Jack Bean Mannosidase (JBM) to 
confirm the presence of high mannose N-glycans. Exoglycosidase digestion was carried 
out, as described by Royal et al. (Royle et al., 2008), on aliquots of the 2-AB labelled 
N-glycan pool, where pool refers to the combined sample from experiments performed 
in triplicate during the initial release of N-glyans (Section 2.2.10.2). On completion of 
the enzymatic digestion the enzyme was removed using 10 kD MWCO filters and 
centrifuged at 13, 105 x g for 2 minutes and then a further 5 minutes after a wash with 
deionised water. The supernatant was dried in a vacuum centrifuge and suspended in 66 
% (v/v) ACN for HILIC UPLC analysis. 
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2.2.10.6 Confirmation of galactose N-glycan identification 
The 2-AB labelled glycan samples were digested with galactosidase to confirm the 
presence of galactose N-glycan. Exoglyconsidase digestion was carried out as described 
by Royle et al. (2008) on aliquots of the 2-AB labelled N-glycan pool. On completion of 
the enzymatic digestion the enzyme was removed using 10 kDa MWCO filters as 
described in Section 2.2.10.5. The supernatant was dried in a vacuum centrifuge and 
suspended in 66 % (v/v) ACN for HILIC UPLC analysis.  
 
2.2.11  Statistical analysis 
Statistical analyses of results were performed using Minitab statistical software package 
version 17 (Coventry, U.K.). One way analysis of variance (ANOVA) and Tukey’s 
multiple comparisons were carried out to test any significant differences among means, 
where the confidence level was set at 95 %. One way analysis of variance (ANOVA) 
and Dunnett’s comparisons were carried out to test any significant differences between 
each test mean and a control mean, where the confidence level was set at 95 % (Tucker, 
2003, Minitab, 2010). Significant levels were defined using p ≤ 0.05. Spearman Rho 
correlation coefficient (r) between the content of total glucose and mannose, to the 
activity (%) of each yeast cell wall material sample was also determined. (The data was 
tested for normality) (Minitab, 2010). 
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3 Results and Discussion 
 
3.1 The effect of yeast growth medium augmentation on yeast cell wall saccharide 
composition. 
Yeasts have been a component of the human diet for the last 7000 years (Cuskin et al., 
2015). Food grade yeasts are used as sources of high nutritional value proteins, enzymes 
and vitamins, with applications in the health food industry as nutritional supplements. 
They are also used as food additives, conditioners and flavouring agents, for the 
production of microbiology media, as well as livestock feeds. Yeasts are included in 
starter cultures, for the production of specific types of fermented foods like cheese, 
bread, sourdoughs, fermented meat and vegetable products, vinegar, etc. (Bekatorou et 
al., 2006). 
It is well documented that the cell wall of various yeast species vary in their 
oligosaccharide composition (Schiavone et al., 2015, Bzducha-Wrobel et al., 2013, Ene 
et al., 2012b, Xie and Lipke, 2010, Backhaus et al., 2010, Liu et al., 2009b, Nguyen et 
al., 1998, Alsteens et al., 2008). Glucan and mannan are the main oligosaccharide 
components of yeast cell wall, the quantities of which can be affected by environmental 
stress and growth conditions (Ene et al., 2012a, Backhaus et al., 2011, Liu et al., 2009b, 
Rodrigues et al., 2006, Aguilar-Uscanga and Francois, 2003). In addition to using 
Saccharomyces cerevisiae var. boulardii, the parent strain from which Actigen® is 
derived; it was decided to subject a number of different species of yeast to a varied 
regime of culture conditions as outlined in Section 2.2.8. Many of the strains chosen for 
this are used industrially. Fifteen ascomycetes, including species from the genera: 
Saccharomyces, Candida, Kluyveromyces, Pichia, and Schizosaccharomyces; and two 
species of basidiomycetes (Rhodotorula), were assessed and their cell wall saccharide 
content analysed. The cell wall composition of Saccharomyces cerevisiae and Candida 
albicans are well studied, no other yeasts have had the depth of biochemical, genetic, or 
genomic analysis as these two strains (Xie and Lipke, 2010). Even with the depth of 
current work on both strains very little published research exists on the effect of 
supplementation of various carbon sources into the growth medium on their cell wall 
composition (Aguilar-Uscanga and Francois, 2003). For this reason the effect different 
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carbon sources in the growth medium had on the cell wall composition of a number of 
strains of yeast was investigated. 
3.1.1 Effect of carbon sources on Saccharomyces spp. cell wall saccharide content 
The addition of 1 and 2 % (w/v) of simple carbon sources to the basal cultivation 
medium was studied to determine how it affected the saccharide composition of the cell 
wall. The basal medium consisted of 1 % (w/v) yeast extract and 2 % (w/v) peptone 
(YP); to this 1 or 2 % (w/v) carbon sources were added. The basal medium containing 2 
% (w/v) glucose as the sole carbon source was chosen as the control as this is a common 
lab medium for the cultivation of yeast. Carbohydrate content of the cell wall samples 
was determined following acid hydrolysis and analysis of the hydrolysate by HPLC as 
described in Section 2.2.9. Acid hydrolysis of the yeast cell wall breaks the cell wall 
oligosaccharides into their component monosaccharides i.e. glucose and mannose 
(Bzducha-Wrobel et al., 2013, Klis et al., 2006). This method has been used extensively 
in the literature to determine the carbohydrate content of biomass (Ruiz and Ehrman, 
1996). Tables 3.1-3.6 list the total cell wall glucose and mannose content of the 17 
species of yeast used in this study following cultivation with various carbon sources at 1 
% and 2 % (w/v) inclusion. The cell wall glucose and mannose content of 
Saccharomyces strains grown in 1 and 2 % (w/v) carbon source are shown in Tables 3.1 
and 3.2. 
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Table 3.1. Saccharide composition of Saccharomyces cell wall following 
cultivation in growth medium containing a sole carbon source (1 % w/v) 
Strain Carbon source % Glucose (w/w) % Mannose (w/w) 
Saccharomyces cerevisiae  
(72) 
Control 11.4 ± 0.6 14.8 ±1.8 
Fructose 7.8 ± 4.3 14.2 ± 3.2 
Galactose 11.0 ± 0.3 14.5 ± 2.0 
Glucose 10.7 ± 0.8 14.6 ± 1.5 
Maltose 15.3 ± 3.0 14.6 ± 1.0 
Mannose 9.6 ± 1.1 16.7 ± 1.1 
Sucrose 12.2 ± 1.6 16.8 ± 3.0 
Saccharomyces pastorianus  
(203) 
Control 20.7 ± 4.5 15.7 ± 5.8 
Fructose 23.6 ± 0.5 19.6 ± 2.3 
Galactose 24.7 ± 0.7 17.0 ± 4.7 
Glucose 23.1 ± 3.6 20.6 ± 2.8 
Maltose 27.3 ± 3.1 20.4 ± 2.5 
Mannose 21.6 ± 0.3 17.7 ± 1.7 
Sucrose 22.2 ± 1.2 17.8 ± 4.8 
Saccharomyces cerevisiae  
(4070) 
Control 10.1 ± 3.5 14.0 ± 4.7 
Fructose 21.1 ± 2.1* 14.0 ± 1.2 
Galactose 9.3 ± 2.0 16.6 ± 4.9 
Glucose 15.4 ± 6.1 16.4 ± 4.3 
Maltose 12.2 ± 5.3 14.0 ± 4.0 
Mannose 16.4 ± 6.1 16.7 ± 4.8 
Sucrose 13.2 ± 3.5 15.4 ± 2.5 
Saccharomyces cerevisiae  
(SC 4) 
Control 13.7 ± 0.1 12.4 ± 2.3 
Fructose 15.8 ± 3.3 13.9 ± 3.8 
Galactose 16.6 ± 4.9 13.7 ± 4.6 
Glucose 16.5 ± 3.7 12.5 ± 2.1 
Maltose 15.0 ± 4.6 14.3 ± 5.2 
Mannose 17.1 ± 2.0 14.7 ± 2.9 
Sucrose 14.4 ± 1.8 12.9 ± 3.4 
Saccharomyces cerevisiae  
(695) 
Control 10.6 ± 1.5 10.9 ± 1.9 
Fructose 14.1 ± 6.3 10.8 ± 1.9 
Galactose 10.9 ± 5.4 12.5 ± 2.1 
Glucose 12.7 ± 6.0 11.9 ± 2.7 
Maltose 14.2 ± 4.4 13.0 ± 2.2 
Mannose 9.1 ± 1.2 12.0 ± 1.4 
Sucrose 14.0 ± 4.0 11.2 ± 3.2 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
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Table 3.1 cont. Saccharide composition of Saccharomyces cell wall following 
cultivation in growth medium containing a sole carbon source (1 % w/v) 
Strain Carbon source % Glucose (w/w) % Mannose (w/w) 
Saccharomyces cerevisiae 
(88) 
Control 13.9 ± 0.8 14.8 ± 2.7 
Fructose 15.1 ± 1.2 14.3 ± 1.3 
Galactose 11.0 ± 1.0 12.0 ± 2.1 
Glucose 16.2 ± 0.3 14.7 ± 1.3 
Maltose 16.9 ± 0.3 16.3 ± 0.4 
Mannose 12.1 ± 1.3 16.9 ± 2.3 
Sucrose 9.9 ± 4.4 10.2± 6.3 
Saccharomyces cerevisiae 
(SC 3) 
Control 17.0 ± 1.4 13.9 ± 1.2 
Fructose 14.4 ± 2.5 13.1 ± 0.6 
Galactose 14.6 ± 2.3 11.7 ± 1.0 
Glucose 14.8 ± 1.4 13.6 ± 0.8 
Maltose 14.0 ± 1.2 13.2 ± 1.0 
Mannose 15.0 ± 1.3 14.6 ± 1.4 
Sucrose 15.7 ± 1.3 13.5 ± 0.9 
Saccharomyces cerevisiae 
(SC 1) 
Control 16.1 ± 0.5 18.5 ± 2.4 
Fructose 19.4 ± 2.7 13.8 ± 2.7 
Galactose 16.5 ± 0.7 19.2 ± 1.5 
Glucose 16.5 ± 1.6 17.4 ± 1.6 
Maltose 17.7 ± 0.6 20.2 ± 3.3 
Mannose 23.5 ± 4.2* 16.1 ± 2.1 
Sucrose 16.4 ± 0.9 18.2 ± 1.7 
Saccharomyces cerevisiae 
(SC 2) 
Control 9.9 ± 1.7 12.2 ± 0.3 
Fructose 10.5 ± 1.1 13.0 ± 1.0 
Galactose 15.5 ± 4.0* 13.6 ± 2.3 
Glucose 10.2 ± 1.4 12.3 ± 0.4 
Maltose 11.5 ± 3.1 11.4 ± 1.4 
Mannose 10.1 ± 1.6 12.4 ± 0.7 
Sucrose 10.7 ± 2.4 12.0 ± 0.8 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
 
A few changes were apparent when strains were cultured with 1 % (w/v) carbon source 
in the growth medium (Table 3.1). The cell wall glucose content of S. cerevisiae 4070 
was significantly higher (21.3 %, w/w) than the control (10.1 %, w/w) when grown in 1 
% (w/v) fructose as the sole carbon source. Mannose (1 %, w/v) as the sole carbon 
source significantly increased the glucose content of S. cerevisiae SC 1 (23.5 %, w/w) 
compared to the control (16.1 %, w/w). The glucose content of S. cerevisiae SC 2 was 
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significantly increased (15.5 %, w/w) compared to the control (9.9 %, w/w) when 
grown in medium containing 1 % (w/v) galactose. Although there were few significant 
differences observed between the cell wall glucose and mannose content of the samples 
grown in 1 % (w/v) carbon sources compared to the control, there were a number of 
interesting observations. The glucose cell wall content for all the strains of 
Saccharomyces ranged from 7.8 % to 27.3 % (w/w) and the mannose cell wall content 
ranged from 10.2 % to 20.2 % (w/w) depending on the carbon source used. Growth 
medium containing 1 % (w/v) fructose as the sole carbon source for S. cerevisiae 72 
yielded the lowest amount of cell wall glucose content (7.8 %, w/w) for all the strains of 
Saccharomyces, however, it was not significantly different to the control. Strains S. 
pastorianus 203 and S. cerevisiae SC 1 had higher overall cell wall glucose and 
mannose content while S. cerevisiae 72 and SC 4 had lower overall cell wall glucose 
content, and S. cerevisiae 695 had the lowest overall cell wall mannose content 
compared to the other strains of Saccharomyces. The cell wall monosaccharide content 
of S. pastorianus 203 grown in 1 % (w/v) carbon sources was between 21.6 and 27.3 % 
(w/w) glucose content and between 17.0 and 20.6 % (w/w) mannose content. While all 
the values of cell wall glucose and mannose content were higher than the control values 
for S. pastorianus none were significantly different. S. cerevisiae SC 1 cell wall content 
was found to approach similarly high levels of glucose and mannose (16.4 – 23.5 %, 
w/w and 13.8 – 20.2 %, w/v) as S. pastorianus 203. 
Table 3.2 shows the cell wall glucose and mannose content for all strains of 
Saccharomyces grown in 2 % (w/v) of the various carbon sources. Some variation was 
noted between the cell wall saccharide content of the Saccharomyces strains. The cell 
wall glucose content for all strains ranged from 8.9 % to 31.8 % (w/w), and the overall 
cell wall mannose content ranged from 10.9 % to 22.5 % (w/w). S. pastorianus 203 was 
again found to have the highest levels of cell wall glucose content of all the 
Saccharomyces strains, while S. cerevisiae SC 1 had the highest mannose content of all 
the Saccharomyces strains when cultured in growth medium containing 2 % (w/v) 
carbon source. 
Differences exist between S. cerevisiae and S. pastorianus, for example, S. pastorianus 
is an allotetraploid hybrid yeast derived from S. cerevisiae and S. bayanus (Rainieri et 
al., 2006). It is a bottom fermenting yeast used in the production of lager, while S. 
cerevisiae (brewer’s yeast) is a top fermenting yeast (Yamagishi and Ogata, 1999); each 
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strain is known to have different surface biochemical composition, surface 
hydrophobicity and aggregation properties. S. cerevisiae strains are richer in proteins 
and more hydrophobic (Dengis et al., 1995). The two strains have similar surface 
ultrastructure but have different cell wall elasticity and polysaccharide properties. Cell 
wall mannans are much more extended on S. cerevisiae compared to S. pastorianus 
(Alsteens et al., 2008). S. pastorianus also contains slightly different glucan linkages, β-
(1, 4) linkages, in the cell wall than those of S. cerevisiae (Bastos et al., 2015, Pinto et 
al., 2015). All of these differences between the two species may contribute to the 
variations in their monosaccharide content.  
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Table 3.2 Saccharide composition of Saccharomyces cell wall following 
cultivation in growth medium containing a sole carbon source (2 % w/v) 
Strain Carbon source % Glucose (w/w) % Mannose (w/w) 
Saccharomyces cerevisiae 
(72) 
Control 11.4 ± 0.6 14.8 ±1.8 
Fructose 11.7 ± 2.4 15.9 ± 0.7 
Galactose 14.2 ± 2.4 15.9 ± 0.7 
Maltose 13.3 ± 2.3 16.8 ± 0.4 
Mannose 11.9 ± 2.2 18.4 ± 0.6 
Sucrose 11.7 ± 2.7 15.7 ± 0.6 
Saccharomyces pastorianus 
(203) 
Control 20.7 ± 4.5 15.7 ± 5.8 
Fructose 20.7 ± 3.8 14.7 ± 4.9 
Galactose 20.0 ± 4.4 15.1 ± 5.9 
Maltose 31.8 ± 5.1 22.5 ± 0.3 
Mannose 23.4 ± 1.0 13.5 ± 1.0 
Sucrose 20.6 ± 2.9 16.4 ± 4.6 
Saccharomyces cerevisiae 
(4070) 
Control 10.1 ± 3.5 14.0 ± 4.7 
Fructose 15.0 ± 1.0 14.4 ± 1.3 
Galactose 8.9 ± 0.7 16.4 ± 2.1 
Maltose 9.9 ± 1.5 17.0 ± 2.3 
Mannose 12.3 ± 1.2 17.4 ± 2.2 
Sucrose 10.1 ± 2.1 14.8 ± 2.9 
Saccharomyces cerevisiae 
(SC 4) 
Control 13.7 ± 0.1 12.4 ± 2.3 
Fructose 13.0 ± 0.8 12.8 ± 2.7 
Galactose 11.0 ± 0.9 12.9 ± 2.7 
Maltose 11.7 ± 1.7 11.2 ± 2.3 
Mannose 14.1 ± 1.5 12.2 ± 2.6 
Sucrose 13.9 ± 0.7 11.8 ± 2.3 
Saccharomyces cerevisiae 
(695) 
Control 10.6 ± 1.5 10.9 ± 1.9 
Fructose 11.3 ± 1.0 14.2 ± 3.7 
Galactose 10.4 ± 1.1 13.5 ± 3.1 
Maltose 13.0 ± 1.6 12.5 ± 3.0 
Mannose 9.3 ± 1.9 13.8 ± 3.1 
Sucrose 12.5 ± 3.1 11.8 ± 2.6 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
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Table 3.2 cont. Saccharide composition of Saccharomyces cell wall following 
cultivation in growth medium containing a sole carbon source (2 % w/v) 
Strain Carbon source % Glucose (w/w) % Mannose (w/w) 
Saccharomyces cerevisiae 
(88) 
Control 13.9 ± 0.8 14.8 ± 2.7 
Fructose 14.3 ± 0.1 16.6 ± 0.4 
Galactose 14.4 ± 0.4 13.8 ± 1.4 
Maltose 17.2 ± 0.3 16.2 ± 0.8 
Mannose 13.3 ± 1.9 16.8 ± 2.2 
Sucrose 12.0 ± 2.7 13.5 ± 3.4 
Saccharomyces cerevisiae 
(SC 3) 
Control 17.0 ± 1.4 13.9 ± 1.2 
Fructose 16.0 ± 1.7 14.0 ± 1.0 
Galactose 14.3 ± 2.2 13.4 ± 0.9 
Maltose 15.9 ± 1.6 13.2 ± 1.2 
Mannose 15.2 ± 2.4 14.9 ± 1.2 
Sucrose 17.9 ± 1.8 14.3 ± 1.3 
Saccharomyces cerevisiae 
(SC 1) 
 
Control 16.1 ± 0.5 18.5 ± 2.4 
Fructose 14.5 ± 0.9 20.5 ± 3.3 
Galactose 15.1 ± 2.6 20.1 ± 2.7 
Maltose 16.5 ± 0.8 20.1 ± 3.2 
Mannose 14.8 ± 1.1 21.2 ± 0.8 
Sucrose 14.2 ± 1.4 18.0 ± 0.5 
Saccharomyces cerevisiae 
(SC 2) 
Control 9.9 ± 1.7 12.2 ± 0.3 
Fructose 9.9 ± 1.6 13.3 ± 1.2 
Galactose 10.1 ± 1.8 11.6 ± 0.6 
Maltose 11.2 ± 1.3 11.8 ± 0.7 
Mannose 10.4 ± 1.9 13.5 ± 1.0 
Sucrose 10.8 ± 1.5 11.5 ± 1.0 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
 
Conversely to 1 % (w/v) fructose as the sole carbon source, 2 % (w/v) fructose as the 
sole carbon source did not cause any significant changes in the cell wall glucose content 
of S. cerevisiae 4070 compared to the control. However, the cell wall glucose content of 
S. cerevisiae 4070 was significantly decreased from 21.5 % to 15.0 % (w/w) with an 
increase in fructose concentration in the growth medium from 1 to 2 % (w/v), indicating 
that the increased concentration of fructose significantly affects the glucose content in 
the cell wall. No other significant differences were observed for cell wall saccharides of 
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the other strains of Saccharomyces when the growth medium contained fructose as the 
sole carbon source.  
The metabolic pathway of fructose fermentation is similar to that of glucose. After 
phosphorylation, fructose-6-phosphate readily enters glycolysis by conversion into 
fructose-1, 6-bisphosphate, while glucose-6-phosphate still has to be converted first into 
fructose-6-phosphate by phosphogluco-isomerase (PGI). The differences in glucose and 
fructose metabolism appears to be located in the transport and/or phosphorylation steps 
(Berthels et al., 2004). The transporters are shared although their affinity for glucose is 
higher than for fructose. Yeast cells possess glucose sensor proteins in the plasma 
membrane of which at least one, Gpr1, is known to have a different affinity for glucose 
and fructose (Rolland et al., 2001). It is not known whether yeast cells posses a specific 
fructose sensor. S. cerevisiae cells grown on medium lacking glucose but containing 
fructose were found to exhibit enhanced agar invasion (Palecek et al., 2002). Fructose 
also induces the expression of Snf1 in the absence of glucose (Palecek et al., 2002); 
Snf1 kinase complex, a key regulator of yeast carbohydrate metabolism, also plays a 
role in the maintenance of cell wall integrity. An increase in Snf1 kinase was shown to 
cause a decrease in yeast cell wall thickness with an increase in carbon source 
concentration (Backhaus et al., 2013). In this study, an increase in fructose 
concentration in the growth medium caused a decrease in cell wall glucose content of 
one strain of Saccharomyces i.e. S. cerevisiae 4070. A decrease in cell wall glucose may 
be associated with a decrease in cell wall thickness as glucan is a major part of the cell 
wall structure (Orlean, 2012). 
Galactose as the sole carbon source at 2 % (w/v) in the growth medium had one 
significant effect on the cell wall saccharide content of these strains of Saccharomyces. 
The glucose content of S. cerevisiae 88 was found to increase significantly from 11.0 to 
14.4 % (w/w) with an increase in galactose concentration from 1 to 2 % (w/v). 
Galactose is known to be a slow fermenting sugar in S. cerevisiae. In contrast to glucose 
and fructose, which are directly incorporated into glycolysis, galactose needs some 
additional metabolic steps; it is metabolised by the enzymes of the Leloir pathway 
(Fonseca et al., 2013). This pathway requires five enzymes to convert galactose to 
glucose-6-phosphate. In order for galactose to be metabolised it must first be 
transported into the cells. Specific sugar transporters are expressed under certain 
conditions. The high affinity galactose transporter Gal2p is expressed in the presence of 
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galactose and repressed in the presence of glucose (Timson, 2007). An increase in cell 
wall glucan grown in galactose as the single carbon source for a single strain of S. 
cerevisiae (CEN.PK133-7D) was described by Aguilar-Uscanga and Francois (2003). 
Regulation of cell wall integrity proteins such as β-(1, 3) and β-(1, 6) glucan synthases 
Fks1, Fks2, and Kre5 by galactose in some strains of yeast, including S. cerevisiae, have 
been reported (Ovalle et al., 1998). These syntheses are involved in cell wall 
construction (Sekiya-Kawasaki et al., 2002). S. cerevisiae cells grown on medium 
lacking glucose but containing galactose exhibited enhanced agar invasion (Palecek et 
al., 2002), suggesting morphological changes occur in the presence of galactose which 
may affect the cell wall saccharide content of the yeast. This was seen with S. cerevisiae 
SC 2 and 88 in this study although the effect was seen with 1 % (w/v) galactose for S. 
cerevisiae 88 and with 2 % (w/v) galactose for S. cerevisiae SC 2. 
Glucose is the preferred carbon source of S. cerevisiae, if present even at low levels 
compared to alternative carbon sources it will be metabolised exclusively (Bisson et al., 
1993). The central pathways of carbohydrate metabolism have evolved to process the 
hexose monosaccharide glucose (Timson, 2007). Glucose in the growth medium did not 
cause any significant changes in the cell wall saccharide content of these 
Saccharomyces spp. nor was it found to have any significant effects on Saccharomyces 
cell wall saccharide content with an increase in the glucose concentration from 1 to 2 % 
(w/v). Perhaps, lower or even higher concentrations of glucose would cause changes in 
the cell wall saccharide content not observed at the concentrations used in this study.  
No significant differences were observed for the cell wall glucose (w/w) content for the 
Saccharomyces strains when grown in growth medium containing 1 or 2 % (w/w) 
maltose. Maltose as the sole carbon source was found to cause changes in the glucose 
and mannose content in the cell wall of S. cerevisiae (Aguilar-Uscanga and Francois, 
2003), but no such changes were seen in this study with maltose as the sole carbon 
source in the growth medium. 
Mannose as the sole carbon source in the growth medium of 2 % (w/v) did not cause 
any significant changes in the cell wall content of the Saccharomyces strains analysed in 
this study compared to the control. Even so, the differences in the cell wall saccharide 
content of S. cerevisiae SC 1 between samples grown in 1 and 2 % (w/v) mannose were 
significant. The cell wall glucose content increased and the cell wall mannose content 
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decreased with the increase of mannose concentration in the growth medium. Many of 
the enzymes of the glycolytic pathway are so specific for glucose that other sugars, even 
other hexoses, are not processed at any appreciable rate (Timson, 2007). Mannose is 
metabolised through different pathways compared to glucose and fructose. In all 
eukaryotes, the activation of mannose initiates from formation of mannose 6-phosphate 
(Man-6-P), which occurs by one of two routes: direct phosphorylation of mannose or 
interconversion from fructose 6-phosphate via phosphomannose isomerase. Excess 
mannose concentrations can lead to an accumulation of Man-6-P which inhibits the 
activity of phosphoglucose isomerase and thus represses glycolysis, protein 
biosynthesis, and cell wall biogenesis (Jin, 2012, Pitkanen et al., 2004). This may 
explain the significant decrease in cell wall glucose content of SC 1 when the 
concentration of mannose was increased from 1 to 2 % (w/v) in the growth medium. 
Palecek et al. (2002) found that changing the carbon source from glucose to mannose 
caused the cell wall composition of a single strain of S. cerevisiae to change leading to 
the conclusion that mannose induced a number of genes related to cell wall structure 
and maintenance proteins. Aguilar-Uscanga and Francois (2003) found that mannose 
supplementation caused changes in the glucan and mannan content of the cell wall 
compared to a glucose supplemented control for a strain of S. cerevisiae. Nonetheless, 
only one strain of S. cerevisiae (SC 1) was significantly affected in this study. The 
difference in the metabolism of mannose by S. cerevisiae compared to other hexoses 
was not reflected in the cell wall saccharide content of the majority of the strains used in 
this study apart from S. cerevisiae SC 1. 
No statistically significant findings were observed between the monosaccharide content 
of the control and that of the samples grown in sucrose as the sole carbon source or 
indeed due to an increase in sucrose concentrations. Sucrose is rapidly hydrolysed to 
fructose and glucose by extracellular invertase followed by uptake and incorporation 
into the glycolytic pathway by S. cerevisiae (Liu et al., 2009b, Lorenz et al., 2000). 
Interestingly, neither of the disaccharides used in this study (sucrose or maltose) caused 
any significant changes in the cell wall glucose or mannose content of any of the 
Saccharomyces strains used compared to the control. It appears from this work that 
sucrose and maltose act similarly to glucose in terms of their effect on the cell wall 
glucose and mannose content in these strains of Saccharomyces. 
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As strains of S. cerevisiae differ slightly from each other, changes in the cell wall 
architecture and content can vary (Xie and Lipke, 2010). Schiavone et al. (2015) found 
that the glucan, mannan and chitin composition between two strains of S. cerevisiae 
were different when grown in a lab medium containing yeast extract, peptone and 
glucose under the same conditions. The glucan content was higher and mannan content 
lower in one strain compared to the other. Differences in the cell wall glucose and 
mannose content of Saccharomyces strains and their controls were also observed in this 
research. A number of studies on the effects of various carbon sources, including 
monosaccharides and disaccharides, on the cell wall composition of S. cerevisiae, found 
that the cell wall glucan and mannan content did change depending on the carbon source 
(Liu et al., 2009b, Palecek et al., 2002, Aguilar-Uscanga and Francois, 2003). Growth 
medium and especially carbon source can influence the cell wall composition (Jaehrig et 
al., 2008).  
The absence of glucose and the presence of different carbon sources have been shown to 
cause metabolic changes in Saccharomyces strains. About 163 genes from S. cerevisiae 
are up regulated in glucose limited conditions. Many of these genes are still poorly 
characterized and their function unknown (Weinhandl et al., 2014). The effect of 
various carbon sources on the metabolic pathways of yeast may be a factor in the 
variation of the cell wall monosaccharide content of individual strains grown in 
different carbon sources.  
 
3.1.2 Effect of carbon source on Kluyveromyces spp. cell wall saccharide content 
Three strains from the genus Kluyveromyces were grown in the modified medium and 
the glucose and mannose content of their cell wall was analysed as described previously 
for the Saccharomyces strains. The outer surface of Kluyveromyces spp. were shown to 
have a three layered ultra structure cell wall consisting of a plasma membrane, a 
polysaccharide glucan layer and an electron dense mannoprotein outer layer (Backhaus 
et al., 2010), similar to S. cerevisiae (Klis et al., 2010, Uccelletti et al., 2005) with 
comparable polysaccharide and mannoprotein composition (Lukondeh et al., 2003a, 
Lukondeh et al., 2003b). The monosaccharide content of the Kluyveromyces samples 
used in this study are shown in Tables 3.3 and 3.4 for 1 and 2 % (w/v) carbon sources. 
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When considering Kluyveromyces, the relatively close phylogenetic relationship with 
Saccharomyces might be expected to facilitate direct comparisons, whereas, with sugar 
metabolism, Saccharomyces is quite unique and has developed a whole series of 
idiosyncrasies not found in other yeast (Lane and Morrissey, 2010). Kluyveromyces, in 
contrast to S. cerevisiae, did not undergo a whole genome duplication event (Fares et 
al., 2013). Unlike S. cerevisiae, Kluyveromyces are Crabtree negative yeast (Lane et al., 
2011), lacking the ability to produce ethanol under aerobic condition, and preferentially 
direct metabolism towards the TCA cycle and optimum energy generation. 
Kluyveromyces are one of the few strains that can use lactose as a carbon and energy 
source (Lane and Morrissey, 2010, Dong and Dickson, 1997). As such, variation in the 
cell wall monosaccharide content between Kluyveromyces and Saccharomyces species 
were expected. K. lactis grows faster on lactose as a carbon source than on glucose 
(Madinger et al., 2009, Dong and Dickson, 1997). K. marxianus is a species that is 
substantially different to the related K. lactis (Lane et al., 2011). The dairy yeast K. 
marxianus, a GRAS organism, has the fastest growth rate of any eukaryotic microbe, 
thermotolerance, and the capacity to assimilate a wide range of sugars (Fonseca et al., 
2013, Lane and Morrissey, 2010). 
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Table 3.3. Saccharide composition of K. lactis and K. marxianus cell wall 
following cultivation in growth medium containing a sole carbon source (1 % w/v) 
Strain Carbon source % Glucose (w/w) % Mannose (w/w) 
Kluyveromyces lactis  
(752) 
Control 16.4 ± 1.1 14.2 ± 1.9 
Fructose 12.7 ± 1.4 13.9 ± 0.7 
Galactose 17.6 ± 0.6 14.2 ± 1.6 
Glucose 19.2 ± 1.2 12.7 ± 1.5 
Maltose 19.5 ± 3.9 10.4 ± 0.4* 
Mannose 12.1 ± 1.1 15.2 ± 0.7 
Sucrose 20.0 ± 1.5 14.7 ± 1.5 
Kluyveromyces 
marxianus 
(701) 
Control 14.5 ± 4.1 11.6 ± 2.3 
Fructose 12.6 ± 1.2 14.0 ± 0.7* 
Galactose 13.9 ± 1.5 13.3 ± 0.5 
Glucose 13.2 ± 1.8 13.7 ± 1.3* 
Maltose 12.8 ± 1.7 12.7 ± 0.6 
Mannose 13.5 ± 1.7 14.0 ± 0.2* 
Sucrose 12.7 ± 1.3 12.9 ± 0.4 
Kluyveromyces 
marxianus 
(2415) 
Control 11.2 ± 0.9 10.3 ± 0.5 
Fructose 34.3 ± 2.9* 13.6 ± 0.8* 
Galactose 10.9 ± 0.5 15.6 ± 0.7* 
Glucose 30.3 ± 1.8* 13.6 ± 0.5* 
Mannose 10.4 ± 0.8 17.4 ± 3.0* 
Sucrose 10.8 ± 0.7 9.9 ± 0.8 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
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Table 3.4. Saccharide composition of K. lactis and K. marxianus cell wall 
following cultivation in growth medium containing a sole carbon source (2 % w/v) 
Strain Carbon source % Glucose (w/w) % Mannose (w/w) 
Kluyveromyces lactis 
(752) 
Control 16.4 ± 1.1 14.2 ± 1.9 
Fructose 13.3 ± 1.2 13.9 ± 0.6 
Galactose 24.1 ± 6.0* 13.5 ± 1.1 
Maltose 22.7 ± 3.1 12.2 ± 1.9 
Mannose 13.1 ± 1.1 14.7 ± 0.5 
Sucrose 19.5 ± 0.7 13.8 ± 0.6 
Kluyveromyces marxianus 
(701) 
Control 14.5 ± 4.1 11.6 ± 2.3 
Fructose 14.9 ± 2.0 13.9 ± 0.6* 
Galactose 13.2 ± 1.8 13.1 ± 0.6 
Maltose 15.6 ± 1.4 13.1 ± 0.2 
Mannose 16.0 ± 2.4 15.8 ± 0.1* 
Sucrose 16.0 ± 1.5 13.5 ± 0.6 
Kluyveromyces marxianus 
(2415) 
Control 11.2 ± 0.9 10.3 ± 0.5 
Fructose 10.6 ± 1.3 12.6 ± 0.3 
Galactose 12.2 ± 1.3 15.1 ± 1.3* 
Maltose 21.1 ± 6.8* 10.2 ± 0.1 
Mannose 9.6 ± 2.0 15.8 ± 3.0* 
Sucrose 12.3 ± 1.3 11.6 ± 0.5 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
 
Each of the strains of Kluyveromyces, grown in medium containing 1 and 2 % (w/v) 
carbon source, were found to have varying cell wall saccharide content between the 
strains. The cell wall glucose and mannose content ranged from 10.4 – 34.3 % (w/w) 
glucose and 9.9 – 17.4 % (w/w) mannose with 1 % (w/v) carbon source in the growth 
medium. Two percent (w/v) carbon source in the growth medium resulted in cell wall 
glucose content ranging from 9.6 – 24.1 % (w/w) and mannose content ranging from 
10.2 – 15.8 % (w/w). A number of significant differences were observed in cell wall 
glucose and mannose content compared to the control for each of the strains. The ability 
to utilize particular sugars, and the pathways used to generate energy from sugars are 
defining features of different yeasts (Lane and Morrissey, 2010).  
A significant difference was observed in the cell wall saccharide content of K. 
marxianus 701 and 2415, but not with K. lactis 752, compared to the control when 
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grown in fructose containing growth medium. The cell wall glucose content of K. 
marxianus 2415 was increased significantly in 1 % (w/v) fructose compared to the 
control. In fact, there was a 3 fold increase in the cell wall glucose content compared to 
the control demonstrating a dramatic difference in the effect of increasing glucose 
concentration as the sole carbon source on the cell wall glucose content; this effect may 
be due to catabolite repression. The cell wall mannose content of both K. marxianus 
2415 and 701 was also significantly increased with 1 % (w/v) fructose as the sole 
carbon source in the growth medium. Fructose (2 %, w/v) as the sole carbon source also 
produced a significant increase in cell wall mannose content of K. marxianus 701, but 
not in 2415. K. marxianus expresses the Frt1 gene, encoding a hexose transporter with a 
high affinity for fructose, and its product mediates active transport of fructose in 
symport with protons (Horak, 2013). Fonseca et al. (2013) found that the growth rate of 
K. marxianus was slower when grown in fructose as the sole carbon source compared to 
glucose. Interestingly, an increase in fructose concentration from 1 to 2 % (w/v) caused 
a significant decrease in the cell wall saccharide content of K. marxianus 2415, 
suggesting a catabolite repression effect. No significant differences in the cell wall 
saccharide content were observed for K. lactis 752, illustrating a difference in the 
metabolism of fructose between the species of Kluyveromyces and the effect on cell 
wall saccharide content. 
Galactose (2 %, w/v) as the sole carbon source in the growth medium significantly 
increased the glucose content of K. lactis 752 (24.1 %, w/w), compared to the control 
values of 16.4 % (w/w), while having no effect on the mannose content. The mannose 
content was significantly increased in K. marxianus 2415 with both 1 and 2 % (w/v) 
galactose concentrations in the growth medium compared to the control. An increase in 
galactose concentration from 1 to 2 % (w/v) as a sole carbon source caused a significant 
increase in the glucose content of K. marxianus 2415. As in S. cerevisiae, galactose is 
metabolised to glucose-6-phosphate via the Leloir pathway in Kluyveromyces (Dong 
and Dickson, 1997). However, there are differences between the species; the basal 
expression of the Lac/Gal genes is higher in Kluyveromyces compared to S. cerevisiae. 
Mechanistically, there are also differences, for example, Kluyveromyces lack a specific 
galactose transporter present in S. cerevisiae (Lane and Morrissey, 2010). K. marxianus 
was found to have a slower growth rate in galactose compared to glucose as the sole 
carbon source, suggesting that galactose uptake is less efficient than other sugars 
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(Fonseca et al., 2013). The Snf1 and Mig1 proteins play similar roles in regulating 
galactose metabolism in S. cerevisiae and K. lactis. The way in which these proteins are 
integrated into the regulatory circuits are unique to each as is the degree to which each 
is controlled by the two proteins (Dong and Dickson, 1997). The Snf1 kinase has been 
associated with cell wall integrity in Kluyveromyces spp., expression of which can cause 
changes in the cell wall composition (Backhaus et al., 2013). This may explain the 
significant changes in the cell wall glucose content of K. lactis 752 and the cell wall 
mannose content of K. marxianus 2415 seen in this study with the use of galactose as 
the sole carbon source in the growth medium. 
Glucose as the sole carbon source had very different effects on the cell wall glucose 
content of both strains of K. marxianus. Growth medium containing 1 % (w/v) glucose 
significantly increased the cell wall glucose content of K. marxianus 2415 compared to 
the control from 11.2 – 34.3 % (w/w). This 3 fold increase in cell wall glucose content 
at 1 % (w/v) glucose as the sole carbon source in the growth medium compared to the 
control may be due to glucose repression at higher concentrations of glucose. 
Interestingly, no such effect was observed with the cell wall glucose content of K. 
marxianus 701. The cell wall mannose content of both strains was significantly 
increased compared to the controls. The content of Kluyveromyces cell wall proteins 
vary in a carbon source dependent manner, with many proteins more readily found in 
the walls of glucose grown cells (Backhaus et al., 2010). As most yeast cell wall 
proteins are glycosylated with mannose residues this may affect the cell wall mannose 
content (De Groot et al., 2005). No significant difference in the cell wall glucose or 
mannose content was observed for K. lactis 752 with glucose as the sole carbon source 
in the growth medium. The glucose uptake pathway is simpler in Kluyveromyces than 
Saccharomyces, with only two glucose transporters and little if any gene redundancy 
(Cairey-Remonnay et al., 2015, Boles and Hollenberg, 1997). Kluyveromyces 
metabolizes glucose predominantly by respiration. Hexose transporter isoforms and 
polymorphisms within the species of K. marxianus (Belloch et al., 2002) may explain 
the differences in cell wall glucose and mannose content seen between the strains in the 
presence of glucose as the sole carbon source. Kluyveromyces spp. are reported to 
express different metabolic sugar transporters (Kht1 and Kht2) in the presence of 
different concentrations of glucose (Milkowski et al., 2001). The concentration of 
glucose in the growth medium was shown to have a dramatic effect on K. marxianus 
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2415 cell wall glucose content in this study. In addition, catabolite repression and strain 
dependent variations have been attributed to the presence of different isoforms of sugar 
transporters, as well as polymorphism within the Kluyveromyces spp. (Rodicio and 
Heinisch, 2013, Belloch et al., 2002), as was seen in this study with K. marxianus 2415. 
From these results glucose as the sole carbon source in the growth medium effected 
each strain of Kluyveromyces differently in terms of cell wall saccharide content. A 
wide spectrum of biotechnological studies on K. marxianus also found that diversity is 
present within the species (Lane et al., 2011).  
Maltose (1 %, w/v) as the sole carbon source in the growth medium caused a significant 
decrease in the cell wall mannose content of K. lactis 752 compared to the control, 14.2 
to 10.4 % (w/w). Maltose at 2 % (w/v) significantly increased the cell wall glucose 
content of K. marxianus 2415 to 21.1 % (w/w) compared to the control (11.2 %, w/w). 
Maltose is hydrolyzed by maltase located in the inner side of the cytoplasmic 
membrane; therefore maltose has to be transported into the cell by a transporter. In K. 
lactis Mal22 encodes a maltase and Mal21 encodes a maltose transporter. These are 
structurally very similar to the S. cerevisiae Mal genes. Maltase synthesis in S. 
cerevisiae is inducible, while in K. lactis induction is strain dependent (Goffrini et al., 
2002). The difference in maltose metabolism and the induction of specific genes may be 
responsible for the changes in the cell wall monosaccharide of K. lactis 752 and K. 
marxianus 2415 compared to the control. 
The mannose content was significantly increased in each strain of K. marxianus (701 
and 2415) when both 1 and 2 % (w/v) mannose was used as the sole carbon source 
compared to the control. No significant affect was detected for the cell wall glucose 
content. The increase of mannose concentration from 1 to 2 % (w/v) also caused a 
significant decrease in the cell wall mannose content of K. marxianus 701. In addition 
to the induction of mannose specific genes in the presence of mannose and the absence 
of glucose, mannose is also metabolised differently to glucose. After mannose 
phosphorylation by hexokinase (Hxk2), mannose is converted to mannose-6-phosphate 
and then isomerized to fructose-6-phosphate by phosphomannose isomerase 
(Rodrussamee et al., 2011). The increase in cell wall mannose content of K. marxianus 
2415 and 701 for both concentrations of mannose as the sole carbon source compared to 
the control is evidence of the effect of mannose metabolism on the cell wall mannose 
content. Interestingly, K. lactis 752 was not subject to any significant changes due to 
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mannose as the sole carbon source in the growth medium, illustrating that differences 
exist between the species of Kluyveromyces. 
Growth medium containing 1 or 2 % (w/v) sucrose as the sole carbon source did not 
have any significant effect on the cell wall saccharide content compared to the control 
for any of the strains of Kluyveromyces. However, increasing the concentration of 
sucrose from 1 to 2 % (w/v) caused a significant increase in the cell wall mannose 
content of K. marxianus 2415 from 10.8 to 12.3 % (w/w). In K. marxianus, inulinase, 
which is closely related to invertase in S. cerevisiae is responsible for fructose 
hydrolysation and is activated by sucrose or inulin (Weinhandl et al., 2014). These 
enzymes exhibit corresponding hydrolytic activities towards sucrose. The majority of 
the inulinase activity is found in the extracellular medium (Lim, 2010). The inulinase of 
Kluyveromyces is in part associated with the cell wall, but, in contrast to the invertase of 
Saccharomyces, much more of the enzyme is actually secreted into the culture fluid 
(Rouwenhorst et al., 1990). The significant increase in cell wall glucose and mannose 
content of K. marxianus 2415 corresponding to an increase in sucrose concentration 
may be influenced by an increase in inulinase activity in certain Kluyveromyces strains. 
Differences in the cell wall glucan and mannoprotein content of two strains of K. 
marxianus, R157 and 1586, were also observed by Nguyen et al. (1998). Further 
metabolic differences were documented in a separate study, as the rate of lactose 
utilization was shown to vary among 13 strains of K. marxianus, indicating that 
differences exist between the metabolic capabilities of different strains (Lane et al., 
2011). In agreement with this study, that carbon source type can influence the cell wall 
glucose and mannose content of Kluyveromyces spp. Backhaus et al. (2010) found that 
different carbon sources could influence the cell wall glucose and mannose content of 
K. lactis. For example, ethanol (3 %, w/v) as the sole carbon source in the growth 
medium was shown to significantly decrease the cell wall mannan content of K. lactis 
compared to a growth medium containing 2 % (w/v) glucose as the sole carbon source. 
These studies support the observations in this study that the influence of the carbon 
source is, for the most part, strain specific. 
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3.1.3 Effect of carbon source on Schizosaccharomyces, Candida, Rhodotorula, and 
Pichia spp. cell wall saccharide content 
The remaining strains of yeast assessed in this study included Schizosaccharomyces 
pombe, Candida utilis, Rhodotorula mucilaginosa, and Pichia membranifaciens. The 
cell wall of these yeast strains were shown to have a similar structure to S. cerevisiae 
consisting of glucan polysaccharides and a mannoprotein layer (Klis et al., 2010). The 
cell wall glucose and mannose content of each strain grown in 1 and 2 % (w/v) carbon 
source was determined as described in Sections 2.2.8-9. S. pombe is a fission yeast with 
a number of distinctive features compared to budding yeast. The monosaccharide cell 
wall composition of S. pombe includes galactose, as galactomannan (Hamilton and 
Gerngross, 2007), a typical yeast mannan oligosaccharide with galactose units bound at 
the terminal positions (Perez and Ribas, 2004). Galactosylation of glycoproteins is a 
unique feature of fission yeast, and does not occur in the budding yeast S. cerevisiae 
(Matsuzawa et al., 2011). As this study was concerned with the glucose and mannose 
content of the yeast cell wall, the galactose content was not quantified for this strain. S. 
pombe and Rhodotorula species are also reported to contain relatively low amounts of 
cell wall mannose compared to other yeast strains such as Saccharomyces, Candida, 
and Pichia (Biswas et al., 2001). Table 3.5 and 3.6 show the cell wall glucose and 
mannose content for these yeast strains grown in growth medium containing 1 and 2 % 
(w/v) of the various carbon sources. A number of yeast strains are unable to assimilate 
certain carbon sources and were excluded from the study.  
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Table 3.5. Saccharide composition of S. pombe, C. utilis, R. mucilaginosa, and P. 
membranifaciens cell wall following cultivation in growth medium containing a sole 
carbon source (1 % w/v) 
Strain Carbon 
source 
% Glucose 
(w/w) 
% Mannose 
(w/w) 
Schizosaccharomyces 
pombe  
(70572) 
Control 27.6 ± 4.0 6.5 ± 2.5 
Fructose 27.5 ± 6.1 5.4 ± 2.7 
Galactose - - 
Glucose 31.1 ± 0.9 5.4 ± 0.7 
Maltose 30.0 ± 3.0 4.9 ± 2.5 
Mannose - - 
Sucrose 21.9 ± 1.5 4.5 ± 2.4 
Candida utilis  
(70167) 
Control 14.8 ± 3.0 10.8 ± 1.5 
Fructose 11.2 ± 0.1* 12.5 ± 0.1 
Galactose - - 
Glucose 11.3 ± 0.1 12.1 ± 0.5 
Maltose 18.7 ± 1.0* 11.9 ± 0.4 
Mannose 11.7 ± 0.5 12.4 ± 0.6 
Sucrose 11.4 ± 0.4* 11.4 ± 0.7 
Rhodotorula  
mucilaginosa 
(70825) 
Control 23.2 ± 1.5 8.6 ± 0.7 
Fructose 18.7 ± 1.0* 5.6 ± 1.8 
Galactose 22.6 ± 1.1 7.8 ± 2.7 
Glucose 26.2 ± 0.3* 9.2 ± 0.4 
Maltose 24.6 ± 3.4 8.2 ± 0.7 
Mannose 24.1 ± 1.0 5.8 ± 2.4 
Sucrose 20.1 ± 0.2 5.7 ± 2.3 
Rhodotorula  
mucilaginosa 
(18184) 
Control 21.7 ± 2.9 8.9 ± 0.4 
Fructose 14.8 ± 1.8* 8.9 ± 1.2 
Galactose 13.9 ± 2.9* 6.9 ± 0.2 
Glucose 21.9 ± 2.7 8.4 ± 2.0 
Maltose 16.9 ± 3.0 5.6 ± 1.5 
Mannose 21.9 ± 2.4 8.7 ± 1.6 
Sucrose 20.3 ± 0.2 10.0 ± 0.0 
Pichia  
membranifaciens 
(326) 
Control 24.1 ± 5.8 18.6 ± 0.8 
Fructose 23.0 ± 7.3 18.6 ± 2.7 
Galactose - - 
Glucose 23.9 ± 1.0 18.6 ± 2.7 
Maltose - - 
Mannose 15.8 ± 1.9 17.7 ± 1.9 
Sucrose - - 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
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Table 3.6. Saccharide composition analysis of S. pombe, C. utilis, R. 
mucilaginosa, and P. membranifaciens cell wall following cultivation in growth 
medium containing a sole carbon source (2 % w/v) 
Strain Carbon 
source 
% Glucose 
(w/w) 
% Mannose 
(w/w) 
Schizosaccharomyces 
pombe 
(70572) 
Control 27.6 ± 4.0 6.5 ± 2.5 
Fructose 23.4 ± 6.1 5.2 ± 1.4 
Galactose - - 
Maltose 30.9 ± 2.0 4.0 ± 2.0 
Mannose - - 
Sucrose 27.5 ± 3.7 3.7 ± 0.4 
Candida utilis 
(70167) 
Control 14.8 ± 3.0 10.8 ± 1.5 
Fructose 12.0 ± 0.0 12.7 ± 0.3 
Galactose - - 
Maltose 15.2 ± 2.1 9.8 ± 2.2 
Mannose 12.0 ± 1.0 8.3 ± 4.3 
Sucrose 10.8 ± 0.5* 9.9 ± 3.9 
Rhodotorula  
mucilaginosa 
(70825) 
Control 23.2 ± 1.5 8.6 ± 0.7 
Fructose 17.4 ± 2.8* 5.1 ± 2.7 
Galactose 20.9 ± 0.7 8.9 ± 1.3 
Maltose 20.7 ± 0.7 7.5 ± 0.2 
Mannose 24.4 ± 0.2 6.3 ± 2.1 
Sucrose 19.3 ± 0.2* 5.2 ± 1.8 
Rhodotorula  
mucilaginosa 
(18184) 
 
Control 21.7 ± 2.9 8.9 ± 0.4 
Fructose 17.7 ± 4.8 7.5 ± 0.8 
Galactose 12.2 ± 3.6* 6.1 ± 0.1* 
Maltose 18.1 ± 2.2 8.4 ± 1.3 
Mannose 15.7 ± 1.9* 7.0 ± 1.2 
Sucrose 22.9 ± 0.1 9.6 ± 0.0 
Pichia 
membranifaciens 
(326) 
Control 24.1 ± 5.8 18.6 ± 0.8 
Fructose 22.2 ± 5.7 18.1 ± 1.2 
Galactose - - 
Maltose - - 
Mannose 16.2 ± 2.4 17.8 ± 1.9 
Sucrose - - 
Results displayed are a representative of the mean of triplicate cultivations ± standard deviation. 
Statistical analysis was performed using Dunnett’s test to evaluate the significance of samples when 
compared to the control and values with an asterisk [*] denotes a significant change (p ≤ 0.05) in the 
composition compared to the control. An independent sample t-test was performed to evaluate the 
significance of 1 and 2 % (w/v) carbon source in the growth medium. Values in bold denotes a significant 
change (p ≤ 0.05) in the saccharide composition between the two concentrations. 
 
With the strain S. Pombe 70572, no significant differences were found between the cell 
wall glucose and mannose content of the samples grown in 1 or 2 % (w/v) for each of 
the carbon sources as the sole carbon source in the growth medium and the control. 
Section 3.1  Results and Discussion 
83 
Nevertheless, a number of observations were made about the glucose and mannose 
content of the cell wall material. S. pombe had the second highest level of glucose in its 
cell wall (31.1 %, w/w) of all the strains of yeast examined in this study. It also had the 
lowest mannose content (3.7 %, w/w) of all the strains. There were no significant 
differences in the cell wall glucose and mannose content between 1 % and 2 % (w/v) 
concentration of carbon source in the growth medium for S. pombe. S. pombe is unable 
to metabolise galactose (Matsuzawa et al., 2011), therefore, it was not cultured in its 
presence. In addition, very weak growth was observed for S. pombe 70572 in mannose 
containing medium and further investigation was not pursued with this carbon source.  
Unlike S. cerevisiae, regulatory mechanisms in glucose sensing and signalling are not 
fully understood in fission yeast (Palabiyik et al., 2013). In S. pombe glucose may be 
fermented under aerobic conditions (Crabtree effect), and a reduction in glucose 
concentration strongly affects cell metabolism and gene expression (Flores et al., 2000). 
The cell wall integrity pathway, a MAPK cascade, that in S. pombe regulates processes 
like cell wall construction and maintenance, becomes activated with glucose withdrawal 
(Madrid et al., 2013). However, in this study no changes were observed in the cell wall 
saccharide content between the concentrations of the carbon sources.  
Candida utilis is a popular “fodder yeast” used to produce single cell protein for the 
animal feed industry (García et al., 2014). This strain was reported to be incapable of 
assimilating galactose as the sole carbon source (CBS, 2015), for this reason the strain 
was not cultured in its presence. A significant decrease in cell wall glucose content was 
observed when grown in 1 % (w/v) fructose (11.2 %, w/w) and sucrose (11.4 %, w/w) 
compared to the control (14.8 %, w/w). An increase in the fructose concentration from 1 
to 2 % (w/v) caused a significant increase in cell wall glucose content. The cell wall 
glucose content was significantly increased with 1 % (w/v) maltose as the sole carbon 
source (18.7 %, w/w), compared to the control. It was evident that increasing the 
concentration of maltose in the growth medium from 1 to 2 % (w/v) caused a significant 
decrease in the cell wall glucose content; suggesting increased maltase activity may 
influence the cell wall glucose content. As the sole carbon source 2 % (w/v) sucrose 
also yielded a significant decrease in the cell wall glucose content compared to the 
control. Various carbon sources are metabolised differently in Candida spp. through the 
induction of required enzymes in the presence of the substrate. Ene et al. (2012b) 
demonstrated that changes in carbon source have been shown to affect Candida cell 
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wall by influencing the cell wall content and structure. When fermentable carbon 
sources are present in high concentrations excess carbon may be directed via hexose 
phosphates to biosyntheses of β-glucan and mannan for cell wall generation (Ene et al., 
2012a). In this study, 2 % (w/v) glucose as the sole carbon source produced 
significantly higher cell wall glucose than was produced by lower concentrations of 1 % 
(w/v) fructose and sucrose in the growth medium. The cell wall β-glucan and 
mannoprotein layer in a number of C. utilis strains was also dependant on the species 
and strain (Bzducha-Wróbel et al., 2012). Culture conditions were shown to induce 
changes in the content of polymers in the glucan and mannoprotein layer, and the 
thickness of the wall when glycerol was used as a carbon source, was thought to be a 
response to stimuli received through stress sensors (Bzducha-Wróbel et al., 2014).  
Rhodotorula mucilaginosa 70825 had high cell wall glucose content (17.4 – 26.2 %, 
w/w) and relatively low mannose content (5.6 – 9.2 %, w/w). Rhodotorula are reported 
to have low cell wall mannose content compared to Saccharomyces, Candida, 
Kluyveromyces, and Pichia strains (Biswas et al., 2001). There was a significant 
decrease in the glucose content of the cell wall when grown in 1 % (w/v) fructose (18.7 
%, w/w) as the sole carbon source compared to the control (23.2 %, w/w). A significant 
increase in the cell wall glucose content was also observed with 1 % (w/v) glucose as 
the sole carbon source in the growth medium (26.2 %, w/w) compared to the control. 
No other significant differences were observed for growth medium containing 1 % 
(w/v) carbon source. With 2 % (w/v) fructose and sucrose as the sole carbon source, 
respectively, the monosaccharide content of the cell wall of R. mucilaginosa 70825 was 
significantly decreased (17.4 %, w/w) and (19.3 %, w/w), compared to the control (23.2 
%, w/v). A significant decrease in the cell wall glucose content of R. mucilaginosa 
70825 was produced by an increase in glucose and sucrose concentration in the growth 
medium; this effect may have been mediated through catabolite repression. There was 
no significant change in the mannose content of the cell wall when the concentration of 
the carbon sources was increased. 
R. mucilaginosa 18184 had significantly less cell wall glucose content compared to the 
control when the growth medium contained 1 % (w/v) fructose and galactose. The cell 
wall glucose and mannose content was significantly decreased (12.2 and 6.1 %, w/w) 
when 2 % (w/v) galactose was used as the sole carbon source compared to the control 
values (21.7 and 8.9 %, w/v). This large decrease in cell wall glucose content was not 
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observed in R. mucilaginosa 70825 with 2 % (w/v) galactose was the sole carbon source 
in the growth medium. A number of significant differences were observed in the cell 
wall glucose and mannose content of R. mucilaginosa 18184 when the concentration of 
mannose and sucrose were increased from 1 to 2 % (w/v). An increase in mannose 
concentration in the growth medium caused a significant decrease in the cell wall 
glucose content from 21.9 to 15.7 % (w/w). However, an increase in mannose 
concentration in the growth medium did not have a significant effect on the cell wall 
glucose content of R. mucilaginosa 70825, suggesting differences exist between these 
two strains’ cell wall composition in response to increased mannose concentration as a 
carbon source. An increase in sucrose concentration in the growth medium also 
increased the cell wall glucose content of R. mucilaginosa 18184 significantly while its 
mannose content was significantly decreased; in contrast to R. mucilaginosa 70825 
where an increase in sucrose concentration in the growth medium significantly 
decreased the cell wall glucose content of 70825. Interestingly, the cell wall glucose 
content of K. marxianus 2415 also increased significantly with a rise in sucrose 
concentration in the growth medium. 
R. mucilaginosa is a strictly aerobic yeast, unlike S. cerevisiae or Kluyveromyces 
species. Rhodotorula species have been shown to successfully metabolise various 
carbon sources, both hexose and pentose sugars, including glucose, xylose, sucrose and 
lactate (Aksu and Eren, 2007, Aksu and Eren, 2005, Xu et al., 2011). Various carbon 
sources are metabolised differently in Rhodotorula spp. Induction and repression of 
particular enzymes occur for the metabolism of specific carbon sources in the absence 
of glucose (Xu et al., 2011, Gupta et al., 1986). These changes may influence the cell 
wall content of the cells as was seen with R. mucilaginosa 70825 and 18184 where 1 % 
(w/v) fructose as the sole carbon source in the growth medium caused a significant 
decrease in the cell wall glucose content compared to the control. Galactose as the sole 
carbon source in the growth medium at both concentrations had a significant effect on 
the cell wall glucose content of R. mucilaginosa 18184, decreasing the cell wall glucose 
and mannose content, but not in R. mucilaginosa 70825. Research on Rhodotorula 
species industrially is focused mostly on the production of carotenoids and data on cell 
wall composition is scarce. 
P. membranifaciens can be used as a biological control organism against Botrytis 
cinerea, the causal organism of the grey mould disease of the grapevine (Masih et al., 
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2001), and for the control of the spoilage yeast Brettanomyces bruxellensis. This strain 
of P. membranifaciens could not assimilate galactose, maltose or sucrose as a carbon 
source (NCYC, 2015), for this reason the yeast was not cultured in the presence of these 
carbon sources. Certain strains of Pichia lack the functional pathway for galactose 
metabolism (Weinhandl et al., 2014). There was no significant difference in either the 
cell wall glucose or mannose content when grown in 1 or 2 % (w/v) carbon source for 
P. membranifaciens. Neither was there any significant differences observed in the cell 
wall glucose and mannose content of P. membranifaciens between 1 and 2 % (w/v) 
carbon source concentrations.  
In the present investigation, the total glucose and mannose content of the cell wall 
varied, depending on the species and strain, and represented 8.2 – 34.3 % (w/w) glucose 
and 3.7 – 21.2 % (w/w) mannose of the total carbohydrate composition regardless of the 
sugar source. In addition, each carbon source and concentration of carbon source 
affected the composition of the cell wall components differently between species and 
between strains of the same species. However, a clear relationship between the glucose 
and mannose content of yeast cell wall material and the carbon source for all strains of 
yeast used in this study was difficult to ascertain. Perhaps an increased concentration of 
the carbon sources, greater than 2 % (w/v), would lead to more significant differences in 
the glucose and mannose content of the yeast cell wall composition of the yeast strains 
when compared to the control. 
It was established by Nguyen et al. (1998), using compositional analysis of the cell 
walls of several yeast species that the portions of the different fractions within the cell 
wall varied with the species and strain. In agreement with their findings, the data from 
this study suggests that the glucose and mannose composition of each of the selected 
yeast varied depending on each species and strain. Several studies have provided 
evidence that the cell wall is not a static entity; rather, it is dynamically remodelled in 
response to its environment (Ene et al., 2015, Teparic and Mrsa, 2013). Yeast cell wall 
polysaccharides and mannoproteins are continually adapted to environmental conditions 
in terms of their abundance and organization (Hall, 2015, Ene et al., 2012a, Ene et al., 
2012b, Backhaus et al., 2011, Xie and Lipke, 2010, Liu et al., 2009b, Aguilar-Uscanga 
and Francois, 2003, Klis et al., 2002). Carbon catabolite repression plays a significant 
role in the regulation of a host of yeast genes (Gancedo, 1998), many of which influence 
the structure and maintenance of yeast cell wall.  
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The purpose of this work was to investigate the possibility of developing a second 
generation Acitgen® product. Actigen® is produced from the mannan oligosaccharide 
(MOS) fraction of S. cerevisiae cell wall. Yeast cell wall MOS have the capacity to 
inhibit type 1 fimbriae containing pathogens from binding to host tissue by acting as an 
alternative binding site for the pathogen. Gedek (1999) suggested that pathogens bound 
to MOS are not capable of binding to the target host and are subsequently removed by 
the flow of secretions. Yeast agglutination tests have been used to demonstrate the 
binding of pathogenic bacteria to yeast and yeast cell wall (Tiago et al., 2012, Perez-
Sotelo et al., 2005, Spring et al., 2000). In the search for a second generation product, it 
was necessary to assess whether the samples generated in this study were effective at 
agglutinating bacteria. A sample or samples with increased bacterial binding properties 
compared to Actigen® would be suitable candidates for further research and 
development as a potential new product. Prior to assessing each of the samples 
discussed in this section, the ability of a yeast cell wall material control (YCWM) 
sample to bind selected pathogenic strains of Salmonella and E. coli with relevance to 
the animal health industry was investigated.  
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3.2  Microscopic imaging of yeast cell wall material agglutination of bacteria. 
Despite functional similarity between the fimbriae of Salmonella and E. coli, the 
fimbriae in these two species are not evolutionarily related, with a lack of virtually any 
significant sequence homology (Kisiela et al., 2013, Kisiela et al., 2012). Fimbriae play 
a critical role in the colonization of specific host cells and tissues by facilitating the 
initial attachment to enterocytes and promoting intestinal colonisation (Borowsky et al., 
2009, Althouse et al., 2003, Baumler et al., 1997, Muller et al., 1991, Eshdat, 1981). 
Type 1 fimbriae are associated with most Salmonella enterica serovars (80 %) and are 
prevalent also in many E. coli spp. (Wu et al., 2012, Wright et al., 2007, Althouse et al., 
2003). E. coli and Salmonella strains containing type 1 fimbriae have been shown to 
agglutinate to Saccharomyces cerevisiae (Tiago et al., 2012, Stevens et al., 2009, 
Eshdat, 1981). The mannan oligosaccharides of S. cerevisiae cell wall (YCWM) act as 
high affinity ligands for the mannose specific type 1 fimbriae of E. coli spp. and 
Salmonella spp. thus preventing their attachment to the mucosal lining of the intestinal 
tract and the subsequent development of enteric disease (Newman, 1994).  
The objective of this aspect of the research was to identify if YCWM had the ability to 
bind specific strains of E. coli and Salmonella in vitro. Four Salmonella spp., classified 
as Salmonella enterica subspecies enterica serotype enteritidis, typhimurium, 
gallinarum and dublin, and three E. coli serotypes, designated O157:H7, O2:K1:H-, and 
O1:K1:H7, were used in this study. Each strain was chosen due to its pathogenicity 
either to domestic food animals or as a zoonotic agent to humans through foodborne 
infection or through direct contact with infected animals. Each of these pathogens can 
have a negative effect on animal production and/or public health. All the strains were 
analysed for positive adhesion to YCWM, this was observed by light microscopy. For 
this study all strains of bacteria were grown under identical culture conditions, as 
described in Section 2.2.1.  
YCWM is based on an extraction of cell wall oligosaccharides from a strain of S. 
cerevisiae. S. cerevisiae cells, produced under strictly controlled conditions, are 
autolyzed and the resulting cell wall material is carefully separated from the 
intracellular yeast contents. YCWM is the basis of Alltech’s Actigen® product. YCWM 
was stained with Safranin O in the absence of any bacteria (Figure 3.1). This control 
sample was prepared using YCWM and 10 mM PBS buffer as outlined in Section 2.2.2. 
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Safranin O is used to test yeast viability (Meledina et al., 2015, Krzepilko, 2009), as it 
stains dead or lysed yeast cells. Safranin O stained the exposed plasma membrane 
phospholipids (Byrne, 1962) attached to the YCWM aiding in the microscopic 
visualisation of the YCWM. It is clear from Figure 3.1 that YCWM when examined 
using light microscopy aggregates with little dispersion on the slide. 
 
Figure 3.1. Cell wall material (YCWM) (1.0 % w/v) fixed to a microscope slide 
and stained with Safranin O. 
Magnification 1000 X 
 
The subsequent images show strains of Salmonella (Figure 3.2) and E. coli (Figure 3.3) 
in the absence of YCWM (A, C, E, and G) and in the presence of YCWM (B, D, F, and 
H). The strains of Salmonella include Salmonella enteritidis (Figure 3.2 A-B), 
typhimurium (Figure 3.2 C-D), gallinarum (Figure 3.2 E-F), and dublin (Figure 3.2 G-
H), and the E. coli strains include E. coli O157:H7 (Figure 3.3 A-B), O2:K1:H- (Figure 
3.3 C-D), and O1:K1:H7 (Figure 3.3 E-F). The YCWM and bacteria cells were mixed 
and allowed to agglutinate on a glass microscope slide before being fixed and stained 
with Safranin O. Safranin O stains Gram negative bacteria, such as E. coli and 
Salmonella, by binding to the thin peptidoglycan layer in their cell wall (Dmitriev et al., 
2004). In the case of Salmonella and E. coli strains the layer is on the surface of the 
bacteria and accessible to the dye without further treatment. 
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Figure 3.2. Microscopic images of Salmonella strains and Salmonella strains + 
YCWM stained with Safranin O. 
(A) Salmonella enteritidis (B) Salmonella enteritidis + YCWM, (C) Salmonella typhimurium, (D) 
Salmonella typhimurium + YCWM, (E) Salmonella gallinarum, (F) Salmonella gallinarum + YCWM, 
(G) Salmonella dublin, (H) Salmonella dublin + YCWM. Examples of bacteria bound to YCWM are 
indicated with black arrows. Magnification 1000X. 
 
Each of the bacteria disperses evenly throughout the glass slides in the absence of 
YCWM. The bacteria were not as evenly distributed in the slides when combined with 
YCWM (Figure 3.2 B, D, E, and H) compared to the slides without YCWM (Figure 3.2 
A, C, E, and G), where there is obvious clumping of the bacteria to the YCWM. There 
are observable differences between the agglutination and the distribution of the cells 
between the Salmonella serovars when mixed with YCWM. Fewer free cells of 
Salmonella enteritidis and gallinarum were visible when mixed with YCWM (Figures 
3.2 B and F) indicating that the cells are adhered to YCWM. However, the agglutination 
to YCWM by Salmonella typhimurium and dublin does not look as comprehensive 
(Figure 3.2 D and H); this is evident by the larger number of free bacterial cells visible 
on the slide.  
The differences in the agglutination to YCWM by the Salmonella serovars shown in 
Figure 3.2 may be explained by the heterogeneity of type 1 fimbriae. Type 1 fimbriae of 
Salmonella are composed primarily of structural protein FimA with a lectin like protein 
(FimH) attached to the tip (Kisiela et al., 2006). FimH is directly involved in binding to 
high mannose oligosaccharides carried by surface glycoproteins of eukaryotic cells, 
including yeast (Jones, 1995, Krogfelt et al., 1990). Significant heterogeneity among 
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FimH adhesins from different serovars and even strains of the same serovar exists and 
are responsible for the selective binding to different mannosylated oligosaccharides. 
These differences are most likely associated with differences in the structure of FimH 
adhesins, and may be partially responsible for the tropism of various Salmonella 
serovars to different species, tissues and cells (Grzymajlo et al., 2013, Guo et al., 2009). 
It has also been shown that amino acid replacements resulting from single nucleotide 
polymorphisms (SNPs) throughout the FimH gene of E. coli or Salmonella enterica 
(Kisiela et al., 2006), conferred different binding phenotypes (Boddicker et al., 2002). 
Salmonella typhimurium and enteritidis, expressing allelic variants of FimH protein, 
were shown to differ by four amino acid residues (Kisiela et al., 2006). This variation in 
amino acids may explain the difference in the agglutination to YCWM seen between 
these four strains in Figure 3.2. Different strains of Salmonella typhimurium containing 
2 different allelic variants of FimH were shown to adhere weakly and strongly to human 
HEp-2 cells (Boddicker et al., 2002). Grzymajlo et al. (2013) also demonstrated 
differences in binding profiles to cell lysates from sheep, pig and cattle enterocytes 
between FimH proteins from host restricted serovars (Salmonella dublin) and broad host 
range serovars represented by FimH adhesin from Salmonella enteritidis. This agreed 
with the current study where differences between the agglutination of Salmonella dublin 
and enteritidis to YCWM were observed in Figure 3.2. Avian adapted Salmonella 
gallinarum contains a FimH variant with a single point mutation at position 78, wherein 
threonine is replaced by isoleucine. This was shown to alter its oligosaccharide binding 
properties (Kisiela et al., 2012, Kisiela et al., 2006). This change was responsible for the 
increased type 1 fimbriae mediated binding of Salmonella gallinarum to chicken 
leukocytes (Kuzminska-Bajor et al., 2012). This FimH variant may be responsible for 
the differences seen in agglutination of Salmonella gallinarum in Figure 3.2 compared 
to the other strains of Salmonella used in this study. 
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C D 
E F 
Figure 3.3. Microscopic images of E. coli strains and E. coli + YCWM stained 
with Safranin O. 
(A) E. coli O157:H7 (B) E. coli O157:H7+ YCWM, (C) E. coli O2:K1:H-, (D) E. coli O2:K1:H- + 
YCWM, (E) E. coli O1:K1:H7, (F) E. coli O1:K1:H7 + YCWM. Examples of bacteria bound to YCWM 
are indicated with black arrows. Magnification 1000X. 
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Microscope analysis of E. coli O157:H7, O2:K1:H-, and O1:K1:H7 cells in the absence 
of YCWM showed an even dispersion throughout Figure 3.3 A, C, and E. While the E. 
coli cells in the presence of YCWM (Figure 3.3 B, D, and F) are not evenly distributed, 
there was clumping of the bacteria to the YCWM. The agglutination to YCWM by the 
E. coli strains was different for each of the strains used in this study, O157:H7, 
O2:K1:H-, and O1:K1:H7, as was observed with the Salmonella strains. In Figure 3.3, 
the agglutination to YCWM by E. coli O157:H7 (Figure 3.3 B) shows more free 
bacteria cells compared to E. coli strains O2:K1:H- and O1:K1:H7. 
In vitro studies by Mirelman et al. (1980) and Firon et al. (1983) observed that E. coli 
agglutinated to S. cerevisiae. E. coli strains containing type 1 fimbriae agglutinated to 
yeast, while strains without type 1 fimbriae did not result in agglutination. They 
concluded that this agglutination was mannose sensitive. Similar work was carried out 
by Nachin et al. (2005), concluding that fimbriation was essential for agglutination to S. 
cerevisiae. Each of the E. coli strains used in this study contained type 1 fimbriae 
(Reiland et al., 2014, Monroy et al., 2005, Iida et al., 2001, Roe, 2001, Gedek, 1999). 
The agglutination patterns observed in Figure 3.3 may be explained by the reported 
differences in FimH or FimH variants of E. coli strains as described by Pizarro-Cerda 
and Cossart (2006). Variants of FimH found on different strains of E. coli, bind with 
varying affinity to different mannose oligosaccharides such as mono or trimannose 
residues. Allelic variants of the FimH adhesin from E. coli strains O2 and O1, differing 
only in one amino acid residue, have different receptor specificities and in addition to 
high mannose type oligosaccharides can bind monomannnose residues (Kisiela et al., 
2006, Weissman et al., 2006, Sokurenko et al., 1995). Structural and functional 
heterogeneity occurs within the class of type 1 fimbriae and adhesive diversity will lead 
to a broader spectrum of receptive surfaces for potential colonization. Differences 
associated with specific amino acids were proposed to be responsible for observed 
differences in the binding to mannan as well as variability in binding specificities 
(Sokurenko et al., 1995). Based upon the amino acid sequences of the E. coli FimH 
adhesin, two sequence homology groups have been described with either mannotriose 
specific or monomannose specific binding (Sokurenko et al., 2001). The reported 
differences in the FimH of E. coli strains can explain the differences observed in the 
agglutination patterns between E. coli O157, O2, and O1 as seen in Figure 3 B, D, and 
F.  
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Research by various groups has demonstrated that YCWM can reduce the prevalence of 
E. coli in vivo. A study by Yalcin et al. (2013) with Ross 308 male broiler chicks 
concluded that the dietary supplementation of yeast cell wall material increased growth 
performance, immunocompetence, and reduced E. coli colonization in the intestine. It 
was also shown that YCWM inhibited E. coli O157:H7 binding to both mucosal 
explants from the jejunum and to bovine colonic cell line cells (Baines et al., 2011). In 
addition, another study found that YCWM reduced the amount of E. coli and 
Salmonella in Ross 308 broilers (Ghosh et al., 2012).  
As previously mentioned the type 1 fimbriae of Salmonella and E. coli are structurally 
and functionally similar while lacking almost any sequence homology (Kisiela et al., 
2013). The difference in sequence homology between Salmonella and E. coli could 
account for the variation observed in agglutination between these two strains based on 
the differences of FimH alleles. In addition to the impact of heterologous FimH on 
mannose binding affinity, the affect of the shaft protein FimA on which each FimH 
protein is presented may also impose conformational constraints on FimH, due to steric 
interference, altering its binding capacity (Duncan et al., 2005). 
The agglutination to YCWM by the bacterial cells was evident in Figures 3.2 and 3.3, 
however, the results are quite subjective and qualitative. The diminutive size of the 
bacterial cells used made it difficult to reliably count how many cells were bound to 
YCWM or remained unbound on the slide. With this in mind an effort was made to 
transfer the agglutination to YCWM by Salmonella and E. coli from slide format to a 96 
well plate format in order to assess if it was possible to make this method uniform and 
quantitative.  
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3.3  Yeast cell wall material binding activity assay development. 
In vitro assay techniques are of paramount importance for biotechnological and 
pharmaceutical research. Compared to in vivo assays, in vitro techniques have the 
advantage of simplifying the system under investigation focusing on a small number of 
components (Vignais and Vignais, 2010). They allow for determination of potential 
mode(s) of action, higher throughput screening of product candidates, and are not 
influenced by environmental factors that may mask in vivo results (temperature, disease, 
pressure, etc.) (Applegate et al., 2010). Development of an assay system to quantify the 
amount of bacteria agglutinating to YCWM will help to further build and maintain 
confidence in the product, monitor batch variation, and identify new products with 
increased bacteria agglutination ability. 
The goal of this section was to develop an assay to quantify the amount of specific 
bacteria bound by YCWM in vitro. Bacteria used in this study included Salmonella 
enteritidis, typhimurium, gallinarum, and dublin, and E. coli O157:H7, O2:K1:H-, and 
O1:K1:H7. Assay conditions had to be optimised for each individual strain. A known 
quantity of bacteria (Salmonella or E. coli spp.) was incubated with YCWM in a 
microtiter plate. The plate was washed; the YCWM and bacteria bound to the YCWM 
were removed. The bacteria remaining on the microtiter plate were quantified by 
enzyme linked immunosorbent assay (ELISA). As a known quantity of bacteria was 
added to the plate initially, the quantity of bacteria bound to YCWM was calculated by 
subtracting what was left on the plate from what was added to the plate initially.  
Prior to this, a standard curve was created in an effort to equate bacterial numbers to 
optical density readings at 650 nm and ultimately to quantify bacterial numbers in 
growing cultures. The ELISA antibody concentrations were also optimised for each 
strain of bacteria, a standard curve was then generated to calculate bacterial numbers 
bound to a microtiter plate. Bacterial numbers (CFU mL-1) were titrated against a fixed 
YCWM concentration to determine the optimum quantity of which YCWM could bind; 
this was carried out for each bacteria strain. Confirmation of the bacterial numbers 
bound to YCWM was assessed by comparing the amount of bacteria removed from the 
microtiter plate by plate count to the numbers determined by the calculated method for 
each strain. Method performance testing was then carried out to evaluate the 
reproducibility of the assays. 
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3.3.1 Generation of standard curve of optical densities versus plate count. 
Optical density readings were taken for a number of different dilutions of growing 
cultures. An aliquot of each of these dilutions was also plate counted as outlined in 
Section 2.2.4.1. The bacterial numbers were plotted against the optical density at 650 
nm (OD650nm) to generate a standard curve. The relationships between OD650nm and CFU 
mL-1 of each of the bacteria strains are shown in Figure 3.4 for Salmonella strains and in 
Figure 3.5 for E. coli strains. 
 
 Salmonella enteritidis  Salmonella typhimurium 
 Salmonella gallinarum   Salmonella dublin  
Figure 3.4. Standard curve of OD650nm readings for Salmonella versus plate 
count CFU mL-1 values for each reading.  
n = 3 for each point. 
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 E. coli O157:H7  E. coli O2:K1:H- 
 
Figure 3.5. Standard curve of OD650nm readings for E. coli versus plate count 
CFU mL-1 values for each reading.  
n = 3 for each point. 
 
Linear standard curves were generated for each strain of bacteria with correlation 
coefficient (r2) values of close to 1 for each strain. Indeed, r2 values for each of the 
strains were shown to be greater than 0.978, indicating that there was a linear 
relationship between the optical density and the bacterial concentration for all strains of 
bacteria tested (Dong-ju, 2012). With this relationship established, OD650nm values were 
used to determine the quantity of bacteria in growing bacterial cultures. 
 
3.3.2 Optimisation of Salmonella and E. coli detection by Enzyme Linked 
Immunosorbent Assay (ELISA). 
A horseradish peroxidise (HRP) labelled rabbit polyclonal antibody (ab53299) with 
specific activity against a mixture of Salmonella serotypes, and a biotin labelled rabbit 
polyclonal antibody (ab20640) with specific activity against a mixture of E. coli 
E. coli O1:K1:H7 
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serotypes were chosen for this study. The anti Salmonella antibody was tested against 
the four strains of Salmonella and the anti E. coli antibody was tested against the three 
strains of E. coli by ELISA. HRP conjugated streptavidin was used as the label for the 
detection of the biotin conjugated anti E. coli antibody. All bacterial strains were 
immobilised to the microtiter plate at pH 7.4 overnight at 37 °C using 10 mM PBS and 
the assays were performed as described in Section 2.2.4.2. Bovine serum albumin 
(BSA) was used as a blocking agent in the assays. The antibodies were diluted and a 
number of different antibody dilutions were assessed using the method outlined in 
Section 2.2.4.2. Absorbance values for blanks, i.e. no bacteria present, were initially 
assessed to determine the background noise of each antibody dilution. The absorbance 
at 410 nm for each concentration of anti Salmonella and anti E. coli antibody against the 
blank (10 mM PBS, pH 7.4) is shown in Figure 3.6. A blank sample should have an 
absorbance at 410 nm of less than 0.1, to confirm no non specific binding (Crowther, 
2009).  
 
Anti Salmonella antibody Anti E. coli antibody 
Figure 3.6. Determination of absorbance values for blanks for the anti 
Salmonella and anti E. coli antibodies. 
n = 9 for each conc. 
 
The antibody dilutions were also tested against a fixed concentration of bacteria, 10^6.5 
CFU mL-1 in the case of Salmonella and 10^7.5 CFU mL-1 for E. coli. Work carried out 
by various groups found that the concentrations of Salmonella in chickens was 
approximately 10^6-7 CFU mL-1 while the concentration of coliforms was higher at 
approximately 10^6-9 CFU mL-1 (Jahanian and Ashnagar, 2015, Guard et al., 2015, 
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Ribeiro et al., 2007, Sims et al., 2004, Spring et al., 2000). Antibody dilutions with 
absorbance readings close to 1 were selected as the signal to blank was also taken into 
consideration. Results for antibody optimisation are presented in Figures 3.7 and 3.8.  
 
 
 
Salmonella enteritidis Salmonella typhimurium 
Salmonella gallinarum Salmonella dublin 
Figure 3.7. Optimisation of anti Salmonella antibody concentration for 
Salmonella quantification. 
n = 3 for each point. Concentration of all Salmonella spp. = 10^6.5 CFU mL-1. 
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E. coli O157:H7 E. coli O2:K1:H- 
 
Figure 3.8.  Optimisation of anti E. coli antibody concentration for E. coli 
quantification. 
n = 3 for each point. Concentration of all E. coli spp. = 10^7.5 CFU mL-1 
 
Comparison of absorbance values at 410 nm which were obtained for Salmonella spp. 
(Figure 3.7), an anti Salmonella antibody concentration of 0.4 µg mL-1 gave an 
optimum absorbance of approximately 1.0 at 410 nm for Salmonella enteritidis. The 
same antibody concentration was chosen for Salmonella typhimurium, Salmonella 
gallinarum, and Salmonella dublin as it produced similar absorbance readings of 1.0. 
This antibody concentration also produced a low background signal (Figure 3.6). A 
comparison of the absorbance values obtained for the E. coli spp. (Figure 3.8) showed 
that an anti E. coli antibody concentration of 0.4 µg mL-1 for E. coli O157:H7 produced 
an absorbance of approximately 1.0 at 410 nm. A concentration of 4 µg mL-1 for the 
antibody for E. coli O2:K1:H- yielded an absorbance of 1.0. A concentration of 1.6 µg 
mL-1 for E. coli O1:K1:H7 antibody gave an optimum absorbance for this strain of 1.0. 
The antibody concentrations for each strain of bacteria described here were chosen as 
E. coli O1:K1:H7 
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there was a loss of sensitivity with the lower antibody concentrations and the 
absorbance signal was too strong at the higher concentrations of the antibodies.  
Once an antibody concentration was selected for each bacterial strain they were tested 
to determine if there was any cross reactivity with YCWM. The assay was performed as 
described in Section 2.2.4.2 with a modification, YCWM (10 µg 100 µL-1) was 
incubated on the microtiter plate in place of bacteria. NUNC Maxisorp plates were 
chosen for this work as they only loosely adsorb hydrophobic macromolecules such as 
yeast cell wall mannan oligosaccharides (Masuoka and Hazen, 2004, Cole-Parmer, 
1997). The absorbance values at 410 nm obtained using the anti Salmonella and anti E. 
coli antibodies at their optimised concentrations are shown in Table 3.7. Low 
absorbance values at 410 nm were obtained for all antibodies tested against YCWM. 
From these data it can be seen that neither the anti Salmonella antibody nor the anti E. 
coli antibodies reacted with YCWM, with absorbance values similar to the blank (10 
mM PBS, pH 7.4). Due to the antibodies’ selectivity for the bacteria strains Salmonella 
and E. coli, low blank values, and a lack of selectivity for YCWM these antibodies were 
used in the further development of the assays. 
 
Table 3.7. Assessment of cross reactivity of antibodies with YCWM. 
Antibody type Antibody 
code 
Antibody  
concentration  
(µg mL-1) 
OD410nm  
YCWM  
10 µg 100 µL-1 
OD410nm  
Blank  
(10 mM PBS) 
Anti E. coli ab20640 0.4 0.078 ± 0.018 0.079 ± 0.004 
Anti E. coli ab20640 1.6 0.070 ± 0.021 0.087 ± 0.005 
Anti E. coli ab20640 4.0 0.084 ± 0.012 0.076 ± 0.003 
Anti Salmonella ab53299 0.4 0.077 ± 0.006 0.066 ± 0.005 
The optical density data for each antibody are represented as the mean ± standard deviation of the 
absorbance at 410 nm. n = 9 for all absorbance values. 
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3.3.3 Quantification of bacteria using an enzyme linked immunosorbent assay 
(ELISA). 
Following the optimisation of the anti Salmonella and anti E. coli antibodies 
concentration, the ELISA’s were carried out to determine the detection limits of the 
optimised antibody concentrations for each strain of bacteria. A standard curve of 
absorbance at 410 nm versus the log10 CFU mL-1 was generated. The results are shown 
in Figure 3.9 for the Salmonella strains and in Figure 3.10 for E. coli strains.  
 
Salmonella enteritidis Salmonella typhimurium 
Salmonella gallinarum Salmonella dublin 
Figure 3.9. Standard curve for detection of Salmonella by ELISA.  
n = 6 for all values 
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E. coli O157:H7 E. coli O2:K1:H- 
 
Figure 3.10. Standard curve for detection of E. coli by ELISA.  
n = 6 for all values. 
 
Analysis of the standard curves in Figure 3.9 indicated that the relationship between the 
absorbance at 410 nm and the bacterial concentration was linear for all concentrations 
of bacteria. The r2 values for each of the strains of Salmonella were greater than 0.933, 
confirming the linear relationship for all the strains of Salmonella. The linear range for 
each strain of Salmonella was between 4.68 – 6.57 log10 CFU mL-1 for enteritidis, 5.11 
– 7.03 log10 CFU mL-1 for typhimurium, 5.08 – 6.45 log10 CFU mL-1 for gallinarum, 
and 5.28 – 6.14 log10 CFU mL-1 for dublin. The anti Salmonella antibody was raised 
against O and H antigens from a mixture of Salmonella strains. As each strain of 
Salmonella used in this study had a unique mixture of O and H antigens, for example, 
Salmonella enteritidis D 1, 9, 12 : g, m : -, typhimurium B 1, 4, 5, 12 : i : 1, 2, 
gallinarum D 1, 9, 12 : -, and dublin D 1, 9, 12 : g, p, the specificity of the antibody 
varied between the strains. The H antigen is known to have highly variable alleles 
between strains (Yue and Schifferli, 2014). 
E. coli O1:K1:H7 
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The standard curves for E. coli spp. are shown in Figure 3.10. The E. coli spp. standard 
curves also had a linear relationship with all concentrations of E. coli used; the r2 values 
for each of the strains of E. coli were greater than 0.976, confirming the linear 
relationship for each strain of E. coli. The linear range for each strain of E. coli was 
between 5.84 – 7.76 log10 CFU mL-1 for E. coli O157:H7, 6.58 – 8.15 log10 CFU mL-1 
for E. coli O2:K1:H-, and 6.14 – 7.82 log10 CFU mL-1 for E. coli O1:K1:H7. The 
numbers of bacteria differ from strain to strain as a result of the specificity of the 
polyclonal antibodies. The polyclonal anti E. coli antibody was similarly raised against 
O and H antigens from a mixture of E. coli strains. The serotypes of the E. coli strains 
used in this study also differed from each other, O157:H7, O2:H-, and O1:H7, possibly 
affecting the specificity of the anti E. coli antibody. These standard curves provided a 
means for the quantification of bacteria bound to a microtiter plate and were used in 
further development of the binding assays.  
 
3.3.4 Determination of the bacterial concentration required for the yeast cell wall 
material binding assay. 
Having optimised the method to quantify bacteria bound to a microtiter plate it was 
necessary to determine what concentration of bacteria was optimal for the cell wall 
material binding assay. The microscope work in the previous section confirmed that 
both Salmonella and E. coli could agglutinate to YCWM. However, this method was 
crude and the amount of bacteria bound to the YCWM could not be determined. To 
optimise the quantity of bacteria which could be bound by a fixed concentration of 
YCWM, a range of bacterial concentrations for each strain of bacteria were incubated 
with 10 µg YCWM, as described in Section 2.2.6. The concentration of the YCWM 
chosen was based on the inclusion level of Actigen® in feed (0.01 % - 0.08 %, w/w).  
YCWM plus the bacteria bound to it were removed from the microtiter plate during the 
washing steps of the assays. The excess bacterial cells not bound to the YCWM 
remaining in the microtiter plate, were quantified by ELISA as outlined in Section 
2.2.4.2. This value was subtracted from the initial amount of bacteria added to the plate 
to determine the quantity of bacteria agglutinated to YCWM. The number of bacteria 
bound to YCWM was expressed as the percent of bacteria removed and was calculated 
by dividing the amount of bacteria removed by the initial quantity of bacteria added to 
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the plate multiplied by 100. The percent bacteria removed from the plate for each 
concentration of bacteria was plotted against the log10 CFU mL-1 and are shown in 
Figures 3.11 and 3.12. 
 
Salmonella enteritidis  Salmonella typhimurium 
Salmonella gallinarum Salmonella dublin  
Figure 3.11. Determination of Salmonella concentration for YCWM binding 
assay.  
n = 9 for all values. YCWM concentration = 10 µg 100 µL-1. 
 
The point at which the graphs begin to decline was the maximum saturation point of the 
YCWM. Concentrations of bacteria greater than this resulted in the excess bacteria not 
bound to the YCWM, binding to the microtiter plate. The concentrations at which the 
YCWM became saturated for each Salmonella strain were as follows: enteritidis = 6.4 
log10 CFU mL-1, typhimurium = 7.0 log10 CFU mL-1, gallinarum = 6.4 log10 CFU mL-1 
and dublin = 6.0 log10 CFU mL-1. These concentrations of bacteria are the 
concentrations used in all subsequent YCWM binding activity assays. 
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E. coli O157:H7 E. coli O2:K1:H- 
 
Figure 3.12. Determination of E. coli concentration for YCWM binding assay.  
n = 9 for all values. YCWM concentration = 10 µg 100 µL-1. 
 
The concentrations at which the YCWM became saturated for each of the E. coli strains 
were E. coli O157:H7 = 7.6 log10 CFU mL-1, E. coli O2:K1:H- = 7.7 log10 CFU mL-1, 
and E. coli O1:K1:H7 = 6.7 log10 CFU mL-1. As with the Salmonella strains, these 
bacterial concentrations were the concentrations of E. coli used in all subsequent 
binding activity assays. The low percentage of bacteria removed of E. coli O2:K1:H- 
may be due to the FimH alleles of this strain and the degree of specificity of the FimH 
lectin for mannan oligosaccharides present in YCWM (Weissman et al., 2006). 
Optimisation of the bacteria concentration allowed for repeat analysis with consistent 
results. 
  
E. coli O1:K1:H7 
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3.3.5 Confirmation of bacteria concentration bound to YCWM. 
To corroborate that the calculated bacterial numbers agglutinated to the YCWM were 
correct, the bacteria removed from the microtiter plate was physically counted by plate 
count method (Section 2.2.4.1). The contents of the wells containing the mixture of 
YCWM and the bacteria were aseptically aspirated into sterile buffer, serially diluted, 
plated on agar plates, incubated overnight, and counted. Calculated removed was 
obtained by subtracting the quantity of bacteria remaining on the plate, determined by 
ELISA, from the quantity of bacteria added to the plate initially. The percent recovery 
of the bacteria was determined using the method outlined by the American Association 
for Laboratory Accreditation (A2LA, 2014); the results for the percent recovery are 
outlined in Table 3.8. 
 
Table 3.8. Percent recovery of bacteria bound by yeast cell wall material. 
Bacteria strain Removed 
bacteria 
(Plate 
count) 
Removed 
bacteria 
(ELISA) 
% Recovery 
  Log10 CFU mL-1 ± SD Actual/ 
Calculated (%) 
     
S. enteritidis 6.479 ± 0.86 6.435 ± 0.01 100.68 ± 0.86 
     
S. typhimurium 7.050 ± 0.56 7.142 ± 0.02 98.71 ± 0.49 
     
S. gallinarum 6.417 ± 0.80 6.497 ± 0.01 98.77 ± 0.83 
     
S. dublin 6.048 ± 0.47 6.052 ± 0.01 99.93 ± 0.55 
     
E. coli O157:H7 7.274 ± 0.63 7.744 ± 0.01 93.93 ± 0.49 
     
E. coli O2:K1:H- 7.524 ± 0.62 7.576 ± 0.3 99.31 ± 0.49 
     
E. coli O1:K1:H7 7.275 ± 0.33 7.478 ± 0.02 97.29 ± 0.25  
n = 3 for all values. SD = Standard deviation. The concentration of YCWM was 10 µg 100 µL-1. 
 
Comparisons of the bacterial number bound to YCWM (Calculated removed) to those 
determined by plate count are very similar. These results indicate that the subtraction 
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method is a suitable alternative to plate counting bacteria bound to YCWM each time 
the assay is run. The percent recovery of the bacterial strains bound to YCWM was 
between 93 % and 101 % for all strains of bacteria examined. The variations between 
the calculated and removed bacteria may be explained by variation in the plate count 
method. The plate count method has the ability to quantify only live bacteria as distinct 
from dead cells, whereas the ELISA method will calculate both live and dead cells as it 
is specific for cell surface antigens. Furthermore, the ELISA takes 2 days to generate 
results whereas the plate count method can take up to 4 days for colonies to appear in 
addition to being more labour intensive, and have lower throughput.  
 
3.3.6 Method performance testing of YCWM activity assay 
Before proceeding to sample analysis using the assays, the reliability of the assays was 
determined for each strain of bacteria. This involved ensuring that results obtained did 
not deviate greatly from day to day and that the method performance could be relied 
upon. The reproducibility and repeatability for each assay was assessed following the 
IUPAC guidelines for single laboratory validations (Thompson et al., 2002). A known 
quantity of bacteria was tested against the standard YCWM (10 µg), as described in 
Section 2.2.5. Two individual replicates of YCWM were prepared and run each day 
(inter assay repeatability) for a minimum of five days (intra assay reproducibility). Six 
replicate values were taken for each individual sample of the YCWM. A known 
quantity of bacteria was added to the plate at the beginning of the experiment. The 
quantity of bacteria bound to YCWM was calculated by subtracting what was left on the 
plate from what was added to the plate initially. The binding activity of the YCWM was 
calculated as follows: 
% 𝐵𝑖𝑛𝑑𝑖𝑛𝑔 = 𝐶𝐹𝑈 𝑏𝑜𝑢𝑛𝑑 𝑡𝑜 𝑌𝐶𝑊𝑀
𝐶𝐹𝑈 𝑎𝑑𝑑𝑒𝑑 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑙𝑦  × 100 
Reliability was determined as the relative standard deviation (RSD) of the percent 
bacteria bound to YCWM on a minimum of five separate occasions. The RSD intra 
assay and inter assay were calculated and the results are shown in Table 3.9.  
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Table 3.9. Repeatability and reproducibility for the yeast cell wall material activity assay 
Pathogen Strain S. enteritidis S. typhimurium S. gallinarum S. dublin O157:H7 O2:K1:H- O1:K1:H7 
% Binding 93.27 % 52.27 % 86.45 % 77.87 % 52.42 % 29.47 % 41.36 % 
SD 2.65 3.98 2.30 7.46 6.00 3.44 4.59 
RSD Intra assay 2.84 7.62 2.66 9.59 11.44 11.69 11.15 
RSD Inter assay 0.5 2.5 0.9 0.6 2.9 2.9 4.7 
n 60 60 60 60 60 60 60 
Results presented are a representation of mean ± standard deviations of a minimum of 60 replicates. Relative standard deviation (RSD) was calculated standard deviation/mean x 
100. n = number of replicates. SD = standard deviation 
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The inter assay RSDs’ varied between 0.5 % and 4.7 % and the intra assay RSDs’ for 
these strains varied between 2.66 % and 11.69 %. The level of precision observed for 
each individual investigation was below the acceptable level of 15 % (Crowther, 2009, 
Huber, 2007). The increased intra assay RSD values between the E. coli and Salmonella 
strains may have been caused by the additional incubation step in the assay with the 
labelled avidin.  
These results show that YCWM binds a specific quantity of Salmonella and E. coli 
depending on the strain. While it was not possible to count the numbers of bacteria 
bound to the YCWM with the microscope work, it is possible to draw some 
comparisons between the percent of bacteria removed (Table 3.9) and the images in 
Figure 3.2 and 3.3. YCWM was shown to remove approximately 90 % Salmonella 
enteritidis, 50 % typhimurium, 85 % gallinarum, and 75 % dublin. The images in Figure 
3.2 show that the amount of bacteria bound to YCWM on the slide after agglutination 
follows a similar trend to the percent bacteria removed, with Salmonella typhimurium 
and dublin showing more free bacteria cells on the slide. Agglutination of E. coli 
O157:H7 to YCWM was determined to be approximately 50 % and this corresponded to 
the image of bound and free cells in Figure 3.3 B. A similar trend may be observed for 
E. coli O1:K1:H7 (Figure 3.3 F), which was approximately 45 % bound to YCWM. 
However, for E. coli O2:K1:H- agglutination to YCWM there were very few free cells 
visible on the slide after agglutination in Figure 3.3 D indicating high agglutination 
while the actual value determined was approximately 30 %. The discrepancies between 
the determined values and the images of agglutination are due to the subjective nature of 
the agglutination on slides. Uniform binding is not seen across the slide and is difficult 
to achieve as the YCWM and bacteria are quickly mixed on the slide. This highlights 
the necessity of a quantitative assay.  
As the YCWM standard material was the same for each experiment, the variation in the 
amount of bacteria agglutinated to the YCWM was strain specific. The variation in 
binding activity between the strains of bacteria may be due to differences in the FimH 
lectin of type 1 fimbriae between these strains. The difference in sequence homology of 
the FimH adhesin between Salmonella and E. coli reported by Kisiela et al. (2013) may 
account for the variation in agglutination seen between these two species. YCWM had 
higher binding activity for Salmonella than for E. coli strains in this study. Furthermore, 
the difference in the binding activity of YCWM was observed in this study between 
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strains of the same species. Significant heterogeneity among FimH adhesins from 
strains of the same serovar exists and are reported to be responsible for the selective 
binding to different mannosylated oligosaccharides. Differences in FimH proteins and 
binding phenotypes have been described between strains of Salmonella enteritidis, 
typhimurium, gallinarum and dublin (Grzymajlo et al., 2013, Kuzminska-Bajor et al., 
2012, Kisiela et al., 2006). Variants of FimH, found on different strains of E. coli, bind 
with varying affinity to different mannose oligosaccharides such as mono- or tri-
mannose residues. The FimH adhesin’s from E. coli strains O2 and O1 have different 
receptor specificities (Kisiela et al., 2006, Weissman et al., 2006, Sokurenko et al., 
1995). The variance in FimH between E. coli O1 and O2 is reflected in the differences 
in the binding activity of these two strains to YCWM seen in this study. Additionally, 
FimH receptors of E. coli bind di- and tri-mannose residues 10 fold higher than D-
mannose (Bouckaert et al., 2006) suggesting that these mannose residues may be less 
prevalent in YCWM resulting in lower binding of E. coli compared to the Salmonella 
strains. The presence of certain mannan oligosaccharides in YCWM may cause 
increased binding of specific strains used in this study to the YCWM. It also confirms 
the requirement for a broader spectrum YCWM product with higher affinity for these 
specific bacterial strains. 
These results demonstrated that the proposed assays can reliably estimate the binding 
activity of YCWM for bacteria. These assays are suitable for screening multiple yeast 
cell wall material samples and will be useful for monitoring lot-to-lot consistency and 
stability of YCWM product, as well as identifying novel products with a high capacity 
to agglutinate bacteria. Based on these findings, these assays were used to determine the 
activity of a number of yeast cell wall samples prepared from various yeast strains 
characterised in Section 3.1.
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3.4  Binding activity of yeast cell wall preparations 
S. cerevisiae cell wall material (YCWM) is sold worldwide under the trade name 
Actigen® as an animal feed supplement, which can bind enteropathogenic bacteria such 
as Salmonella and E. coli spp. and reduce colonisation (Luquetti et al., 2012, Biggs et 
al., 2007). Bacteria bound to yeast cell wall material do not bind to the mucous 
membranes of the gut in vivo and are swept away by the flow of secretions (Gedek, 
1999). YCWM is rich in mannan oligosaccharides and these polymers in the cell wall 
are responsible for the binding of bacteria via mannose specific type 1 fimbriae (Sharon 
and Ofek, 2000). Quantification of the bacteria agglutinated by YCWM is a major 
advantage in the search for new products for the animal health industry. Following 
development and method performance testing of the yeast cell wall material binding 
assays, a selection of the cell wall samples generated and analysed in Section 3.1 of this 
thesis were assessed for their capacity to bind the bacteria listed previously. Cell wall 
samples from yeast grown in medium containing glucose as a sole carbon source were 
screened because glucose is an inexpensive carbon source (Liu, 2012) in the event of 
scale up. Samples grown in medium containing mannose as the sole carbon source were 
also analysed as they were shown to slightly increase the cell wall mannose content of a 
number of yeast cell wall samples compared to the controls in Section 3.1. The 
relationship between the cell wall monosaccharide content and the binding activity of 
the cell wall samples was also investigated. All samples were prepared as described in 
Section 2.2.8 and subjected to the yeast cell wall material binding activity assays as 
described in Section 2.2.5 using YCWM as the control. The binding activity of each 
sample for a number of bacterial strains is presented in Figures 3.13 – 3.26.  
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Figure 3.13. Binding activity of Salmonella enteritidis by yeast YCWM samples 
grown in medium containing 1 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
 
Figure 3.14. Binding activity of Salmonella enteritidis by yeast YCWM samples 
grown in medium containing 2 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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Figure 3.15.  Binding activity of Salmonella typhimurium by yeast YCWM 
samples grown in medium containing 1 % (w/v) glucose or mannose as the sole 
carbon source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
 
Figure 3.16. Binding activity of Salmonella typhimurium by yeast YCWM 
samples grown in medium containing 2 % (w/v) glucose or mannose as the sole 
carbon source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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Figure 3.17. Binding activity of Salmonella gallinarum by yeast YCWM samples 
grown in medium containing 1 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
Figure 3.18. Binding activity of Salmonella gallinarum by yeast YCWM samples 
grown in medium containing 2 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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Figure 3.19. Binding activity of Salmonella dublin by yeast YCWM samples 
grown in medium containing 1 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
Figure 3.20. Binding activity of Salmonella dublin by yeast YCWM samples 
grown in medium containing 2 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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The percent binding activity of the cell wall samples ranged between 70.2 and 96.5 % 
for S. enteritidis, 35.7 to 87.2 % for S. typhimurium, 61.1 to 93.7 % for S. gallinarum, 
and 58.1 to 93.8 % for S. dublin, shown in Figures 3.12-3.20. The percent glucose and 
mannose content (%, w/w) of the yeast cell wall samples were also presented: mannose 
content ranged between 3.7 and 21.2 % (w/w), and glucose content ranged between 8.2 
and 34.3 % (w/w) (Tables 3.1-3.6). One-way analysis of variance (ANOVA) and 
Dunnett’s multiple comparisons were carried out to identify any significant differences 
among percent binding activity compared to the control sample (YCWM), where the 
confidence level was set at 95 %. The YCWM standard was prepared through an 
industrial autolytic process, outlined in Section 1.7, whereas the yeast samples were 
prepared under lab conditions (Section 2.2.3.2).  
With respect to Salmonella enteritidis, the binding activity for the majority of yeast cell 
wall samples was significantly different to the YCWM control sample. Twenty eight 
samples were identified with significantly higher binding activity than the control and 
18 with lower binding activity, while 17 samples had similar binding activity to the 
control. The sample with the highest activity (96.5 %) was identified as cell wall from 
S. pombe 70572 grown in 2 % (w/v) glucose containing medium; while cell wall sample 
from SC 1 grown in 1 % (w/v) mannose containing medium had the lowest binding 
activity with Salmonella enteritidis. S. cerevisiae 695 grown in 1 % (w/v) mannose 
containing medium also had high binding activity (96.2 %), as did S. cerevisiae SC 4 
grown in 2 % (w/v) glucose and mannose as the sole carbon source in the growth 
medium. Of the remaining samples K. lactis 752 grown in 1 % (w/v) glucose as the sole 
carbon source was shown to have high binding activity (95.9 %).  
For Salmonella typhimurium, the majority of the samples were again shown to have 
higher binding activity than the control. Forty eight samples had a higher binding 
activity for Salmonella typhimurium, 14 samples had the same activity, while only 5 
samples were found to have lower activity than the control. S. pombe 70572 sample, 
grown in medium containing 2 % (w/v) glucose as the sole carbon source, was 
identified as having the highest binding activity (87.2 %) for Salmonella typhimurium. 
Again, SC 1 grown in medium containing 1 or 2 % (w/v) mannose had the lowest 
binding activity for Salmonella typhimurium (35 and 38 %). Samples from K. lactis 752 
and K. marxianus 2415 grown in 1 % (w/v) glucose containing growth medium 
demonstrated high binding activity similar to S. pombe 70572. Of the Saccharomyces 
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strains tested for binding activity against Salmonella typhimurium, SC 4 and 695 
samples grown in medium containing 1 % (w/v) medium had high binding activity. Cell 
wall from SC 2 and SC 3, grown in 1 % glucose containing medium also had high 
activity.  
With respect to Salmonella gallinarum, thirty eight samples were found to have 
significantly higher binding activity than the control, 18 samples with the same binding 
activity, and 12 samples with lower binding activity than the control. Cell wall from S. 
pombe 70572 grown in growth medium containing 2 % (w/v) glucose was identified as 
having the highest binding activity (93.2 %). The sample with the lowest binding 
activity for Salmonella gallinarum was from P. membranifaciens 326 grown in each of 
the 4 carbon source combinations. S. cerevisiae 695 grown in growth medium 
containing 1 % mannose as the sole carbon source was shown to have the highest 
binding activity (91.9 %) for Salmonella gallinarum of all the stains of Saccharomyces 
used. K. marxianus 2415 had the highest binding activity of the Kluyveromyces strains 
and its binding activity was significantly higher than the control. 
Of all the samples tested against Salmonella dublin, 54 samples had significantly higher 
activity than the control, with 12 samples having similar binding activity to the control, 
while only 4 samples had significantly lower binding activity than the control. 
Interestingly, S. cerevisiae SC 2 cell wall, grown in growth medium containing 1 % 
(w/v) glucose as the sole carbon source, had the highest binding activity (93.8 %) of all 
the cell wall samples for Salmonella dublin. Cell wall from S. pombe 70572 grown in 
growth medium containing 2 % (w/v) glucose as the sole carbon source also had a 
significantly high binding activity of 86.6 % for Salmonella dublin. R. mucilaginosa 
18184 cell wall, grown in 1 % (w/v) glucose and 1 % (w/v) mannose containing 
medium, had very high binding activity (93.5 and 92.6 %) against Salmonella dublin 
compared to the control. As with Salmonella enteritidis and typhimurium, SC 1 had the 
lowest binding activity with Salmonella dublin of 58 %. S. cerevisiae 695 grown in 
growth medium containing 1 % (w/v) mannose as the sole carbon source also had 
significantly high binding activity compared to the control for Salmonella dublin. 
Similarly, K. lactis 752 grown in growth medium containing 1 % glucose had the 
highest binding activity (89.8 %) of all the Kluyveromyces strains used for Salmonella 
dublin.  
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From these results a number of cell wall samples ranked higher in binding activity for 
all strains of Salmonella compared to the other samples. The cell wall samples with high 
binding activity for all Salmonella strains included cell wall from S. pombe 70572 
grown in growth medium containing 2 % (w/v) glucose, S. cerevisiae 695 grown in 
growth medium containing 1 % (w/v) mannose, and K. lactis 752 grown in growth 
medium containing 1 % (w/v) glucose; indicating that the cell wall of certain yeast 
strains contain fractions that are involved in increased binding activity for type 1 
fimbriae containing Salmonella. Indeed the cell wall content of yeast is known to vary 
between strains (Jaehrig et al., 2008, Klis et al., 2002). Each cell wall sample was 
shown to contain various amounts of cell wall glucose and mannose. Nevertheless, it 
may be that the structure and not the content of the cell wall saccharides is important in 
binding bacteria (Shoaf-Sweeney and Hutkins, 2009). 
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Figure 3.21. Binding activity of E. coli O157:H7 by yeast YCWM samples grown 
in medium containing 1 % (w/v) glucose or mannose as the sole carbon source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
Figure 3.22. Binding activity of E. coli O157:H7 by yeast YCWM samples grown 
in medium containing 2 % (w/v) glucose or mannose as the sole carbon source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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Figure 3.23. Binding activity of E. coli O2:K1:H- by yeast YCWM samples grown 
in medium containing 1 % (w/v) glucose or mannose as the sole carbon source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
Figure 3.24. Binding activity of E. coli O2:K1:H- by yeast YCWM samples grown 
in medium containing 2 % (w/v) glucose or mannose as the sole carbon source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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Figure 3.25. Binding activity of E. coli O1:K1:H7 by yeast YCWM samples 
grown in medium containing 1 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements. 
 
Figure 3.26. Binding activity of E. coli O1:K1:H7 by yeast YCWM samples 
grown in medium containing 2 % (w/v) glucose or mannose as the sole carbon 
source. 
Means labelled with an asterisk [*] are significantly different to the control, p ≤ 0.05. n = 3 for 
monosaccharide concentration. n = 9 for activity measurements.  
Strain name Strain name 
Strain name Strain name 
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The binding activity of the cell wall samples for the E. coli strains are shown in Figures 
3.21-3.26. In contrast to the activity results of the Salmonella strains, all samples were 
found to have significantly higher binding activity than the control. With respect to E. 
coli O157:H7, the cell wall of S. cerevisiae 72 grown in growth medium containing 2 % 
(w/v) mannose had the highest activity (88.5 %). Interestingly, S. cerevisiae 72 cell 
wall, grown in growth medium containing 2 % (w/v) glucose, had the lowest percent 
activity (71.8 %) of all the samples. S. pombe 70572 cell wall, grown in medium 
containing 2 % (w/v) glucose as the sole carbon source, also had high activity (87.3 %). 
K. lactis 752 grown in 1 % (w/v) mannose was found to have high binding activity with 
this strain of E. coli. As with strains of Salmonella, cell wall samples from S. cerevisiae 
695 grown in growth medium containing 1 and 2 % (w/v) glucose and 1 % (w/v) 
mannose had high binding activity for E. coli O157:H7 of above 85 %. As with E. coli 
O157:H7, all samples had significantly higher binding activity than the control sample 
for E. coli O2:K1:H-. R. mucilaginosa 18184 cell wall grown in 1 % (w/v) mannose had 
the highest binding activity. This sample also had high activity for Salmonella dublin. In 
contrast to R. mucilaginosa 18184, R. mucilaginosa 70825 cell wall was shown to have 
very low percent activity for this strain of E. coli (51.5 %); confirming that the cell wall 
of Rhodotorula spp. is a highly varied structure (Klimek-Ochab et al., 2011). As with 
Salmonella gallinarum, P. membranifaciens 326 cell wall samples had the lowest 
binding activity with this strain of E. coli (48.3 %). S. pombe 70572 cell wall, grown in 
growth medium containing 2 % (w/v) glucose as the sole carbon source, was shown to 
have high activity for binding E. coli O2:K1:H- (89.4 %). Samples from K. lactis 752 
and K. marxianus 2415 were also shown to have high binding activity for this strain. A 
number of S. cerevisiae samples including 695, SC 3, and SC 1 also demonstrated high 
binding activity. The binding activities of all samples were significantly higher than the 
control for E. coli O1:K1:H7. K. lactis 752 cell wall, grown in growth medium 
containing 1 % (w/v) glucose, was shown to have the highest percent activity (95.7 %) 
for E. coli O1:K1:H7. Once more P. membranifaciens 326 grown in a number of carbon 
sources was shown to have the lowest binding activity of all the samples (60.1 – 70 %). 
S. pombe cell wall grown in growth medium containing 2 % (w/v) glucose also had high 
binding activity (92.1 %) for E. coli O1:K1:H7. A number of S. cerevisiae samples also 
demonstrated high binding activity for this strain of bacteria.  
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While the samples with the highest binding activity vary between strains of bacteria, a 
number of cell wall samples were found to have high binding activity with the majority 
of bacterial strains. These samples include S. pombe 70572 grown in 2 % (w/v) glucose 
as the sole carbon source in the growth medium, S. cerevisiae 695 grown in 1 % (w/v) 
mannose as the sole carbon source in the medium, and K. lactis 752 grown in 1 % (w/v) 
glucose as the sole carbon source in the growth medium. In addition, the binding 
activities of these samples were significantly higher than the control for all strains of 
bacteria used in this study. Cell wall samples that can bind more bacteria than the 
control sample are of interest for the development and production of new or next 
generation products for the control of type 1 fimbriae containing Salmonella and E. coli. 
From the binding activity results of the samples, it is difficult to draw conclusions 
between the binding activity and the saccharide content without carrying out correlation 
analysis on the data to determine if there is a relationship between the two. A Spearman-
Rho test was used to determine any positive or negative correlations in the glucose or 
mannose content and the binding activity of the samples for each strain of bacteria. A 
positive (+) correlation, when an increase in monosaccharide content correlated with an 
increase in binding activity, or a negative correlation (-), when an increase in 
monosaccharide content correlating with a decrease in binding activity, are presented in 
Table 3.10 and 3.11. There were numerous statistically significant correlations (p ≤ 
0.05) between the glucose or mannose content (% w/w) and the binding activity of the 
yeast samples. One limitation of this type of statistical approach is that it only measures 
the relationship between two variables and does not allow for determination of cause 
and effect (Elliott and Woodward, 2006). 
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Table 3.10. Summary of correlations observed for the relationship between binding of Salmonella and the monosaccharide 
content. 
  Salmonella 
enteritidis 
Salmonella  
typhimurium 
Salmonella 
gallinarum 
Salmonella 
dublin 
Yeast YCWM  Glucose  
(% w/w) 
Mannose  
(% w/w) 
Glucose 
 (% w/w) 
Mannose  
(% w/w) 
Glucose  
(% w/w) 
Mannose  
(% w/w) 
Glucose  
(% w/w) 
Mannose  
(% w/w) 
          
Saccharomyces cerevisiae 72 + - + -  - +  
Saccharomyces pastorianus 203 - + -  - +  + 
Saccharomyces cerevisiae  4070 -   +  + - - 
Saccharomyces cerevisiae SC 4      +   
Saccharomyces cerevisiae 695    - -  -  
Saccharomyces cerevisiae SC 3 -  - +  - -  
Saccharomyces cerevisiae SC 1   + -     
Saccharomyces cerevisiae SC 2         
Kluyveromyces lactis 752 + - + - - + + - 
Kluyveromyces marxianus 701  - - -  - - - 
Kluyveromyces marxianus 2415 -  + -    + 
Schizosaccharomyces pombe 70572 + + - + + +  - 
Candida utilis 70167  +     +  
Rhodotorula mucilaginosa 70825 - + - + - + - + 
Pichia membranifaciens 326      -   
Rhodotorula mucilaginosa 18184 +    -  +  
Significant Spearman Rho correlations are represented here (p ≤ 0.05). Positive correlations are denoted with (+) and negative correlations with (-).  
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Table 3.11. Summary of correlations observed for the relationship between binding of E. coli and the monosaccharide content. 
  E. coli O157:H7 E. coli O2:K1:H- E. coli O1:K1:H7 
Yeast YCWM  Glucose 
(% w/w) 
Mannose 
(% w/w) 
Glucose 
(% w/w) 
Mannose 
(% w/w) 
Glucose 
(% w/w) 
Mannose 
(% w/w) 
        
Saccharomyces cerevisiae 72  +  + + + 
Saccharomyces pastorianus 203 -  -  -  
Saccharomyces cerevisiae  4070 + + - -   
Saccharomyces cerevisiae SC 4 + +     
Saccharomyces cerevisiae 695  - + - + - 
Saccharomyces cerevisiae SC 3 +  +   + 
Saccharomyces cerevisiae SC 1   - + + - 
Saccharomyces cerevisiae SC 2       
Kluyveromyces lactis 752 + - + - + - 
Kluyveromyces marxianus 701  -  -  - 
Kluyveromyces marxianus 2415  + + - - + 
Schizosaccharomyces pombe 70572   -  -  
Candida utilis 70167   + - +  
Rhodotorula mucilaginosa 70825 - +  + - + 
Pichia membranifaciens 326 + + + + + + 
Rhodotorula mucilaginosa 18184   + +   
Significant Spearman Rho correlations are represented here (p ≤ 0.05). Positive correlations are denoted with (+) and negative correlations with (-). 
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The results in Table 3.10 and 3.11 underscore the considerable variation in the 
correlation data between the yeast cell wall sample’s glucose and mannose content and 
the binding activity for the strains of bacteria. Of the yeast samples shown to have high 
binding activity with the majority of bacterial strains S. pombe 70572 was found to have 
varying correlations between its cell wall monosaccharide content and its binding 
activity for each strain of bacteria. A negative correlation was found between the cell 
wall glucose content of S. pombe 70572 and the binding activity for E. coli O2:K1:H-, 
O1:K1:H7, and Salmonella typhimurium. A positive correlation between the cell wall 
glucose content and the binding activity existed for Salmonella enteritidis and 
gallinarum. The cell wall mannose content of S. pombe was positively correlated with 
Salmonella enteritidis, typhimurium, and gallinarum, and negatively correlated with 
Salmonella dublin. K. lactis 752 was found to have a significant positive correlation 
between the cell wall glucose content and the binding activity for each strain of E. coli 
and for Salmonella enteritidis, typhimurium, and dublin, while a significant negative 
correlation was shown for the cell wall mannose content and the binding activity for the 
same strains. Similar to K. lactis 752, S. cerevisiae 695 was found to have a negative 
correlation between the cell wall mannose content and the binding activity for all strains 
of E. coli and with Salmonella typhimurium. Furthermore, a positive correlation 
between the cell wall glucose content of S. cerevisiae 695 and the binding activity was 
found for E. coli O2:K1:H- and O1:K1:H7, while a negative correlation between cell 
wall glucose content and the binding activity of Salmonella gallinarum and dublin was 
observed. It is evident that there is no clear pattern between the yeast cell wall 
monosaccharide content and the binding activity of these strains.  
The relationship between the monosaccharide content and the binding activity was 
unclear from these results. It suggests that other factors are involved in the binding 
activity of samples and not necessarily the glucose and mannose content of the samples. 
The differences observed may be dependent on the strain of yeast and the structure of 
the mannan oligosaccharides. Again differences in the cell wall material structure and 
content between different strains of yeast within the same species have been reported 
(Lane et al., 2011, Nguyen et al., 1998). Differences in the binding activity between cell 
wall samples derived from different strains of same species were observed with all 
strains of bacteria in this study. For example, cell wall samples from the various strains 
within the same species of Saccharomyces, Kluyveromyces, or Rhodotorula displayed 
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different binding activities, and correlations between cell wall saccharide content and 
binding activity, from other cell wall samples from the same species. Tiago et al. (2012) 
also found that certain strains of Saccharomyces could agglutinate Salmonella and E. 
coli quicker than others in vitro. K. marxianus 2415 displayed a different set of 
correlations between binding activity and cell wall glucose or mannose content when 
compared to the other two strains of Kluyveromyces. This may be due to reported 
differences between various strains of Kluyveromyces (Belloch et al., 2002).  
The correlation between the cell wall glucose or mannose content of the samples and 
binding activity for bacteria did not follow an obvious pattern, with several samples 
having positive correlations between the glucose or mannose content and the binding 
activity of various strains of Salmonella or E. coli and negative correlations between the 
glucose and mannose content and the binding activity with others. Differences in the 
composition or structure of the cell wall mannans of various yeast strains exist. For 
example, the mannose segment of S. cerevisiae cell wall is predominately composed of 
α-(1, 2), α-(1, 3) and α-(1, 6) mannan linkages. Candida spp. produce poly β-(1, 2) 
linked mannose chains attached by linkages to their mannans. Pichia spp. do not contain 
the α-(1, 3) mannan caps of S. cerevisiae mannan chains (Gemmill and Trimble, 1999). 
S. pombe contain α-(1, 2) linked galactose side chains (Perez and Ribas, 2004). And 
Kluyveromyces species contain GlcNAc residues on their mannan oligosaccharides 
(Park et al., 2011). Rhodotorula species have mannose side chains containing 
alternating β-(1, 3) and β-(1, 4) linked residues (McGinnis, 2012). According to Badia 
et al. (2013) it is the structure of the cell wall mannans that are important in the binding 
activity of type 1 fimbriae containing bacteria. For example, different strains of E. coli, 
bind with varying affinity to different mannose oligosaccharides such as mono or 
trimannose residues (Shoaf-Sweeney and Hutkins, 2009, Weissman et al., 2006). 
The search for cell wall samples as potential new products with high binding activity for 
specific pathogens led to the discovery of a number of candidate samples. These include 
S. pombe 70572, S. cerevisiae 695, and K. lactis 752. Each yeast strain is currently 
employed in an industrial or commercial application and are GRAS (Benito et al., 2014, 
van Ooyen et al., 2006, Parker et al., 1980). S. pombe 70572 cell wall, grown in 2 % 
(w/v) glucose as the sole carbon source in the growth medium, was found to have 
significantly higher binding activity than the control for each strain of Salmonella and 
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E. coli. The cell wall of this fission yeast is known to differ from budding yeast such as 
S. cerevisiae in a number of ways. Acid hydrolysis and subsequent analysis of the 
hydrolysate revealed it to have relatively low cell wall mannose content compared to 
other yeast strains. Moreover, S. pombe contains galactomannans in its cell wall as 
opposed to the more common yeast mannans (Ballou et al., 1994). Galactomannans are 
a yeast mannan with galactose units bound at terminal positions, mainly by α-(1, 2) and 
β-(1, 2)-linkages (Hamilton and Gerngross, 2007, Perez and Ribas, 2004). This yeast 
also contains unconventional α-(1, 3) glucan residues located on the surface of the cell 
wall. Interestingly, while traces of GlcNAc, the monomer from which the polymer 
chitin is composed, have been found in the cell wall of this yeast no chitin has ever been 
identified in the cell wall (Perez and Ribas, 2004). These unique properties of S. pombe 
may explain why this strain of yeast had high binding activity with all strains of 
bacteria. A study using β-galactomannan oligosaccharides in pig feed showed a 
significant reduction in the Salmonella populations, including Salmonella typhimurium, 
compared to an untreated control group (Andres-Barranco et al., 2015). In vitro 
investigations also found that galactomannans reduced the adhesion of Salmonella 
typhimurium and E. coli to pig intestinal cell line IPI-2I (Badia et al., 2013). 
Interestingly, E. coli K88 which is mannose resistant, as it contains type 4 (F4) and not 
type 1 fimbriae, was also sensitive to galactomannan residues (Gonzalez-Ortiz et al., 
2014, Badia et al., 2013). This indicates that galactomannans may have a wider range of 
target binding sites other than the mannose sensitive type 1 lectins. 
S. cerevisiae 695 cell wall sample, grown in medium containing 1 % (w/v) mannose as 
the sole carbon source, had significantly higher binding activity than the control for all 
strains of bacteria. Interestingly, this cell wall sample had relatively low levels of cell 
wall glucose (~ 9 %, w/w) and mannose (~ 12 %, w/w). This suggests that further 
investigation into the structure of the mannan oligosaccharides fraction is necessary. 
The high activity of this sample may be due to the hypermannosylated residues of cell 
wall glycoproteins of S. cerevisiae spp. S. cerevisiae mannoproteins contain long α-(1, 
6) linked mannose backbones linked with shorter α-(1, 2) and α-(1, 3) mannose side 
chains (Orlean, 2012). However, the cell wall samples from other strains of 
Saccharomyces used in this study had different binding activities to each other. A 
review by Klis et al. (2006) states that the cell wall content of different strains of S. 
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cerevisiae can vary between strains. This supports the observation that binding activity 
may be strain dependent.  
K. lactis 752 has a cell wall structure similar to S. cerevisiae (Backhaus et al., 2011). 
However, different carbon sources were shown to influence the cell wall architecture 
and content of Kluyveromyces compared to Saccharomyces species, signifying 
fundamental differences between the cell walls of the various stains of yeast (Backhaus 
et al., 2010). Additionally, Kluyveromyces species are known to add GlcNAc, a 
common modification of mammalian oligosaccharides (Park et al., 2011), during 
glycosylation and this might contribute to the increased activity seen with a number of 
bacteria stains. GlcNAc residues are part of a number of pathogen oligosaccharide 
adherence sites on host mucosal surfaces, including endothelial, respiratory, stomach, 
and genital, for a variety of species (Shoaf-Sweeney and Hutkins, 2009, Firon et al., 
1984).  
In contrast to the samples with high binding activity, P. membranifaciens had the lowest 
binding activity with a number of strains of bacteria regardless of the carbon source. 
Hypermannosylation occurs less frequently and to a lesser extent in Pichia spp. (Liu et 
al., 2009a). Pichia spp. are known to have shorter N-glycans than Saccharomyces spp., 
in addition they lack α-(1, 3) linked mannan caps on their mannan oligosaccharides 
(Gemmill and Trimble, 1999) due to the absence of an α-(1, 3) mannosyltransferase 
(Wildt and Gerngross, 2005). These differences may be contributing factors to the 
decreased binding activity of this species as type 1 fimbriae containing bacteria have 
been reported to bind α-(1, 3) mannanoligosaccharides (Shoaf-Sweeney and Hutkins, 
2009).  
Interestingly, no significant difference in the cell wall monosaccharide content was 
observed for samples grown in growth medium containing any of the carbon sources for 
S. pombe 70572, S. cerevisiae 695, and K. lactis 752. Different concentrations of carbon 
source have been shown to alter the cell wall composition of Saccharomyces (Liu et al., 
2009b, Aguilar-Uscanga and Francois, 2003) but these studies looked at only one 
specific strain of Saccharomyces, expanding their study to include other strains may 
have shown different results similar to the observations in this study. It is difficult to 
explain the variation in binding activity between the samples based on the cell wall 
glucose and mannose content; it may be due instead to the structure of the N-linked 
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mannans of the cell wall proteins (Schierholt et al., 2011). N-linked glycoproteins of 
yeast cell wall are hypermannosylated structures extending out from the cell (Lipke and 
Ovalle, 1998). 
As the bacterial binding mechanisms are only partially understood, it may be that cell 
wall structure, yeast strain diversity, and non specific interactions might also play 
important roles in bacterial agglutination. The structure of the carbohydrate, specifically 
the mannan fraction, of the yeast cell wall material samples may be critical in the 
binding activity of the samples. Fragmentation of the complex sugar moieties of the 
high activity yeast samples was undertaken. Comparison of the profiles generated for 
each sample was carried out to try and explain the differences in activity observed for 
each sample. 
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3.5  N-glycan profiling of yeast cell wall samples. 
The role of complex oligosaccharides and bacteria binding has been well documented 
(Shoaf-Sweeney and Hutkins, 2009, Yang et al., 2008, Terré et al., 2007, Mourao et al., 
2006, Sharon and Ofek, 2000, Spring et al., 2000, Oyofo et al., 1989). Some strains of 
bacteria were found to vary as much as 100 fold with their affinity to various mannan 
oligosaccharides (Sharon, 2006). With this in mind, analysis of the N-glycan profile of 
yeast cell wall material samples with high binding activity for type 1 fimbriae 
containing bacteria was carried out. 
The majority of the proteins found on the cell surfaces of most organisms are 
glycosylated (Bowman and Free, 2006, Andreishcheva et al., 2004). Glycosylation is 
the most common and most diverse protein modification in eukaryotic cells (Zhou et al., 
2007). N- and O-linked glycosylation of S. cerevisiae, C. albicans, P. pastrious, K. 
lactis, and S. pombe glycoproteins have been studied in depth (De Groot et al., 2005, 
Wildt and Gerngross, 2005). Glycans are attached at the reducing terminus through N-
acetylglucosamine (GlcNAc) to the amide group of certain asparagine (Asn) residues 
and are typically comprised of seven or more component monosaccharides (Haltiwanger 
and Lowe, 2004). Yeast N-glycans have a common core type oligosaccharide with 9-13 
mannose residues, which may be extended with an α-(1, 6) mannosyl backbone heavily 
substituted with short mannosyl side chains, to produce hypermannosylated glycans. 
These long hypermannosylated structures attached to cell wall proteins extend out from 
the cell (Jigami, 2008, Lipke and Ovalle, 1998). The variation in binding activity of 
YCWM may be attributed to more than just the mannose or glucose content but rather 
to the complexity of how these sugars are linked together (Sharon, 2006). The aim of 
this section was to examine the glycan profile for a number of yeast cell wall material 
samples, to shed light on whether differences between their profiles corresponded to 
differences in their binding activities.  
Yeast cell wall samples were chosen for N-glycan analysis based on their high binding 
activity for type 1 fimbriae containing bacteria. The samples chosen for further analysis 
are listed in Table 3.12. The control YCWM was also subjected to N-linked glycan 
analysis.  
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Table 3.12. Yeast cell wall samples for glycan profiling. 
Yeast strain Carbon source (% w/v) 
S. cerevisiae (695) 1 % (w/v) Mannose 
S. Pombe (70572) 2 % (w/v) Glucose 
K. lactis (752) 1 % (w/v) Glucose 
 
3.5.1 N-glycan analysis of yeast cell wall samples. 
The cell wall proteins were extracted from the samples using CHAPS extraction buffer 
as described in Section 2.2.10.1. In order to profile the N-glycans, they were first 
released from the polypeptide backbone (Triguero et al., 2010) by PNGase F digestion 
(Section 2.2.10.2). The glycan samples were fluorescently labelled with 2-
aminobenzamide (2-AB) and analysed by hydrophilic interaction chromatography 
(HILIC-UPLC) (Section 2.2.10.3-4). This is a variation of normal phase 
chromatography that allows detection at femtomole levels (Royle et al., 2008). Polar 
analytes partition between an immobilized water layer surrounding a polar stationary 
phase in a high solvent environment. Weak interactions, such as van der Waal forces 
and hydrogen bonding, become significantly enhanced. Oligosaccharide retention is 
based on the interaction of hydrophilic surfaces on sugar molecules with the polar 
HILIC phase. The larger oligosaccharides contain more hydrophilic surfaces and have 
increased retention times. Very large polysaccharides contain too many hydrophilic 
surfaces to be resolved on the column and are eluted in the wash step. However, 
digestion of the N-glycan samples with specific glycosidases reduce the larger 
oligosaccharide chains that are outside the range of the method to shorter chain 
saccharides or monomers within the range of the method (Royle et al., 2006). Once the 
oligosaccharides have been enzymatically digested the UPLC profile can be re-analysed 
and peak shifts will identify peaks that originally contained glycans with the 
monosaccharides of interest. As YCWM was used as the control in the yeast cell wall 
material binding assays its glycan profile was analysed as a reference. The results are 
shown in Figure 3.27. 
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Figure 3.27. HILIC chromatogram of 2-AB labelled YCWM PNGase F digested 
sample. 
Samples were run on equal weight basis and in duplicate.     arrows indicate peaks that resolved at the 
same time in the glycan profile of S. cerevisiae 695, K. lactis 752, and S. pombe 70572. 
 
YCWM is produced from S. cerevisiae var. boulardii, the PNGase F digest of this 
sample had a glycan retention profile between 3 and 16 minutes. The chromatogram 
was cropped between 3 and 16 minutes to exclude the excess 2-AB label peak which 
elutes at 1 minute, a large monosaccharide peak that eluted between 2 and 3 minutes, 
and material that came off in the wash step above 16 minutes. The saccharides elute 
based on the size of the glycan polymers. Monomers elute first followed by 
oligosaccharides of increasing size.  
In S. cerevisiae the N-glycans consist of mannose residues elongated from the GlcNAc 
core. Yeast glycans are hypermannosylated (Wildt and Gerngross, 2005) and can 
contain more than 150 mannose residues (Liu et al., 2009a). The N-glycan profile of 
YCWM (Figure 3.27) contains many peaks which represent oligosaccharides of 
different lengths and complexity. The large peaks at the beginning of the glycan profile 
between 3 and 5 minutes indicate an abundance of short chain sugar residues. This 
chromatogram also indicates that there are numerous oligosaccharides of different 
lengths present in this sample, eluting between 5 and 15 minutes. In addition, the solid 
arrows in Figure 3.27 indicate peaks that resolved at the same time in the glycan profile 
of the other samples analysed (Figure 3.28-3.30). Analysis of the glycan profiles 
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allowed for comparison between YCWM and samples with increased binding activity. 
Both common and sample specific peaks were identified. 
 
Figure 3.28. HILIC chromatogram of 2-AB labelled S. cerevisiae 695 PNGase F 
digested sample. 
Samples were run on equal weight basis and in duplicate.    arrows indicate peaks that resolved at the 
same time in the glycan profile of YCWM, K. lactis 752, and S. pombe 70572. 
 
 
Figure 3.29. HILIC chromatogram of 2-AB labelled K. lactis 752 PNGase F 
digested sample. 
Samples were run on equal weight basis and in duplicate.     arrows indicate peaks that resolved at the 
same time in the glycan profile of YCWM, S. cerevisiae 695, and S. pombe 70572. 
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Figure 3.30.  HILIC chromatogram of 2-AB labelled S. pombe 70572 PNGase F 
digested sample. 
Samples were run on equal weight basis and in duplicate.     arrows indicate peaks that resolved at the 
same time in the glycan profile of YCWM, S. cerevisiae 695, and S. pombe 70572. 
 
The common peaks in each of the profiles had retention times of approximately 4.1, 4.6, 
5.9, 6.7, 7.1, 7.6, 8.3, 8.5, 9.2, 10.8, and 14.5 minutes. These samples shared eleven 
peaks with the same retention time in the glycan region, indicating that oligosaccharides 
of the same length were present in each of the samples. In addition to the common 
peaks, each of the profiles contained peaks that were sample specific. For example, the 
YCWM profile contained a peak at 6.1 and at 7.4 minutes that were not present in the 
other samples. There were four peaks unique to S. cerevisiae 695’s glycan profile at 9.5, 
12.8, 13.8, and 14.4 minutes shown in Figure 3.28. Interestingly, S. cerevisiae 695 and 
YCWM contained peaks common to each other, but absent in the other samples, at 8.7, 
8.8, 9.6, 10.4, 10.7, 12.1 and 13.4 minutes. These two profiles demonstrated a degree of 
similarity between the two strains of Saccharomyces. However, the differences in the 
peak profiles mentioned above between the two samples allude to differences in the 
structures or complexity of the oligosaccharides which may in part contribute to the 
higher binding activity of S. cerevisiae 695 for type 1 fimbriae containing bacteria 
compared to YCWM. K. lactis 752 contained unique peaks at 9.9, 10.1, 11.4, 11.6, 13.1, 
and 13.9 minutes. This strain was identified to have the most unique peaks (6) 
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compared to the other sample analysed. S. pombe 70572 also had a number of unique 
peaks at 5.1, 7.9, 12.5, and 15.2 minutes.  
It may be speculated that the common peaks identified between the samples, described 
previously and displayed with solid black arrows in Figure 3.27-3.30, contain 
oligosaccharides that may be involved in binding activity. Each sample was also found 
to have its own glycan profile containing oligosaccharide residues specific to the 
individual sample. The presence of unique peaks in each sample is in agreement with 
reports that have identified different N-glycan structures of various yeast strains 
(McGinnis, 2012, Park et al., 2011, Perez and Ribas, 2004, Gemmill and Trimble, 
1999). 
As mannose and mannose linked oligosaccharides are associated with binding to the 
FimH lectin of type 1 fimbriae it was necessary to ascertain if the N-glycan 
oligosaccharides present in each of the profiles were indeed mannan oligosaccharide 
chains. Each of the glycan samples were digested with the exoglycosidase Jack Bean 
Mannosidase (JBM). JBM hydrolyses α-(1, 2), α-(1, 3), and α-(1, 6) linked mannose 
residues back to a single mannose residue linked to a GlcNAc core, this β-(1, 4) linkage 
is not hydrolyzed by JBM (Mulloy et al., 2009). The subsequent JBM digested glycan 
profiles for each of the samples are shown in Figures 3.31-3.34. Disappearance of a 
peak after JBM digestion confirmed the presence of α-(1, 2), α-(1, 3), and/or α-(1, 6) 
linked mannose in a peak. New peaks are the product of larger oligosaccharides reduced 
to shorter oligosaccharides. Liberated monosaccharides eluted in the peak at 2-3 
minutes were not shown in the chromatograms as the peaks were too large and skewed 
the chromatograms, making it difficult to identify changes in the smaller peaks. 
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Figure 3.31. HILIC chromatogram of (A) YCWM PNGase F digested and (B) 
YCWM PNGase F and JBM digested samples. 
Samples were run on equal weight basis and in duplicate.      arrows indicate the peaks in A that 
disappeared in B. 
A number of peaks disappeared from the YCWM chromatogram when the glycan 
sample was digested with JBM compared to the PNGase F digested sample, confirming 
the peaks were indeed mannose chains. Ten peaks disappeared in the YCWM samples 
upon digestion with JBM, as indicated with solid arrows in Figure 3.31 A. These peaks 
eluted at 5.1, 5.7, 6.8, 7.4, 8.1, 9.3, 9.6, 10.7, 12.0, 13.4, and 14.6 minutes in the 
PNGase F digested sample but were absent in the JBM digested sample. The liberated 
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mannose residues from these mannan oligosaccharides were eluted in the large 
monosaccharide peak resolved between 2 and 3 minutes.  
A number of undigested peaks remain in the chromatogram, these may be either 
mannose oligosaccharides that were not completely digested due to the ability of JBM 
to release α-(1, 2) and α-(1, 6) linkages more efficiently than α-(1, 3) linked mannans 
or due to the presence of β-glucan residues. β-glucans are a large part of the yeast cell 
wall (Klis et al., 2002) but are not involved in the binding of type 1 fimbriae and were 
not investigated further. 
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Figure 3.32. HILIC chromatogram of (A) S. cerevisiae 695 PNGase F digested 
and (B) S. cerevisiae 695 PNGase F and JBM digested. 
Samples were run on equal weight basis and in duplicate.      arrows indicate the peaks in A that 
disappeared in B. 
 
Similarly the N-glycans of S. cerevisiae 695 were subjected to enzymatic digestion with 
JBM. A number of peaks were digested back to a single peak at the beginning of the 
chromatogram between 2 and 3 minutes indicating the presence of mannose linked 
residues. Peaks that disappeared in Figure 3.32 B are shown with solid arrows in Figure 
3.32 A. A triple peak between 6.5 and 7.5 minutes was reduced to a double peak with 
enzymatic digestion, where the middle peak at 6.8 minutes was removed. Similarly, a 
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triple peak between 9 and 10 minutes was reduced to a double peak, and single peaks at 
10.7, 13.4 and 14.6 minutes were also removed. The disappearance of these peaks 
indicated the presence of mannan oligosaccharides. A number of peaks that were 
digested by JBM in S. cerevisiae 695 were also digested in the YCWM sample, and 
included the peaks at 6.8, 10.7, 13.4, and 14.6 minutes. This implied that these two 
samples contained similar sized mannan oligosaccharides based on retention times. The 
mannan oligosaccharide at 9.4 minutes was a unique peak to S. cerevisiae 695 
compared to the YCWM sample demonstrating diversity between the samples.  
A number of peaks remained undigested by JBM indicating that these peaks did not 
contain mannose. These remaining peaks may have been protected from digestion by a 
greater number of α-(1, 3) linked mannose residues present in the sample compared to 
the YCWM. As mentioned previously, hypermannosylated oligosaccharides are too 
large to be resolved on the column. However, digestion with JBM may shorten these 
residues which were then resolved on the column and detected. The peaks undigested by 
JBM may also contain β-glucan residues as was seen in the YCWM sample.  
The difference in the JBM digested profiles of S. cerevisiae 695 cell wall and YCWM 
seen here may be due to the difference in the parent strains, S. cerevisiae and S. 
cerevisiae var. boulardii. From these results there were more short chain mannan 
oligosaccharides present in the YCWM sample. These results agree with Bzducha-
Wrobel et al. (2013) who demonstrated a difference in the cell wall composition 
between S. cerevisiae R9 (brewer’s yeast) and S. cerevisiae var boulardii. S. cerevisiae 
var. boulardii was found to have a higher cell wall mannoprotein content compared to 
S. cerevisiae R9, while S. cerevisiae R9 cell wall was characterised by an increased β-
glucan content compared to S. cerevisiae var. boulardii. 
As S. cerevisiae 695 had increased binding activity for all strains of bacteria compared 
to YCWM, the structure of the mannan oligosaccharides may be important in binding 
activity. The presence of a number of unique peaks in S. cerevisiae 695, including a 
mannan oligosaccharide peak at 9.4 minutes, correlated with increased binding activity 
of type 1 fimbriae containing bacteria.  
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Figure 3.33.  HILIC chromatogram of (A) K. lactis 752 PNGase F digested and (B) 
K. lactis 752 PNGase F and JBM digested samples. 
Samples were run on equal weight basis and in duplicate.      arrows indicate the peaks in A that 
disappeared in B after JBM digestion.       arrows in B indicate the presence of new peaks not present in 
A.  
 
K. lactis 752, grown in 1 % (w/v) glucose as the sole carbon source, had high binding 
activity for all bacterial strains used in this study. K. lactis is both scientifically and 
biotechnologically one of the most relevant non-Saccharomyces yeasts. The vast use of 
K. lactis as a model eukaryote can be ascribed to its GRAS status and to the availability 
of molecular tools for genetic manipulation (Rodicio and Heinisch, 2013). K. lactis is 
 
Fl
uo
re
sc
en
ce
 (L
U)
 
 
Fl
uo
re
sc
en
ce
 (L
U
) 
Retention Time (minutes) 
Retention Time (minutes) 
A 
B 
Section 3.5  Results and Discussion 
144 
known to contain long chain mannan oligosaccharides in its cell wall (Zanni et al., 
2009). The N-glycans of K. lactis are high mannose structures and resemble those 
produced in S. cerevisiae but are typically smaller (Wildt and Gerngross, 2005). 
Hydrolysis of the N-glycan sample with JBM removed a number of peaks in the 
PNGase F digested sample confirming the presence of mannose oligosaccharides in the 
sample.  
There are clear observable differences in the glycan profile of the PNGase F digested K. 
lactis 752 sample (Figure 3.33 A) and the sample subsequently digested with JBM 
(Figure 3.33 B). A number of peaks were removed from the PNGase F digested sample, 
indicated by black arrows in Figure 3.33 A, at 6.8, 9.9, 11.4, 11.6, 12.7 and 13.1 
minutes. These peaks were shown by enzymatic digestion to contain mannan 
oligosaccharides. The peaks with retention times of 9.9, 11.4, and 13.1 minutes were 
identified as unique peaks for this sample and absent in the other samples. Interestingly, 
only one of the mannan oligosaccharide peaks (6.8 minutes) of K. lactis was also 
present in the YCWM sample. In fact, K. lactis 752 had the least number of common 
mannan oligosaccharides peaks to that of YCWM of all the samples analysed. These 
unique mannan oligosaccharides may be responsible for the increased binding activity 
seen with this sample.  
In addition to the disappearance of peaks, a number of new peaks were also resolved in 
the JBM digested sample. These new peaks are represented with dashed arrows in the 
chromatogram (Figure 3.33 B) and were resolved at 3.5, 5.8, 5.9, 6.4, 6.6, 7.9, and 12.1 
minutes. In contrast to S. cerevisiae, K. lactis contains GlcNAc residues on the outer 
chain part of its N-glycans (Abeijon et al., 1996). GlcNAc is not reported to bind type 1 
fimbriae containing bacteria and was not investigated further. Furthermore, 
Kluyveromyces glycans are rich in α-(1,3) mannose side chains (Liu et al., 2009a) 
which are not as readily digested by JBM. 
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Figure 3.34. HILIC chromatogram of (A) S. pombe 70572 PNGase F digested, (B) 
S. pombe 70572 PNGase F and JBM digested, and (C) S. pombe PGNase F and 
galactosidase digested samples. 
Samples were run on equal weight basis and in duplicate.       arrows indicate the peaks in A that 
disappeared in B after JBM digestion.      arrows in B indicate the presence of new peaks not present in  
A.     arrows in A indicate the peaks that disappeared in C after galactosidase digestion;     arrows in C 
indicate the presence of new peaks not present in A. 
Section 3.5  Results and Discussion 
146 
The final sample chosen for glycan analysis was S. pombe 70572, grown in 2 % (w/v) 
glucose as the sole carbon source. S. pombe 70572 was the only fission yeast used in 
this study, it is important in the production of wine (Benito et al., 2014), heterologous 
proteins, and as a model eukaryotic (Nkeze et al., 2015, Magnelli et al., 2005). The cell 
wall material of this yeast is unusual compared to budding yeast as it contains α-(1, 3) 
glucan and galactomannan (Konomi et al., 2003). Galactomannans are yeast mannan 
oligosaccharides with galactose units bound at terminal positions, mainly by α-(1, 2) 
linkages (Hamilton and Gerngross, 2007, Perez and Ribas, 2004). 
A number of peaks were shown to contain mannan oligosaccharides as they were 
digested with JBM and absent from Figure 3.34 B, as shown by the solid arrows in 
Figure 3.34 A. These mannan oligosaccharides were resolved at 5.6, 6.3, 6.8, 7.9, 9.1, 
and 13.4 minutes. Of these digested peaks, the peaks resolved at 5.6, 6.3, 7.9, and 9.1 
minutes in the PNGase F sample were unique to S. pombe 70572 compared to the other 
samples analysed. These unique mannan oligosaccharides may be involved in the 
increased binding activity of this sample for type 1 fimbriae containing bacteria. Two of 
the mannan oligosaccharides of S. pombe 70572, resolved at 6.8 and 13.4 minutes, were 
also present in both S. cerevisiae 695 and YCWM. Furthermore, new peaks appeared in 
the JBM digested sample at 4.6, 6.6, 7.6, and 12.1 minutes and are represented by 
dashed arrows in Figure 3.34 B. These new peaks suggest that some of the mannan 
oligosaccharides and the hypermannosylated chains were hydrolysed to even shorter 
oligosaccharide chains. As S. pombe contains galactomannans, these new peaks may 
contain galactose residues. Galacomannans have been shown to reduce Salmonella 
infection in vivo (Andres-Barranco et al., 2015) and to reduce Salmonella binding to 
porcine intestinal epithelial cells in vitro (Badia et al., 2013), and were investigated 
further.  
To determine the presence of galactose linked mannan oligosaccharides, the PNGase F 
digested sample of S. pombe 70527 was digested with galactosidase and the results are 
shown in Figure 3.34 C. The results from the digestion of the sample with galactosidase 
demonstrated that a number of peaks were reduced to monomers of galactose and short 
chain mannose residues, as the galactose residues are terminally linked to the mannose 
side chains (Perez and Ribas, 2004). The peaks containing galactose were at the 
beginning of the glycan region with retention times of 3.7, 4.0, 4.2, 4.5, and 4.6 
minutes, shown with dotted arrows in Figure 3.34 A. These released monomers were 
Section 3.5  Results and Discussion 
147 
eluted in the peak between 2-3 minutes. In addition there were a number of new peaks 
present in the galactosidase digested sample at retention times of 11.0, 11.9, 12.1, 12.5, 
and 13.8 minutes, shown with dashed arrows in Figure 3.34 C. It may be hypothesized 
that these peaks represent galactomannans that were hydrolysed to mannan chains of 
different length from the hypermannosylated polysaccharides too large to be resolved 
before galactosidase digestion. It was evident that the glycan profile for the JBM 
digested and the galactosidase digested sample of S. pombe 70572 contained different 
peak profiles. The large peak at 7.9 minutes in Figure 3.34 A and C was definitely 
shown to be a mannan oligosaccharide as it was not digested by galactosidase. This 
mannan oligosaccharide peak at 7.9 minutes was unique to S. pombe and may be 
involved in the increased binding activity of this sample for type 1 fimbriae containing 
bacteria. S. pombe 70572 has been shown to contain both mannan and galactomannan 
residues in its N-glycans by enzymatic digestion and HILIC analysis. Mannan and 
galactomannan oligosaccharides in the N-glycan profile of this sample may be involved 
in the increased binding activity of this sample.  
N-glycan analysis of the cell wall from three samples (S. cerevisiae, K. lactis, and S. 
pombe), revealed the presence of both short and long chain mannan oligosaccharides. 
While there were a number of common peaks in the PNGase F digested fraction of all 
the samples, the N-glycan profiles did differ between the samples. The JBM digestion 
of the samples produced different profiles for each cell wall sample indicating that the 
structure of the oligosaccharides differ between the samples. Unique mannan 
oligosaccharide peaks were identified in each of the samples. These unique peaks may 
be involved in the increased binding activity of these samples compared to the YCWM 
sample. 
Other groups have proposed the importance of the oligosaccharide structure in the 
binding activity to type 1 fimbriae lectin (Badia et al., 2013, Schierholt et al., 2011, 
Shoaf-Sweeney and Hutkins, 2009, Sharon, 2006). Some of the common peaks between 
the strains may represent mannan oligosaccharide structures that have specific binding 
activity for type 1 fimbriae containing bacteria. However, further work is necessary to 
characterise the N-glycans present in these samples to elucidate their structure and role 
in the binding activity for type 1 fimbriae containing bacteria. The galactomannan 
residues of S. pombe 70572 may also have a significant role in binding activity. 
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This method of glycan analysis was limited as it only allowed for the identification of 
glycans with a relatively low number of monosaccharide units (up to 20). Due to the 
increased number of hydrophilic residues of long chain oligosaccharides and 
polysaccharides of yeast cell wall these residues were beyond the range of the column. 
This method was originally developed for the determination of mammalian protein N-
glycans which are considerably shorter than yeast N-glycans and contain many different 
glycan residues including glucose, N-acetylglucosamine, galactose, mannose, sialic 
acid, fructose, xylose, and N-acetylgalactosamine. In addition, there are several possible 
mannose glycoforms due to linkage isomerism (Tao et al., 2014) and it is not possible to 
distinguish between them using this method of exoglycosidase digestion with JBM and 
HILIC analysis. Characterisation would require more specific enzymes 
(endoglycosidases) such as α-(1, 2) mannosidase, α-(1, 3) mannosidase, or α-(1, 6) 
mannosidase with subsequent LC-MS analysis (Mulloy et al., 2009).  
The variety of oligosaccharide chains in both length and complexity between samples 
may be the reason for variation in the binding activity of the cell wall material for 
different strains of bacteria. As the FimH lectins are heterogenous between strains of 
bacteria (Kisiela et al., 2013) they may be more or less specific for certain 
oligosaccharides present in the cell wall material sample. The binding mechanisms 
involved are still not fully understood and the results of this study underline the 
complexity of this. Biological variation in cell wall structure and natural diversity make 
predictions even more difficult. Macromolecular structure of polymers isolated from 
cell walls of various yeasts may be characterized by various degrees of polymerization 
and branching. Further in depth research is necessary to definitively characterise cell 
wall mannan components, the relationship between bacterial agglutination, and their 
structure. 
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4.  Conclusion 
The initial aim of this study was the production and characterisation of cell wall 
samples from a variety of yeast species in search of a new or next generation MOS 
product. A collection of yeast strains were cultured in growth medium containing 
different concentrations of various simple carbon sources to assess the effect of carbon 
source on the cell wall saccharide content. The cell wall glucose content of the strains 
ranged from 8.2 – 34.3 % (w/w) and the cell wall mannose content was between 3.7 – 
21.2 % (w/w), showing that the total glucose and mannose content of the cell wall for 
each of the strains varied, depending on both the species and the strain. The influence of 
the carbon source and its concentration on the cell wall saccharide composition of yeast 
species was also found to be strain specific. Only a few strains of Saccharomyces were 
observed to be significantly different from the 2 % (w/v) glucose as sole carbon source 
control in terms of cell wall glucose and mannose content when the growth medium 
contained different carbon sources. For example, S. cerevisiae 4070 had a 2 fold 
increase in cell wall glucose content when grown in growth medium containing 1 % 
(w/v) fructose (21.1 %, w/w) compared to the 2 % (w/v) glucose control (10.1 %, w/w). 
The cell wall glucose content of S. cerevisiae SC 1 was significantly increased (23.5 %, 
w/w) compared to the control (16.1 %, w/w) with 1 % (w/v) mannose as the sole carbon 
source in the growth medium. No significant changes were observed in the cell wall 
saccharide content of the seven remaining strains of Saccharomyces used in this study 
compared to the 2 % (w/v) glucose control at 1 or 2 % (w/v) carbon source in the 
growth medium. There were a number of significant effects with the strains of 
Kluyveromyces depending on the carbon source. For example, the majority of carbon 
sources at both 1 and 2 % (w/v) in the growth medium caused a significant increase in 
cell wall mannose content of K. marxianus 701 and 2415 when compared to the 2 % 
(w/v) glucose control; while fewer significant changes were observed in the glucose 
content of the cell wall samples. In contrast to this with K. lactis 752, fewer significant 
differences in cell wall saccharide content versus the control were seen. Carbon source 
also had significant effects on the cell wall saccharide content of Rhodotorula strains. 
The cell wall glucose content of both strains of Rhodotorula was significantly reduced 
when grown in 1 % (w/v) fructose containing growth medium compared to the 2 % 
(w/v) glucose containing control medium. A number of other carbon sources including 
mannose had a significant effect on the cell wall glucose content of these strains, 
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however, no significant changes were observed for the cell wall mannose content of 
these strains when the growth medium contained 1 % (w/v) of any of the carbon sources 
used. C. utilis 70167 also had a number of significant changes in the cell wall glucose 
content, but not the mannose content, when grown in medium containing different 
carbon sources. No significant changes were observed in the cell wall saccharide 
content of S. pombe 70572 or P. membranifaciens 326 when grown in medium 
containing 1 or 2 % (w/v) carbon sources. A clear trend was not observed between the 
carbon source and the cell wall saccharide content of the yeast samples, the effect of 
carbon source on the cell wall saccharide content was shown to be strain specific.  
Increases in the concentration of the carbon sources from 1 to 2 % (w/v) were shown to 
have significant effects on the cell wall saccharide content of certain samples. Medium 
containing 2 % (w/v) mannose significantly decreased the cell wall glucose content of S. 
cerevisiae SC 1 compared to medium containing 1 % (w/v) mannose from 23.5 to 14.8 
% (w/w). An increase in fructose concentration in the growth medium from 1 to 2 % 
also significantly decreased the cell wall glucose content of S. cerevisiae 4070 from 
21.1 to 15.0 % (w/w). Fructose at 2 % (w/v) in the growth medium caused a 3 fold 
decrease in the cell wall glucose content of K. marxianus 2415 compared to medium 
containing 1 % (w/v) fructose, from 34.3 to 10.6 % (w/w). There were significant 
differences in the cell wall glucose and mannose content of K. marxianus 2415 
observed with a change in the concentration of a number of carbon sources. An increase 
in sucrose concentration from 1 to 2 % (w/v) caused significant changes in the cell wall 
glucose content of both R. mucilaginosa 70825 and 18184. The overall effects of the 
concentration of carbon source on the yeast cell wall saccharide content were strain 
specific and thought to be related to catabolite repression where an increase in carbon 
source concentration caused a decrease in cell wall glucose or mannose content.  
In the search for a second generation MOS product, it was necessary to assess whether 
the yeast cell wall samples generated in this study were effective at agglutinating 
bacteria. Prior to assessing these samples, the binding ability of the existing product, 
yeast cell wall material (YCWM), was first investigated. Initially, seven strains of type 
1 fimbriae containing bacteria were assessed for their ability to agglutinate to a sample 
of YCWM derived from S. cerevisiae var. boulardii. Four strains of Salmonella 
(enteritidis, typhimurium, gallinarum and dublin) and three strains of E. coli (O157:H7, 
O2:K1:H-, and O1:K1:H7), were chosen for their pathogenicity to either domestic food 
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animals or as a zoonotic agent of human infection. Analysis of the agglutination of the 
bacteria to YCWM was performed initially by light microscopy. YCWM had the 
capacity to bind each of the bacterial strains, though variation seemed to exist in the 
agglutination between the bacterial strains, although this was difficult to clearly 
identify. This method was subjective and uniform binding was not shown across the 
microscope slide as the YCWM and bacteria were mixed on the slide. It was also 
difficult to reliably count the amount of bacteria bound to the YCWM based on the size 
of the bacterial cells. This clearly indicated the need for a more reliable quantifiable 
method of determining YCWM’s capacity to bind different pathogenic species. A 
quantitative in vitro assay was developed for each strain of bacteria, listed previously.  
In an effort to make the microscope agglutination analysis quantitative, the method was 
transferred to a 96 well plate format. To determine the number of bacterial cells bound 
to YCWM a known amount of bacteria was incubated with a specific concentration of 
YCWM in a 96 well plate. YCWM and bacteria agglutinated to YCWM were removed 
from the plate by washing. The excess bacteria, not bound to YCWM, remained bound 
to the microtiter plate and were quantified by ELISA. The quantity of bacteria bound to 
YCWM was calculated by subtracting what was left on the plate from what was added 
to the plate initially. The binding activity was calculated by dividing the quantity of 
bacteria bound to YCWM by the initial amount of bacteria added and multiplied by 100, 
this was expressed as percent binding activity. Each step in the assay was optimised and 
the assay was subjected to precision and accuracy testing prior to analysing any 
samples. The assay was also optimised for each bacterial strain used in this thesis. The 
binding activity of YCWM was different for each strain of bacteria. For example, 
YCWM bound 93 % of the Salmonella enteritidis added to the plate intially, 52 % 
typhimurium, 86 % gallinarum, 78 % dublin, and 52 % E. coli O157:H7, 29 % 
O2:K1:H-, and 41 % O1:K1:H7. The low binding of E. coli O2:K1:H- to YCWM 
highlights the need for second generation MOS products with increased binding activity 
for such strains. These assays were used to assess the binding activity of yeast samples 
generated in the first part of this thesis.  
Although the assay has high throughput, due to its 96 well format, it was not possible to 
analyse all the yeast samples as over 192 samples were generated. The binding activity 
of samples grown in growth medium containing glucose as the sole carbon source 
because of its low cost, and samples grown in growth medium containing mannose as 
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the sole carbon source as they were shown to slightly increase the cell wall mannose 
content of a number of samples, were assessed. Interestingly, the binding activity of the 
cell wall samples were found to be significantly higher than the YCWM for all strains 
of E. coli, while there was greater variation in the range of binding activity for the 
strains of Salmonella. A number of cell wall samples were identified with significantly 
higher binding activity than the YCWM control for all strains of bacteria. These 
samples included cell wall material derived from S. pombe 70572, grown in medium 
containing 2 % (w/v) glucose, K. lactis 752, grown in medium containing 1 % (w/v) 
glucose, and S. cerevisiae 695, grown in medium containing 1 % (w/v) mannose. The 
increased binding activity of the cell wall samples compared to the YCWM was thought 
to be related to the differences in the mannan oligosaccharide content of the samples 
and the specificity of the FimH lectin for these different mannose residues. As the cell 
wall saccharide content of all the samples was previously determined in this study a 
correlation between the saccharide content and the activity was carried out.  
A number of significant correlations were found between each of the monosaccharide 
contents and the binding activity of the cell wall samples; however, no clear pattern was 
evident. Cell wall samples derived from different strains of yeast, even within the same 
species, did not share many similar correlations between cell wall saccharide content 
and binding activity for bacteria. Although correlations do not imply causation, the 
variation in the correlations between the monosaccharide content and the binding 
activity for the different strains of bacteria indicated that the quantity of cell wall 
mannose may not be critical in relation to the binding activity of the samples. In 
addition, strains such as S. pombe and Rhodotorula, with low cell wall mannose content, 
were found to have high binding activity for a number of the bacterial strains. Factors 
such as the structure are conceivably more important in terms of the binding of bacteria 
by these samples. With this in mind, comparison of the glycan structure of these 
samples was performed to determine if a link existed between high binding activity and 
the structure of the mannan oligosaccharides present in the samples. 
In-depth analysis of the N-glycan profile of cell wall samples with significantly high 
binding activity, e.g. S. cerevisiae 695, K. lactis 752, and S. pombe 70572, was carried 
out, the control YCWM was also analysed. Mannosidase digestion confirmed the 
presence of mannan oligosaccharides in each of the samples. Each cell wall sample had 
a number of peaks in common with the YCWM control; in addition, unique mannan 
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oligosaccharides were also identified in each of the samples. These unique peaks may 
be responsible for the increased binding activity of these samples compared to the 
control. Further examination of the S. pombe 70572 profiles by galactosidase digestion 
confirmed the presence of galactomannan residues. This was exclusive to this strain and 
galactomannans have been reported to reduce the adhesion of Salmonella and E. coli in 
vitro (Badia et al., 2013, Searle et al., 2010) and in vivo (Andres-Barranco et al., 2015).  
A significant outcome of this study was the development of a quantitative assay to 
determine the amount of different bacterial strains that YCWM can agglutinate. This 
assay can be used to screen samples and help in new product development. It can also 
be adapted for other type 1 fimbriated strains of bacteria. Binding activity of each batch 
of MOS type products could also be monitored using the developed assays thus adding 
to the existing quality assurance process. Full assay validation studies will be carried 
out on each of the assays to ensure that the assays meet international standards set at the 
International Conference of Harmonisation (ICH, 1996).  
S. pombe 70572 was found to have the highest binding activity for all strains of bacteria. 
Galactomannans have been reported to reduce type 1 fimbriae containing Salmonella 
and E. coli colonisation in vitro and in vivo (Andres-Barranco et al., 2015, Badia et al., 
2013). In addition, galactomannans have also been shown to reduce mannose resistant 
enterotoxigenic E. coli K88, which contains type 4 fimbriae (F4) in vitro (Badia et al., 
2012). An in vivo challenge type study would be required to confirm the efficacy of S. 
pombe cell wall at reducing pathogen load in animals.  
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Table A 1. Spearman-Rho correlations for Salmonella Spp. 
  
S. enteritidis S. typhimurium S. gallinarum S. dublin 
  
Cell wall saccharide content 
Yeast strain 
 
Glucose  Mannose  Glucose  Mannose  Glucose  Mannose  Glucose  Mannose  
S. cerevisiae 72 Binding Activity 0.491 -0.347 0.342 -0.574 0.328 -0.33 0.691 0.146 
 
P value 0.003 0.041 0.041 0 0.051 0.049 0 0.396 
S. pastorianus 203 Binding Activity -0.397 0.43 -0.83 -0.074 -0.445 0.44 -0.155 0.572 
 
P value 0.017 0.009 0 0.667 0.007 0.007 0.365 0 
S. cerevisiae 4070 Binding Activity -0.545 -0.309 -0.155 0.457 -0.12 0.567 -0.397 -0.462 
 
P value 0.001 0.067 0.365 0.005 0.487 0 0.017 0.005 
S. cerevisiae SC 4 Binding Activity -0.301 -0.194 -0.312 -0.402 0.276 0.467 -0.206 -0.206 
 
P value 0.074 0.258 0.064 0.015 0.103 0.004 0.229 0.229 
S. cerevisiae 695 Binding Activity -0.306 -0.258 0.141 -0.555 -0.385 -0.163 -0.344 -0.199 
 
P value 0.069 0.128 0.412 0 0.02 0.343 0.04 0.246 
S. cerevisiae SC 3 Binding Activity -0.868 -0.301 -0.612 0.05 0.062 -0.416 -0.847 -0.208 
 
P value 0 0.074 0 0.771 0.719 0.012 0 0.223 
S. cerevisiae SC 1 Binding Activity -0.048 0.048 0.344 -0.344 0.306 -0.306 0.079 -0.079 
 
P value 0.782 0.782 0.04 0.04 0.069 0.069 0.647 0.647 
S. cerevisiae SC 2 Binding Activity 0.203 -0.045 0.196 -0.06 0.273 0.036 0.112 -0.234 
 
P value 0.234 0.792 0.252 0.729 0.108 0.835 0.514 0.169 
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Table A 2. Spearman-Rho correlations for E. coli Spp. 
  O157:H7 O2:K1:H- O1:K1:H7 
  Cell wall saccharide content 
Yeast strain  Glucose  Mannose Glucose Mannose Glucose Mannose 
S. cerevisiae 72 Activity 0.182 0.538 0.289 0.61 0.057 0.78 
 P value 0.289 0.001 0.087 0 0.739 0 
S. pastorianus 203 Activity -0.529 -0.108 -0.78 -0.325 -0.344 -0.12 
 P value 0.001 0.532 0 0.053 0.04 0.487 
S. cerevisiae 4070 Activity 0.517 0.49 -0.682 -0.337 0.031 -0.148 
 P value 0.001 0.002 0 0.044 0.857 0.388 
S. cerevisiae SC 4 Activity 0.407 0.394 0.101 0.261 0.072 0.112 
 P value 0.014 0.017 0.589 0.155 0.677 0.516 
S. cerevisiae 695 Activity 0.311 -0.486 0.755 -0.916 0.478 -0.524 
 P value 0.065 0.003 0 0 0.003 0.001 
S. cerevisiae SC 3 Activity 0.725 -0.062 0.488 -0.28 0.136 0.863 
 P value 0 0.719 0.003 0.098 0.428 0 
S. cerevisiae SC 1 Activity -0.088 0.088 -0.514 0.514 0.366 -0.366 
 P value 0.608 0.608 0.001 0.001 0.028 0.028 
S. cerevisiae SC 2 Activity -0.201 0.115 -0.169 -0.109 -0.019 -0.053 
 P value 0.24 0.505 0.363 0.559 0.912 0.761 
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Table A 3. Spearman-Rho correlations for Salmonella Spp. 
  
S. enteritidis S. typhimurium S. gallinarum S. dublin 
  
Cell wall saccharide content 
Yeast Strains 
 
Glucose  Mannose  Glucose Mannose  Glucose  Mannose Glucose Mannose  
K. lactis 752 Activity 0.749 -0.749 0.71 -0.71 -0.648 0.648 0.813 -0.813 
 P value 0 0 0 0 0 0 0 0 K. marxianus 701 Activity -0.285 -0.608 -0.541 -0.686 -0.289 -0.806 -0.56 -0.758 
 P value 0.092 0 0.001 0 0.087 0 0 0 K. marxianus 2415 Activity -0.469 0.258 0.713 -0.837 -0.203 0.007 0.098 0.605 
 P value 0.004 0.128 0 0 0.234 0.967 0.569 0 R. mucilaginosa 70825 Activity -0.914 0.426 -0.952 0.55 -0.848 0.702 -0.872 0.678 
 P value 0 0.01 0 0.001 0 0 0 0 S. pombe 70572 Activity 0.553 0.862 -0.472 0.943 0.631 0.582 0.121 -0.553 
 P value 0.003 0 0.013 0 0 0 0.483 0 P. membranifaciens 326 Activity -0.179 -0.079 -0.017 0.057 -0.22 -0.395 0.27 0.151 
 P value 0.295 0.647 0.923 0.739 0.197 0.017 0.111 0.38 C. utilis 70167 Activity -0.297 0.383 -0.191 0.277 -0.124 0.086 0.6 0.151 
 P value 0.079 0.021 0.264 0.101 0.47 0.618 0 0.38 R. mucilaginosa 18184 Activity 0.41 -0.227 -0.313 0.189 -0.841 -0.122 0.889 0.234 
 P value 0.013 0.183 0.063 0.27 0 0.479 0 0.169 
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Table A 4. Spearman-Rho correlations for E. coli Spp. 
  
O157:H7 O2:K1:H7 O1:K1:H7 
  
Cell wall saccharide content 
Yeast Strains 
 
Glucose Mannose  Glucose  Mannose  Glucose  Mannose  
K. lactis 752 Activity 0.665 -0.665 0.705 -0.705 0.725 -0.725 
 P value 0 0 0 0 0 0 K. marxianus 701 Activity -0.242 -0.486 -0.283 -0.515 -0.23 -0.761 
 P value 0.156 0.003 0.124 0.003 0.178 0 K. marxianus 2415 Activity 0.01 0.545 0.682 -0.868 -0.624 0.706 
 P value 0.956 0.001 0 0 0 0 R. mucilaginosa 70825 Activity -0.547 0.583 -0.26 0.442 -0.568 0.408 
 P value 0.001 0 0.2 0.024 0 0.014 S. pombe 70572 Activity 0.13 -0.141 -0.714 -0.031 -0.341 -0.227 
 P value 0.448 0.411 0 0.857 0.042 0.182 P. membranifaciens 326 Activity 0.596 0.627 0.423 0.488 0.749 0.687 
 P value 0.00 0.00 0.01 0.003 0.000 0.000 C. utilis 70167 Activity 0.213 0.041 0.82 -0.385 0.44 0.01 
 P value 0.213 0.814 0 0.02 0.007 0.956 R. mucilaginosa 18184 Activity -0.039 -0.06 0.83 0.42 -0.243 0.012 
 P value 0.821 0.729 0 0.014 0.153 0.945 
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